<html lang="en" class="js"><head><link rel="preload" href="/static/fonts/HardingText-Regular-Web-cecd90984f.woff2" as="font" type="font/woff2" crossorigin=""><script async="" src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2"></script><script type="text/javascript" async="" src="https://pagead2.googlesyndication.com/tag/js/gpt.js"></script><script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-MRVXSHQ"></script><script type="text/javascript" src="https://www.nature.com/Ru9jqcigMjG7l1ZtQNr99adYEDGrBWTDsqUXdVQW7RJyKesSKtpsvoy2AQnOItzv42fvzpPknYvYI79mUPGXaw=="></script><script src="https://cmp.nature.com/production_live/en/consent-bundle-8-85.js" onload="initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')"></script>
    <title>In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial | Nature Medicine</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/nm.rss">


    
        

        <script id="save-data-connection-testing">
            function hasConnection() {
                return navigator.connection || navigator.mozConnection || navigator.webkitConnection || navigator.msConnection;
            }

            function createLink(src) {
                var preloadLink = document.createElement("link");
                preloadLink.rel = "preload";
                preloadLink.href = src;
                preloadLink.as = "font";
                preloadLink.type = "font/woff2";
                preloadLink.crossOrigin = "";
                document.head.insertBefore(preloadLink, document.head.firstChild);
            }

            var connectionDetail = {
                saveDataEnabled: false,
                slowConnection: false
            };

            var connection = hasConnection();
            if (connection) {
                connectionDetail.saveDataEnabled = connection.saveData;
                if (/\slow-2g|2g/.test(connection.effectiveType)) {
                    connectionDetail.slowConnection = true;
                }
            }

            if (!(connectionDetail.saveDataEnabled || connectionDetail.slowConnection)) {
                createLink("/static/fonts/HardingText-Regular-Web-cecd90984f.woff2");
            } else {
                document.documentElement.classList.add('save-data');
            }
        </script>
    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin="">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480">

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"genetics-research;translational-research","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Nature Medicine","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article","status":null}},"article":{"doi":"10.1038/s41591-022-01737-y"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Irina Gurevich","Pooja Agarwal","PeiPei Zhang","John A. Dolorito","Stacie Oliver","Henry Liu","Nicholas Reitze","Nikhil Sarma","Isin Sinem Bagci","Kunju Sridhar","Visesha Kakarla","Vamsi K. Yenamandra","Mark Oâ€™Malley","Marco Prisco","Sara F. Tufa","Douglas R. Keene","Andrew P. South","Suma M. Krishnan","M. Peter Marinkovich"],"publishedAt":1648425600,"publishedAtString":"2022-03-28","title":"In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Genetics research,Translational research"},"journal":{"pcode":"nm","title":"nature medicine","volume":"28","issue":"4","id":41591,"publishingModel":"Hybrid Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"BR","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card--major .c-card__title,.c-card__title,.u-h2,.u-h3,h2,h3{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.u-h3,h3{font-size:1.25rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}button{border-radius:0;cursor:pointer;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}h1{font-weight:700;-webkit-font-smoothing:antialiased;font-family:Harding,Palatino,serif;font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,.u-h3,h2{font-family:Harding,Palatino,serif;letter-spacing:-.0117156rem}.c-card--major .c-card__title,.u-h2,h2{font-weight:700;-webkit-font-smoothing:antialiased;font-size:1.5rem;line-height:1.6rem}.u-h3{font-size:1.25rem}.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h4,h5,h6{font-weight:700;-webkit-font-smoothing:antialiased;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,h3{font-family:Harding,Palatino,serif;font-size:1.25rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,h3{font-weight:700;-webkit-font-smoothing:antialiased;letter-spacing:-.0117156rem;line-height:1.4rem}.c-reading-companion__figure-title,.u-h4,h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;letter-spacing:-.0117156rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Harding,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #eee;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.c-article-recommendations-card__meta-type,.c-meta .c-meta__item:first-child{font-weight:700}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.app-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-meta{color:inherit;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-list-reset{list-style:none;margin:0;padding:0}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-nature-branded-1dd982e2cc.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href="/static/images/favicons/nature/apple-touch-icon-f39cb19454.png">
<link rel="icon" type="image/png" sizes="48x48" href="/static/images/favicons/nature/favicon-48x48-b52890008c.png">
<link rel="icon" type="image/png" sizes="32x32" href="/static/images/favicons/nature/favicon-32x32-3fe59ece92.png">
<link rel="icon" type="image/png" sizes="16x16" href="/static/images/favicons/nature/favicon-16x16-951651ab72.png">
<link rel="manifest" href="/static/manifest.json" crossorigin="use-credentials">
<link rel="mask-icon" href="/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg" color="#000000">
<link rel="shortcut icon" href="/static/images/favicons/nature/favicon.ico">
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content="/static/browserconfig.xml">
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-c8a573ca90.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-d17603b9e9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-e9d2061c95.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-1cbf3a8b56.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script><script id="js-position1" data-test="global-article-js" defer="" src="/static/js/global-article-es6-bundle-c8a573ca90.js"></script><script id="js-position2" data-test="shared-js" defer="" src="/static/js/shared-es6-bundle-e9d2061c95.js"></script><script id="js-position3" data-test="header-150-js" defer="" src="/static/js/header-150-es6-bundle-5bb959eaa1.js"></script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","description":"Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in COL7A1, the gene encoding the anchoring fibril component, collagen VII (C7). Here, we evaluated beremagene geperpavec (B-VEC), an engineered, non-replicating COL7A1 containing herpes simplex virus type 1 (HSV-1) vector, to treat RDEB skin. B-VEC restored C7 expression in RDEB keratinocytes, fibroblasts, RDEB mice and human RDEB xenografts. Subsequently, a randomized, placebo-controlled, phase 1 and 2 clinical trial (NCT03536143) evaluated matched wounds from nine RDEB patients receiving topical B-VEC or placebo repeatedly over 12â€‰weeks. No grade 2 or above B-VEC-related adverse events or vector shedding or tissue-bound skin immunoreactants were noted. HSV-1 and C7 antibodies sometimes presented at baseline or increased after B-VEC treatment without an apparent impact on safety or efficacy. Primary and secondary objectives of C7 expression, anchoring fibril assembly, wound surface area reduction, duration of wound closure, and time to wound closure following B-VEC treatment were met. A patient-reported painâ€“severity secondary outcome was not assessed given the small proportion of wounds treated. A global assessment secondary endpoint was not pursued due to redundancy with regard to other endpoints. These studies show that B-VEC is an easily administered, safely tolerated, topical molecular corrective therapy promoting wound healing in patients with RDEB. Preclinical data and results from a phase 1 and 2 trial demonstrate preliminary safety and efficacy of topical gene therapy for recessive dystrophic epidermolysis bullosa","datePublished":"2022-03-28T00:00:00Z","dateModified":"2022-03-28T00:00:00Z","pageStart":"780","pageEnd":"788","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41591-022-01737-y","keywords":["Genetics research","Translational research","Biomedicine","general","Cancer Research","Metabolic Diseases","Infectious Diseases","Molecular Medicine","Neurosciences"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig3_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig4_HTML.png"],"isPartOf":{"name":"Nature Medicine","issn":["1546-170X","1078-8956"],"volumeNumber":"28","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group US","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Irina Gurevich","url":"http://orcid.org/0000-0001-9576-0456","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Pooja Agarwal","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"PeiPei Zhang","url":"http://orcid.org/0000-0003-0918-0610","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"John A. Dolorito","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Stacie Oliver","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Henry Liu","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Nicholas Reitze","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Nikhil Sarma","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Isin Sinem Bagci","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Kunju Sridhar","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Visesha Kakarla","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Vamsi K. Yenamandra","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mark Oâ€™Malley","url":"http://orcid.org/0000-0002-5463-977X","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Marco Prisco","affiliation":[{"name":"Thomas Jefferson University","address":{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sara F. Tufa","url":"http://orcid.org/0000-0002-6447-8041","affiliation":[{"name":"Shriners Hospital for Children","address":{"name":"Microscopy Unit, Shriners Hospital for Children, Portland, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Douglas R. Keene","affiliation":[{"name":"Shriners Hospital for Children","address":{"name":"Microscopy Unit, Shriners Hospital for Children, Portland, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Andrew P. South","url":"http://orcid.org/0000-0001-7650-0835","affiliation":[{"name":"Thomas Jefferson University","address":{"name":"Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Suma M. Krishnan","affiliation":[{"name":"Krystal Biotech","address":{"name":"Krystal Biotech, Pittsburgh, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"M. Peter Marinkovich","url":"http://orcid.org/0000-0001-5528-8046","affiliation":[{"name":"Stanford University School of Medicine","address":{"name":"Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"},{"name":"Veterans Affairs Medical Center, Palo Alto","address":{"name":"Veterans Affairs Medical Center, Palo Alto, Stanford, USA","@type":"PostalAddress"},"@type":"Organization"}],"email":"mpm@stanford.edu","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41591-022-01737-y">
    
    
    <meta name="journal_id" content="41591">
    <meta name="dc.title" content="In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial">
    <meta name="dc.source" content="Nature Medicine 2022 28:4">
    <meta name="dc.format" content="text/html">
    <meta name="dc.publisher" content="Nature Publishing Group">
    <meta name="dc.date" content="2022-03-28">
    <meta name="dc.type" content="OriginalPaper">
    <meta name="dc.language" content="En">
    <meta name="dc.copyright" content="2022 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply">
    <meta name="dc.rights" content="2022 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply">
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="dc.description" content="Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in COL7A1, the gene encoding the anchoring fibril component, collagen VII (C7). Here, we evaluated beremagene geperpavec (B-VEC), an engineered, non-replicating COL7A1 containing herpes simplex virus type 1 (HSV-1) vector, to treat RDEB skin. B-VEC restored C7 expression in RDEB keratinocytes, fibroblasts, RDEB mice and human RDEB xenografts. Subsequently, a randomized, placebo-controlled, phase 1 and 2 clinical trial (NCT03536143) evaluated matched wounds from nine RDEB patients receiving topical B-VEC or placebo repeatedly over 12â€‰weeks. No grade 2 or above B-VEC-related adverse events or vector shedding or tissue-bound skin immunoreactants were noted. HSV-1 and C7 antibodies sometimes presented at baseline or increased after B-VEC treatment without an apparent impact on safety or efficacy. Primary and secondary objectives of C7 expression, anchoring fibril assembly, wound surface area reduction, duration of wound closure, and time to wound closure following B-VEC treatment were met. A patient-reported painâ€“severity secondary outcome was not assessed given the small proportion of wounds treated. A global assessment secondary endpoint was not pursued due to redundancy with regard to other endpoints. These studies show that B-VEC is an easily administered, safely tolerated, topical molecular corrective therapy promoting wound healing in patients with RDEB. Preclinical data and results from a phase 1 and 2 trial demonstrate preliminary safety and efficacy of topical gene therapy for recessive dystrophic epidermolysis bullosa">
    <meta name="prism.issn" content="1546-170X">
    <meta name="prism.publicationName" content="Nature Medicine">
    <meta name="prism.publicationDate" content="2022-03-28">
    <meta name="prism.volume" content="28">
    <meta name="prism.number" content="4">
    <meta name="prism.section" content="OriginalPaper">
    <meta name="prism.startingPage" content="780">
    <meta name="prism.endingPage" content="788">
    <meta name="prism.copyright" content="2022 This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply">
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com">
    <meta name="prism.url" content="https://www.nature.com/articles/s41591-022-01737-y">
    <meta name="prism.doi" content="doi:10.1038/s41591-022-01737-y">
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41591-022-01737-y.pdf">
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41591-022-01737-y">
    <meta name="citation_journal_title" content="Nature Medicine">
    <meta name="citation_journal_abbrev" content="Nat Med">
    <meta name="citation_publisher" content="Nature Publishing Group">
    <meta name="citation_issn" content="1546-170X">
    <meta name="citation_title" content="In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial">
    <meta name="citation_volume" content="28">
    <meta name="citation_issue" content="4">
    <meta name="citation_publication_date" content="2022/04">
    <meta name="citation_online_date" content="2022/03/28">
    <meta name="citation_firstpage" content="780">
    <meta name="citation_lastpage" content="788">
    <meta name="citation_article_type" content="Article">
    <meta name="citation_fulltext_world_readable" content="">
    <meta name="citation_language" content="en">
    <meta name="dc.identifier" content="doi:10.1038/s41591-022-01737-y">
    <meta name="DOI" content="10.1038/s41591-022-01737-y">
    <meta name="size" content="234262">
    <meta name="citation_doi" content="10.1038/s41591-022-01737-y">
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41591-022-01737-y&amp;api_key=">
    <meta name="description" content="Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in COL7A1, the gene encoding the anchoring fibril component, collagen VII (C7). Here, we evaluated beremagene geperpavec (B-VEC), an engineered, non-replicating COL7A1 containing herpes simplex virus type 1 (HSV-1) vector, to treat RDEB skin. B-VEC restored C7 expression in RDEB keratinocytes, fibroblasts, RDEB mice and human RDEB xenografts. Subsequently, a randomized, placebo-controlled, phase 1 and 2 clinical trial (NCT03536143) evaluated matched wounds from nine RDEB patients receiving topical B-VEC or placebo repeatedly over 12â€‰weeks. No grade 2 or above B-VEC-related adverse events or vector shedding or tissue-bound skin immunoreactants were noted. HSV-1 and C7 antibodies sometimes presented at baseline or increased after B-VEC treatment without an apparent impact on safety or efficacy. Primary and secondary objectives of C7 expression, anchoring fibril assembly, wound surface area reduction, duration of wound closure, and time to wound closure following B-VEC treatment were met. A patient-reported painâ€“severity secondary outcome was not assessed given the small proportion of wounds treated. A global assessment secondary endpoint was not pursued due to redundancy with regard to other endpoints. These studies show that B-VEC is an easily administered, safely tolerated, topical molecular corrective therapy promoting wound healing in patients with RDEB. Preclinical data and results from a phase 1 and 2 trial demonstrate preliminary safety and efficacy of topical gene therapy for recessive dystrophic epidermolysis bullosa">
    <meta name="dc.creator" content="Gurevich, Irina">
    <meta name="dc.creator" content="Agarwal, Pooja">
    <meta name="dc.creator" content="Zhang, PeiPei">
    <meta name="dc.creator" content="Dolorito, John A.">
    <meta name="dc.creator" content="Oliver, Stacie">
    <meta name="dc.creator" content="Liu, Henry">
    <meta name="dc.creator" content="Reitze, Nicholas">
    <meta name="dc.creator" content="Sarma, Nikhil">
    <meta name="dc.creator" content="Bagci, Isin Sinem">
    <meta name="dc.creator" content="Sridhar, Kunju">
    <meta name="dc.creator" content="Kakarla, Visesha">
    <meta name="dc.creator" content="Yenamandra, Vamsi K.">
    <meta name="dc.creator" content="Oâ€™Malley, Mark">
    <meta name="dc.creator" content="Prisco, Marco">
    <meta name="dc.creator" content="Tufa, Sara F.">
    <meta name="dc.creator" content="Keene, Douglas R.">
    <meta name="dc.creator" content="South, Andrew P.">
    <meta name="dc.creator" content="Krishnan, Suma M.">
    <meta name="dc.creator" content="Marinkovich, M. Peter">
    <meta name="dc.subject" content="Genetics research">
    <meta name="dc.subject" content="Translational research">
    <meta name="citation_reference" content="citation_journal_title=JAMA Dermatol.; citation_title=Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry; citation_author=J-D Fine; citation_volume=152; citation_publication_date=2016; citation_pages=1231-1238; citation_doi=10.1001/jamadermatol.2016.2473; citation_id=CR1">
    <meta name="citation_reference" content="citation_journal_title=J. Cell Biol.; citation_title=Laminin 5 binds the NC-1 domain of type VII collagen; citation_author=P Rousselle; citation_volume=138; citation_publication_date=1997; citation_pages=719-728; citation_doi=10.1083/jcb.138.3.719; citation_id=CR2">
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem.; citation_title=Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermalâ€“dermal adherence in human skin; citation_author=M Chen; citation_volume=272; citation_publication_date=1997; citation_pages=14516-14522; citation_doi=10.1074/jbc.272.23.14516; citation_id=CR3">
    <meta name="citation_reference" content="citation_journal_title=J. Cell Biol.; citation_title=Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain; citation_author=L Bruckner-Tuderman; citation_volume=131; citation_publication_date=1995; citation_pages=551-559; citation_doi=10.1083/jcb.131.2.551; citation_id=CR4">
    <meta name="citation_reference" content="Marinkovich, M. P. Inherited epidermolysis bullosa. In Fitzpatrickâ€™s Dermatology 9th edn (eds Kang, S. et al.) Ch. 60 (McGraw Hill Medical, 2019).">
    <meta name="citation_reference" content="citation_journal_title=Br. J. Dermatol.; citation_title=Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility; citation_author=C Has; citation_volume=183; citation_publication_date=2020; citation_pages=614-627; citation_doi=10.1111/bjd.18921; citation_id=CR6">
    <meta name="citation_reference" content="citation_journal_title=Orphanet J. Rare Dis.; citation_title=A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa; citation_author=JY Tang; citation_volume=16; citation_publication_date=2021; citation_doi=10.1186/s13023-021-01811-7; citation_id=CR7">
    <meta name="citation_reference" content="citation_journal_title=J. Invest. Dermatol.; citation_title=Gene therapy for epidermolysis bullosa; citation_author=MP Marinkovich, JY Tang; citation_volume=139; citation_publication_date=2019; citation_pages=1221-1226; citation_doi=10.1016/j.jid.2018.11.036; citation_id=CR8">
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Bone marrow transplantation for recessive dystrophic epidermolysis bullosa; citation_author=JE Wagner; citation_volume=363; citation_publication_date=2010; citation_pages=629-639; citation_doi=10.1056/NEJMoa0910501; citation_id=CR9">
    <meta name="citation_reference" content="citation_journal_title=JCI Insight; citation_title=Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa; citation_author=S Eichstadt; citation_volume=4; citation_publication_date=2019; citation_pages=e130554; citation_doi=10.1172/jci.insight.130554; citation_id=CR10">
    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa; citation_author=Z Siprashvili; citation_volume=316; citation_publication_date=2016; citation_pages=1808-1817; citation_doi=10.1001/jama.2016.15588; citation_id=CR11">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Regeneration of the entire human epidermis using transgenic stem cells; citation_author=T Hirsch; citation_volume=551; citation_publication_date=2017; citation_pages=327-332; citation_doi=10.1038/nature24487; citation_id=CR12">
    <meta name="citation_reference" content="citation_journal_title=JCI Insight; citation_title=Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa; citation_author=SM Lwin; citation_volume=4; citation_publication_date=2019; citation_pages=e126243; citation_doi=10.1172/jci.insight.126243; citation_id=CR13">
    <meta name="citation_reference" content="citation_journal_title=Nat. Biotechnol.; citation_title=Immunization via hair follicles by topical application of naked DNA to normal skin; citation_author=H Fan, Q Lin, GR Morrissey, PA Khavari; citation_volume=17; citation_publication_date=1999; citation_pages=870-872; citation_doi=10.1038/12856; citation_id=CR14">
    <meta name="citation_reference" content="citation_journal_title=Mol. Ther.; citation_title=Immune responses to viral gene therapy vectors; citation_author=JL Shirley, YP Jong, C Terhorst, RW Herzog; citation_volume=28; citation_publication_date=2020; citation_pages=709-722; citation_doi=10.1016/j.ymthe.2020.01.001; citation_id=CR15">
    <meta name="citation_reference" content="citation_journal_title=Cell. Mol. Life Sci.; citation_title=Entry of herpesviruses into mammalian cells; citation_author=EE Heldwein, C Krummenacher; citation_volume=65; citation_publication_date=2008; citation_pages=1653-1668; citation_doi=10.1007/s00018-008-7570-z; citation_id=CR16">
    <meta name="citation_reference" content="citation_journal_title=Front. Cell. Infect. Microbiol.; citation_title=Herpes simplex virus evasion of early host antiviral responses; citation_author=EI Tognarelli; citation_volume=9; citation_publication_date=2019; citation_pages=127; citation_doi=10.3389/fcimb.2019.00127; citation_id=CR17">
    <meta name="citation_reference" content="citation_journal_title=Front. Immunol.; citation_title=Innate immune evasion of alphaherpesvirus tegument proteins; citation_author=L Yang; citation_volume=10; citation_publication_date=2019; citation_pages=2196; citation_doi=10.3389/fimmu.2019.02196; citation_id=CR18">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter; citation_author=ML Oldham; citation_volume=529; citation_publication_date=2016; citation_pages=537-540; citation_doi=10.1038/nature16506; citation_id=CR19">
    <meta name="citation_reference" content="citation_journal_title=Methods Mol. Biol.; citation_title=Engineering HSV-1 vectors for gene therapy; citation_author=WF Goins; citation_volume=2060; citation_publication_date=2020; citation_pages=73-90; citation_doi=10.1007/978-1-4939-9814-2_4; citation_id=CR20">
    <meta name="citation_reference" content="citation_journal_title=Curr. Gene Ther.; citation_title=HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy; citation_author=AL Epstein, P Marconi, R Argnani, R Manservigi; citation_volume=5; citation_publication_date=2005; citation_pages=445-458; citation_doi=10.2174/156652305774329285; citation_id=CR21">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy; citation_author=A Fritsch; citation_volume=118; citation_publication_date=2008; citation_pages=1669-1679; citation_doi=10.1172/JCI34292; citation_id=CR22">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue; citation_author=S Ortiz-Urda; citation_volume=111; citation_publication_date=2003; citation_pages=251-255; citation_doi=10.1172/JCI200317193; citation_id=CR23">
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Control of somatic tissue differentiation by the long non-coding RNA TINCR; citation_author=M Kretz; citation_volume=493; citation_publication_date=2013; citation_pages=231-235; citation_doi=10.1038/nature11661; citation_id=CR24">
    <meta name="citation_reference" content="citation_journal_title=Br. J. Dermatol.; citation_title=Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy; citation_author=N Ishii; citation_volume=150; citation_publication_date=2004; citation_pages=843-851; citation_doi=10.1111/j.1365-2133.2004.05933.x; citation_id=CR25">
    <meta name="citation_reference" content="citation_journal_title=BMC Med.; citation_title=Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions; citation_author=HH Ayoub, H Chemaitelly, LJ Abu-Raddad; citation_volume=17; citation_publication_date=2019; citation_doi=10.1186/s12916-019-1285-x; citation_id=CR26">
    <meta name="citation_reference" content="citation_journal_title=J. Am. Acad. Dermatol.; citation_title=Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: a retrospective and cohort natural history study; citation_author=DC Solis; citation_volume=85; citation_publication_date=2021; citation_pages=1296-1298; citation_doi=10.1016/j.jaad.2020.08.118; citation_id=CR27">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients; citation_author=DT Woodley; citation_volume=127; citation_publication_date=2017; citation_pages=3028-3038; citation_doi=10.1172/JCI92707; citation_id=CR28">
    <meta name="citation_reference" content="citation_journal_title=J. Cell Biol.; citation_title=Type VII collagen forms an extended network of anchoring fibrils; citation_author=DR Keene, LY Sakai, GP Lunstrum, NP Morris, RE Burgeson; citation_volume=104; citation_publication_date=1987; citation_pages=611-621; citation_doi=10.1083/jcb.104.3.611; citation_id=CR29">
    <meta name="citation_reference" content="citation_journal_title=Annu. Rev. Biomed. Eng.; citation_title=Viral vectors for gene therapy: translational and clinical outlook; citation_author=MA Kotterman, TW Chalberg, DV Schaffer; citation_volume=17; citation_publication_date=2015; citation_pages=63-89; citation_doi=10.1146/annurev-bioeng-071813-104938; citation_id=CR30">
    <meta name="citation_reference" content="citation_journal_title=Mol. Genet. Metab.; citation_title=Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency; citation_author=JM Wilson; citation_volume=96; citation_publication_date=2009; citation_pages=151-157; citation_doi=10.1016/j.ymgme.2008.12.016; citation_id=CR31">
    <meta name="citation_reference" content="citation_journal_title=Curr. Gene Ther.; citation_title=Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis; citation_author=S Knight, M Collins, Y Takeuchi; citation_volume=13; citation_publication_date=2013; citation_pages=211-227; citation_doi=10.2174/1566523211313030006; citation_id=CR32">
    <meta name="citation_reference" content="citation_journal_title=J. Clin. Invest.; citation_title=Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy; citation_author=RJ Chandler; citation_volume=125; citation_publication_date=2015; citation_pages=870-880; citation_doi=10.1172/JCI79213; citation_id=CR33">
    <meta name="citation_reference" content="Gene therapy needs a long-term approach. Nat. Med. 27, 563 (2021).">
    <meta name="citation_reference" content="citation_journal_title=Sci. Transl. Med.; citation_title=APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa; citation_author=RJ Cho; citation_volume=10; citation_issue=455; citation_publication_date=2018; citation_pages=eaas9668; citation_doi=10.1126/scitranslmed.aas9668; citation_id=CR35">
    <meta name="citation_reference" content="citation_journal_title=Mol. Ther.; citation_title=Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa; citation_author=J Remington; citation_volume=17; citation_publication_date=2009; citation_pages=26-33; citation_doi=10.1038/mt.2008.234; citation_id=CR36">
    <meta name="citation_reference" content="citation_journal_title=Dev. Dyn.; citation_title=Cellular origin of the dermalâ€“epidermal basement membrane; citation_author=MP Marinkovich, DR Keene, CS Rimberg, RE Burgeson; citation_volume=197; citation_publication_date=1993; citation_pages=255-267; citation_doi=10.1002/aja.1001970404; citation_id=CR37">
    <meta name="citation_reference" content="citation_journal_title=Cell Transplant.; citation_title=Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes; citation_author=DM Supp; citation_volume=28; citation_publication_date=2019; citation_pages=1242-1256; citation_doi=10.1177/0963689719857657; citation_id=CR38">
    <meta name="citation_reference" content="citation_journal_title=Br. J. Dermatol.; citation_title=Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy; citation_author=ES Gorell, N Nguyen, Z Siprashvili, MP Marinkovich, AT Lane; citation_volume=173; citation_publication_date=2015; citation_pages=821-823; citation_doi=10.1111/bjd.13737; citation_id=CR39">
    <meta name="citation_reference" content="citation_journal_title=J. Am. Acad. Dermatol.; citation_title=Patient reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: a global cross-sectional survey; citation_author=VA Eng; citation_volume=85; citation_publication_date=2021; citation_pages=1161-1167; citation_doi=10.1016/j.jaad.2020.03.028; citation_id=CR40">
    <meta name="citation_reference" content="citation_journal_title=Ann. NY Acad. Sci.; citation_title=Making an epidermis; citation_author=MI Koster; citation_volume=1170; citation_publication_date=2009; citation_pages=7-10; citation_doi=10.1111/j.1749-6632.2009.04363.x; citation_id=CR41">
    <meta name="citation_reference" content="citation_journal_title=J. Cell Biol.; citation_title=The dermalâ€“epidermal junction of human skin contains a novel laminin variant; citation_author=MP Marinkovich, GP Lunstrum, DR Keene, RE Burgeson; citation_volume=119; citation_publication_date=1992; citation_pages=695-703; citation_doi=10.1083/jcb.119.3.695; citation_id=CR42">
    <meta name="citation_reference" content="citation_journal_title=Nat. Genet.; citation_title=Corrective gene transfer in the human skin disorder lamellar ichthyosis; citation_author=KA Choate, DA Medalie, JR Morgan, PA Khavari; citation_volume=2; citation_publication_date=1996; citation_pages=1263-1267; citation_doi=10.1038/nm1196-1263; citation_id=CR43">
    <meta name="citation_reference" content="citation_journal_title=J. Cell Biol.; citation_title=Type VII collagen is a major structural component of anchoring fibrils; citation_author=LY Sakai, DR Keene, NP Morris, RE Burgeson; citation_volume=103; citation_publication_date=1986; citation_pages=1577-1586; citation_doi=10.1083/jcb.103.4.1577; citation_id=CR44">
    <meta name="citation_author" content="Gurevich, Irina">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Agarwal, Pooja">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Zhang, PeiPei">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Dolorito, John A.">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Oliver, Stacie">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Liu, Henry">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Reitze, Nicholas">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Sarma, Nikhil">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Bagci, Isin Sinem">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Sridhar, Kunju">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Kakarla, Visesha">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Yenamandra, Vamsi K.">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author" content="Oâ€™Malley, Mark">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Prisco, Marco">
    <meta name="citation_author_institution" content="Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA">
    <meta name="citation_author" content="Tufa, Sara F.">
    <meta name="citation_author_institution" content="Microscopy Unit, Shriners Hospital for Children, Portland, USA">
    <meta name="citation_author" content="Keene, Douglas R.">
    <meta name="citation_author_institution" content="Microscopy Unit, Shriners Hospital for Children, Portland, USA">
    <meta name="citation_author" content="South, Andrew P.">
    <meta name="citation_author_institution" content="Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, USA">
    <meta name="citation_author" content="Krishnan, Suma M.">
    <meta name="citation_author_institution" content="Krystal Biotech, Pittsburgh, USA">
    <meta name="citation_author" content="Marinkovich, M. Peter">
    <meta name="citation_author_institution" content="Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, USA">
    <meta name="citation_author_institution" content="Veterans Affairs Medical Center, Palo Alto, Stanford, USA">
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access">
    <meta name="twitter:site" content="@naturemedicine">
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:image:alt" content="Content cover image">
    <meta name="twitter:title" content="In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial">
    <meta name="twitter:description" content="Nature Medicine - Preclinical data and results from a phase 1 and 2 trial demonstrate preliminary safety and efficacy of topical gene therapy for recessive dystrophic epidermolysis bullosa">
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png">
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41591-022-01737-y">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Nature">
    <meta property="og:title" content="In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial - Nature Medicine">
    <meta property="og:description" content="Preclinical data and results from a phase 1 and 2 trial demonstrate preliminary safety and efficacy of topical gene therapy for recessive dystrophic epidermolysis bullosa">
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png">
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
<style type="text/css">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}@media (min-width:680px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:16px!important;margin-right:0!important}}@media (min-width:980px){html[dir=rtl] .cc-banner__footer .cc-banner__button:not(:last-child){margin-left:24px!important;margin-right:0!important}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:"";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:"";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url("data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}html[dir=rtl] .cc-switch__input[type=checkbox]{margin-left:8px!important;margin-right:0!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:"";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;font-style:normal;font-weight:400;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:"";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url("data:image/svg+xml;base64,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");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><script async="" type="text/javascript" src="https://injections.readcube.com/nature/inject.fa744f3f.js"></script></head>
<body class="article-page"><dialog class="cc-banner" data-cc-banner="" data-nosnippet="" aria-labelledby="cc-banner-label" open="">
		<div class="cc-banner__content" autofocus="" tabindex="-1">
			<div class="cc-banner__container">
				<div class="cc-banner__header">
					<h2 class="cc-banner__title" id="cc-banner-label">Your privacy, your choice</h2>
				</div>
				<div class="cc-banner__body">
					<div class="cc-banner__policy">
						<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href="https://www.nature.com/info/privacy" data-cc-action="privacy">privacy policy</a> for more information on the use of your personal data.</p><p><button type="button" data-cc-action="preferences" class="cc-button cc-button--link cc-button--text">Manage preferences</button> for further information and to change your choices.</p>
					</div>
					
				</div>
				<div class="cc-banner__footer">
					
			<button data-cc-action="accept" class="cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept">Accept all cookies</button>
			
		
				</div>
			</div>
		</div>
	</dialog>

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90" style="display: none !important;">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1" class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide" data-ad-type="top" data-test="top-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="728x90" data-gpt-targeting="type=article;pos=top;artid=s41591-022-01737-y;doi=10.1038/s41591-022-01737-y;subjmeta=2056,308,575,692;kwrd=Genetics+research,Translational+research">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=31841965&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01737-y%26doi%3D10.1038/s41591-022-01737-y%26subjmeta%3D2056,308,575,692%26kwrd%3DGenetics+research,Translational+research">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=728x90&amp;c=31841965&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41591-022-01737-y%26doi%3D10.1038/s41591-022-01737-y%26subjmeta%3D2056,308,575,692%26kwrd%3DGenetics+research,Translational+research"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header="" data-track-component="nature-150-split-header" style="border-color:#e40428">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/nm" data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/nm/header-95e59e63930e5d6009bad2c23a42ab2d.svg" height="32" alt="Nature Medicine">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link" data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search" href="javascript:;" data-header-expander="" data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"></path></svg><span>Search</span>
                            </a><div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width has-tethered u-js-hide" data-track-component="nature-150-split-header" hidden="">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected="">All journals</option>
                                    <option value="nm">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced" data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href="https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41591-022-01737-y"><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--explore" data-track="click" data-track-action="open explore expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header" hidden="">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-articles" data-track="click" data-track-action="research articles" data-track-label="link" data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-and-analysis" data-track="click" data-track-action="reviews &amp; analysis" data-track-label="link" data-test="explore-nav-item">
                                    Reviews &amp; Analysis
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/news-and-comment" data-track="click" data-track-action="news &amp; comment" data-track-label="link" data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/podcast" data-track="click" data-track-action="podcasts" data-track-label="link" data-test="explore-nav-item">
                                    Podcasts
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/current-issue" data-track="click" data-track-action="current issue" data-track-label="link" data-test="explore-nav-item">
                                    Current issue
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/collections" data-track="click" data-track-action="collections" data-track-label="link" data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://www.facebook.com/Nature-Medicine-193691346949/" data-track="click" data-track-action="facebook" data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link" href="https://twitter.com/naturemedicine" data-track="click" data-track-action="twitter" data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id=5" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-external="" data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"></path></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="javascript:;" class="c-header__link" data-header-expander="" data-test="menu-button--about-the-journal" data-track="click" data-track-action="open about the journal expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                    </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/aims" data-track="click" data-track-action="aims &amp; scope" data-track-label="link">
                                    Aims &amp; Scope
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-information" data-track="click" data-track-action="journal information" data-track-label="link">
                                    Journal Information
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/journal-impact" data-track="click" data-track-action="journal metrics" data-track-label="link">
                                    Journal Metrics
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editors" data-track="click" data-track-action="about the editors" data-track-label="link">
                                    About the Editors
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/research-cross-journal-editorial-team" data-track="click" data-track-action="research cross-journal editorial team" data-track-label="link">
                                    Research Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/reviews-cross-journal-editorial-team" data-track="click" data-track-action="reviews cross-journal editorial team" data-track-label="link">
                                    Reviews Cross-Journal Editorial Team
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/statistics-advisory-panel" data-track="click" data-track-action="statistical advisory panel" data-track-label="link">
                                    Statistical Advisory Panel
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/our-publishing-models" data-track="click" data-track-action="our publishing models" data-track-label="link">
                                    Our publishing models
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-values-statement" data-track="click" data-track-action="editorial values statement" data-track-label="link">
                                    Editorial Values Statement
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/editorial-policies" data-track="click" data-track-action="editorial policies" data-track-label="link">
                                    Editorial Policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/content" data-track="click" data-track-action="content types" data-track-label="link">
                                    Content Types
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/web-feeds" data-track="click" data-track-action="web feeds" data-track-label="link">
                                    Web Feeds
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/contact" data-track="click" data-track-action="contact" data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="javascript:;" class="c-header__link c-header__link--dropdown-menu" data-header-expander="" data-test="menu-button--publish" data-track="click" data-track-action="open publish with us expander" data-track-label="button" role="button" aria-haspopup="true" aria-expanded="false">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"></path></svg>
                                        </a><nav class="c-header__dropdown has-tethered u-js-hide" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header" hidden="">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/submission-guidelines" data-track="click" data-track-action="submission guidelines" data-track-label="link">
                                    Submission Guidelines
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/for-reviewers" data-track="click" data-track-action="for reviewers" data-track-label="link">
                                    For Reviewers
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services" data-track="nav_language_services" data-track-context="header publish with us dropdown menu" data-track-action="manuscript author services" data-track-label="link manuscript author services" href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&amp;utm_medium=Website_Nature&amp;utm_campaign=Platform+Experimentation+2022&amp;utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" href="/nm/open-access-funding" data-test="funding-eligibility-link" data-track="click_explore_funding" data-track-context="header publish with us" data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link" href="https://mts-nmed.nature.com/cgi-bin/main.plex" data-track="click_submit_manuscript" data-track-context="submit link in Nature header dropdown menu" data-track-action="submit manuscript" data-track-label="link (publish with us dropdown menu)" data-track-external="" data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"></path></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link" href="https://journal-alerts.springernature.com/subscribe?journal_id=41591" rel="nofollow" data-track="nav_sign_up_for_alerts" data-track-action="Sign up for alerts" data-track-label="link (desktop site header)" data-track-external="">
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"></path></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link" href="https://www.nature.com/nm.rss" data-track="click" data-track-action="rss feed" data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope="" itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature medicine"><span itemprop="name">nature medicine</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link" href="/nm/articles?type=article" itemprop="item" data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="name">articles</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10" xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container" data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar u-hide" id="js-enable-context-bar" data-test="context-bar" data-context-bar="" aria-hidden="true">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01737-y.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01737-y.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Article</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2022-03-28">28 March 2022</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial</h1>
                    <ul class="c-article-author-list c-article-author-list--short js-no-scroll" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Irina-Gurevich-Aff1" data-author-popup="auth-Irina-Gurevich-Aff1" data-author-search="Gurevich, Irina" data-track-context="researcher popup with no profile" data-track-index="1_19">Irina Gurevich</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-9576-0456"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-9576-0456</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Pooja-Agarwal-Aff2" data-author-popup="auth-Pooja-Agarwal-Aff2" data-author-search="Agarwal, Pooja" data-track-context="researcher popup with no profile" data-track-index="2_19">Pooja Agarwal</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-PeiPei-Zhang-Aff2" data-author-popup="auth-PeiPei-Zhang-Aff2" data-author-search="Zhang, PeiPei" data-track-context="researcher popup with no profile" data-track-index="3_19">PeiPei Zhang</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0003-0918-0610"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-0918-0610</a></span><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-John_A_-Dolorito-Aff1" data-author-popup="auth-John_A_-Dolorito-Aff1" data-author-search="Dolorito, John A." data-track-context="researcher popup with no profile" data-track-index="4_19">John A. Dolorito</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Stacie-Oliver-Aff2" data-author-popup="auth-Stacie-Oliver-Aff2" data-author-search="Oliver, Stacie" data-track-context="researcher popup with no profile" data-track-index="5_19">Stacie Oliver</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Henry-Liu-Aff2" data-author-popup="auth-Henry-Liu-Aff2" data-author-search="Liu, Henry" data-track-context="researcher popup with no profile" data-track-index="6_19">Henry Liu</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Nicholas-Reitze-Aff2" data-author-popup="auth-Nicholas-Reitze-Aff2" data-author-search="Reitze, Nicholas" data-track-context="researcher popup with no profile" data-track-index="7_19">Nicholas Reitze</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Nikhil-Sarma-Aff2" data-author-popup="auth-Nikhil-Sarma-Aff2" data-author-search="Sarma, Nikhil" data-track-context="researcher popup with no profile" data-track-index="8_19">Nikhil Sarma</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Isin_Sinem-Bagci-Aff1" data-author-popup="auth-Isin_Sinem-Bagci-Aff1" data-author-search="Bagci, Isin Sinem" data-track-context="researcher popup with no profile" data-track-index="9_19">Isin Sinem Bagci</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Kunju-Sridhar-Aff1" data-author-popup="auth-Kunju-Sridhar-Aff1" data-author-search="Sridhar, Kunju" data-track-context="researcher popup with no profile" data-track-index="10_19">Kunju Sridhar</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Visesha-Kakarla-Aff1" data-author-popup="auth-Visesha-Kakarla-Aff1" data-author-search="Kakarla, Visesha" data-track-context="researcher popup with no profile" data-track-index="11_19">Visesha Kakarla</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Vamsi_K_-Yenamandra-Aff1" data-author-popup="auth-Vamsi_K_-Yenamandra-Aff1" data-author-search="Yenamandra, Vamsi K." data-track-context="researcher popup with no profile" data-track-index="12_19">Vamsi K. Yenamandra</a><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Mark-O_Malley-Aff2" data-author-popup="auth-Mark-O_Malley-Aff2" data-author-search="Oâ€™Malley, Mark" data-track-context="researcher popup with no profile" data-track-index="13_19">Mark Oâ€™Malley</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-5463-977X"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-5463-977X</a></span><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Marco-Prisco-Aff3" data-author-popup="auth-Marco-Prisco-Aff3" data-author-search="Prisco, Marco" data-track-context="researcher popup with no profile" data-track-index="14_19">Marco Prisco</a><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Sara_F_-Tufa-Aff4" data-author-popup="auth-Sara_F_-Tufa-Aff4" data-author-search="Tufa, Sara F." data-track-context="researcher popup with no profile" data-track-index="15_19">Sara F. Tufa</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0002-6447-8041"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0002-6447-8041</a></span><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Douglas_R_-Keene-Aff4" data-author-popup="auth-Douglas_R_-Keene-Aff4" data-author-search="Keene, Douglas R." data-track-context="researcher popup with no profile" data-track-index="16_19">Douglas R. Keene</a><sup class="u-js-hide"><a href="#Aff4" tabindex="-1">4</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Andrew_P_-South-Aff3" data-author-popup="auth-Andrew_P_-South-Aff3" data-author-search="South, Andrew P." data-track-context="researcher popup with no profile" data-track-index="17_19">Andrew P. South</a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-7650-0835"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-7650-0835</a></span><sup class="u-js-hide"><a href="#Aff3" tabindex="-1">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Suma_M_-Krishnan-Aff2" data-author-popup="auth-Suma_M_-Krishnan-Aff2" data-author-search="Krishnan, Suma M." data-track-context="researcher popup with no profile" data-track-index="18_19">Suma M. Krishnan</a><sup class="u-js-hide"><a href="#Aff2" tabindex="-1">2</a></sup> &amp; </li><li class="c-article-author-list__show-more" aria-label="Show all 19 authors for this article" title="Show all 19 authors for this article">â€¦</li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-M__Peter-Marinkovich-Aff1-Aff5" data-author-popup="auth-M__Peter-Marinkovich-Aff1-Aff5" data-author-search="Marinkovich, M. Peter" data-corresp-id="c1" data-track-context="researcher popup with no profile" data-track-index="19_19">M. Peter Marinkovich<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide">&nbsp;
            <a class="js-orcid" href="http://orcid.org/0000-0001-5528-8046"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-5528-8046</a></span><sup class="u-js-hide"><a href="#Aff1" tabindex="-1">1</a>,<a href="#Aff5" tabindex="-1">5</a></sup>&nbsp;</li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/nm" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Nature Medicine</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span>&nbsp;28</b>,&nbsp;<span class="u-visually-hidden">pages </span>780â€“788 (<span data-test="article-publication-year">2022</span>)<a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">46k <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                    <li class="c-article-metrics-bar__item" data-test="citation-count">
                        <p class="c-article-metrics-bar__count">109 <span class="c-article-metrics-bar__label">Citations</span></p>
                    </li>
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">544 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/s41591-022-01737-y/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    
                    
                </header>

                
    

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Recessive dystrophic epidermolysis bullosa (RDEB) is a lifelong genodermatosis associated with blistering, wounding, and scarring caused by mutations in <i>COL7A1</i>, the gene encoding the anchoring fibril component, collagen VII (C7). Here, we evaluated beremagene geperpavec (B-VEC), an engineered, non-replicating <i>COL7A1</i> containing herpes simplex virus type 1 (HSV-1) vector, to treat RDEB skin. B-VEC restored C7 expression in RDEB keratinocytes, fibroblasts, RDEB mice and human RDEB xenografts. Subsequently, a randomized, placebo-controlled, phase 1 and 2 clinical trial (NCT03536143) evaluated matched wounds from nine RDEB patients receiving topical B-VEC or placebo repeatedly over 12â€‰weeks. No grade 2 or above B-VEC-related adverse events or vector shedding or tissue-bound skin immunoreactants were noted. HSV-1 and C7 antibodies sometimes presented at baseline or increased after B-VEC treatment without an apparent impact on safety or efficacy. Primary and secondary objectives of C7 expression, anchoring fibril assembly, wound surface area reduction, duration of wound closure, and time to wound closure following B-VEC treatment were met. A patient-reported painâ€“severity secondary outcome was not assessed given the small proportion of wounds treated. A global assessment secondary endpoint was not pursued due to redundancy with regard to other endpoints. These studies show that B-VEC is an easily administered, safely tolerated, topical molecular corrective therapy promoting wound healing in patients with RDEB.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-024-67398-8/MediaObjects/41598_2024_67398_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41598-024-67398-8?fromPaywallRec=false" data-track="select_recommendations_1" data-track-context="inline recommendations" data-track-action="click recommendations inline - 1" data-track-label="10.1038/s41598-024-67398-8">Identification of novel small molecule-based strategies of COL7A1 upregulation and readthrough activity for the treatment of recessive dystrophic epidermolysis bullosa
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">16 August 2024</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41572-020-0210-0/MediaObjects/41572_2020_210_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41572-020-0210-0?fromPaywallRec=false" data-track="select_recommendations_2" data-track-context="inline recommendations" data-track-action="click recommendations inline - 2" data-track-label="10.1038/s41572-020-0210-0">Epidermolysis bullosa
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                        
                                         <span class="c-article-meta-recommendations__date">24 September 2020</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope="" itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41467-024-49400-z/MediaObjects/41467_2024_49400_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link" itemprop="url" href="https://www.nature.com/articles/s41467-024-49400-z?fromPaywallRec=false" data-track="select_recommendations_3" data-track-context="inline recommendations" data-track-action="click recommendations inline - 3" data-track-label="10.1038/s41467-024-49400-z">A scalable and cGMP-compatible autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">11 July 2024</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1749519835,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Main"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Main</h2><div class="c-article-section__content" id="Sec1-content"><p>Recessive dystrophic epidermolysis bullosa (RDEB) is a devastating rare genetic skin disease with a prevalence of 1.35 per million in the United States<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Fine, J.-D. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatol. 152, 1231â€“1238 (2016)." href="/articles/s41591-022-01737-y#ref-CR1" id="ref-link-section-d68921275e640">1</a></sup>. RDEB is caused by mutations in <i>COL7A1</i>, the gene encoding collagen VII (C7), which is assembled into anchoring fibrils (AFs), the basement membrane structures that anchor the epidermis and dermis together. C7 contains two essential non-collagenous (NC) domains: NC1, which inserts AFs into the basement membrane<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Rousselle, P. et al. Laminin 5 binds the NC-1 domain of type VII collagen. J. Cell Biol. 138, 719â€“728 (1997)." href="/articles/s41591-022-01737-y#ref-CR2" id="ref-link-section-d68921275e647">2</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Chen, M. et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermalâ€“dermal adherence in human skin. J. Biol. Chem. 272, 14516â€“14522 (1997)." href="/articles/s41591-022-01737-y#ref-CR3" id="ref-link-section-d68921275e650">3</a></sup>, and NC2, which promotes AF assembly<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Bruckner-Tuderman, L. et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. J. Cell Biol. 131, 551â€“559 (1995)." href="/articles/s41591-022-01737-y#ref-CR4" id="ref-link-section-d68921275e654">4</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Marinkovich, M. P. Inherited epidermolysis bullosa. In Fitzpatrickâ€™s Dermatology 9th edn (eds Kang, S. et al.) Ch. 60 (McGraw Hill Medical, 2019)." href="/articles/s41591-022-01737-y#ref-CR5" id="ref-link-section-d68921275e657">5</a></sup>. C7 defects impair dermalâ€“epidermal cohesion and produce lifelong widespread painful blistering and fibrosis starting at birth, accompanied by scarring, susceptibility to infection and a predisposition to skin cancer<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Marinkovich, M. P. Inherited epidermolysis bullosa. In Fitzpatrickâ€™s Dermatology 9th edn (eds Kang, S. et al.) Ch. 60 (McGraw Hill Medical, 2019)." href="/articles/s41591-022-01737-y#ref-CR5" id="ref-link-section-d68921275e661">5</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. 183, 614â€“627 (2020)." href="/articles/s41591-022-01737-y#ref-CR6" id="ref-link-section-d68921275e664">6</a></sup>. This disease is extremely burdensome to patients<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Tang, J. Y. et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet J. Rare Dis. 16, 175 (2021)." href="/articles/s41591-022-01737-y#ref-CR7" id="ref-link-section-d68921275e669">7</a></sup>, however, no approved corrective therapies for RDEB currently exist.</p><p>A number of earlier C7 replacement strategies have been evaluated for RDEB<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Marinkovich, M. P. &amp; Tang, J. Y. Gene therapy for epidermolysis bullosa. J. Invest. Dermatol. 139, 1221â€“1226 (2019)." href="/articles/s41591-022-01737-y#ref-CR8" id="ref-link-section-d68921275e676">8</a></sup>. The first approach, bone marrow transplantation, promoted C7 expression and wound healing; however, long-term results remain unclear and the procedure is associated with a mortality rate approaching 30% <sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Wagner, J. E. et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N. Engl. J. Med. 363, 629â€“639 (2010)." href="/articles/s41591-022-01737-y#ref-CR9" id="ref-link-section-d68921275e680">9</a></sup>. Another earlier approach, graft placement of ex vivo <i>COL7A1</i> retrovirally modified autologous keratinocytes, promoted C7 expression and durable wound healing in RDEB skin, however, this varied from patient to patient and slowly declined over time<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Eichstadt, S. et al. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight 4, e130554 (2019)." href="/articles/s41591-022-01737-y#ref-CR10" id="ref-link-section-d68921275e687">10</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e690">11</a></sup>. A similar autologous keratinocyte ex vivo approach was used to promote laminin-332 expression and wound healing in junctional epidermolysis bullosa skin using a <i>LAMB3</i> retroviral vector<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature 551, 327â€“332 (2017)." href="/articles/s41591-022-01737-y#ref-CR12" id="ref-link-section-d68921275e698">12</a></sup>. Grafts in these studies required general anesthesia, a specialized surgical team for graft placement, and postoperative graft immobilization procedures ranging from a 1â€‰week hospitalization for <i>COL7A1</i> RDEB grafts<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e705">11</a></sup> to induction of prolonged coma in an isolation chamber for <i>LAMB3</i> junctional epidermolysis bullosa grafts<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature 551, 327â€“332 (2017)." href="/articles/s41591-022-01737-y#ref-CR12" id="ref-link-section-d68921275e712">12</a></sup>. Transfer of ex vivo lentiviral-modified <i>COL7A1</i>-expressing RDEB fibroblasts to the skin of patients with RDEB has also been studied<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight 4, e126243 (2019)." href="/articles/s41591-022-01737-y#ref-CR13" id="ref-link-section-d68921275e720">13</a></sup>. This approach does not require skin grafting and instead injects genetically modified fibroblasts directly into the skin. However, as in the other ex vivo cell engineering approaches, this technique still requires collection of skin tissue followed by resource-intensive cell engineering and expansion at specialized manufacturing centers<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="#ref-CR11" id="ref-link-section-d68921275e724">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature 551, 327â€“332 (2017)." href="#ref-CR12" id="ref-link-section-d68921275e724_1">12</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight 4, e126243 (2019)." href="/articles/s41591-022-01737-y#ref-CR13" id="ref-link-section-d68921275e727">13</a></sup>.</p><p>Correction of genetic skin diseases via direct gene transfer in vivo has been a longstanding yet unrealized goal in the gene therapy field. Previous attempts at naked DNA skin transfer have proven insufficient for disease correction<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Fan, H., Lin, Q., Morrissey, G. R. &amp; Khavari, P. A. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat. Biotechnol. 17, 870â€“872 (1999)." href="/articles/s41591-022-01737-y#ref-CR14" id="ref-link-section-d68921275e734">14</a></sup>. Although viral vectors augment in vivo gene transfer efficiency, undesired immune reactions often result, especially upon repeat treatment<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Shirley, J. L., de Jong, Y. P., Terhorst, C. &amp; Herzog, R. W. Immune responses to viral gene therapy vectors. Mol. Ther. 28, 709â€“722 (2020)." href="/articles/s41591-022-01737-y#ref-CR15" id="ref-link-section-d68921275e738">15</a></sup>. Herpes simplex virus type 1 (HSV-1) vectors, in contrast, both efficiently infect cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Heldwein, E. E. &amp; Krummenacher, C. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 65, 1653â€“1668 (2008)." href="/articles/s41591-022-01737-y#ref-CR16" id="ref-link-section-d68921275e742">16</a></sup> and resist immune clearance<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Tognarelli, E. I. et al. Herpes simplex virus evasion of early host antiviral responses. Front. Cell. Infect. Microbiol. 9, 127 (2019)." href="/articles/s41591-022-01737-y#ref-CR17" id="ref-link-section-d68921275e746">17</a></sup>, which is partially explained by the innate immune-evasive properties of HSV tegument proteins<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Yang, L. et al. Innate immune evasion of alphaherpesvirus tegument proteins. Front. Immunol. 10, 2196 (2019)." href="/articles/s41591-022-01737-y#ref-CR18" id="ref-link-section-d68921275e750">18</a></sup> and evidence suggesting that HSV-1 infected cell protein 47 (ICP47) directly inhibits the transporter associated with antigen processing<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Oldham, M. L. et al. A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter. Nature 529, 537â€“540 (2016)." href="/articles/s41591-022-01737-y#ref-CR19" id="ref-link-section-d68921275e755">19</a></sup>. Natural immune-evading functions coupled with deletion of pro-inflammatory genes from the HSV-1 vector backbone<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Goins, W. F. et al. Engineering HSV-1 vectors for gene therapy. Methods Mol. Biol. 2060, 73â€“90 (2020)." href="/articles/s41591-022-01737-y#ref-CR20" id="ref-link-section-d68921275e759">20</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Epstein, A. L., Marconi, P., Argnani, R. &amp; Manservigi, R. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Curr. Gene Ther. 5, 445â€“458 (2005)." href="/articles/s41591-022-01737-y#ref-CR21" id="ref-link-section-d68921275e762">21</a></sup> make newer generation modified HSV-1 vectors especially well-suited for gene therapy.</p><p>The large ~9â€‰kb <i>COL7A1</i> transgene needed for RDEB skin correction poses additional challenges for vector engineering. Beyond the capacity of most viral vectors, including adenoviruses and adeno-associated viruses, <i>COL7A1</i> can only be functionally expressed in lentiviral and retroviral vectors after extensive vector modifications<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e775">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight 4, e126243 (2019)." href="/articles/s41591-022-01737-y#ref-CR13" id="ref-link-section-d68921275e778">13</a></sup>. HSV-1 viruses, in contrast, have transgene payload capacities exceeding 30â€‰kb. Because they are non-integrating and episomal, HSV-1 vectors do not pose any insertional mutagenesis risk. In total, these properties make HSV-1 vectors particularly suitable for in vivo direct gene transfer.</p><p>We describe here the development and clinical translation of a topical gene therapy treatment for RDEB that can be repeatedly applied without serious adverse events. Beremagene geperpavec (B-VEC), a replication-defective HSV-1 vector containing two copies of the <i>COL7A1</i> coding sequence, efficiently restored C7 expression in RDEB keratinocytes and fibroblasts in vitro. Topical B-VEC promoted skin integrity and robust C7 expression, followed by its assembly into basement membrane-associated AFs in vivo in C7-deficient mice and primary human RDEB skin xenografts. With preclinical data providing the scientific rationale, we evaluated the clinical translation to humans in a phase 1 and 2 exploratory study, that is, the first-ever clinical trial of topical gene therapy. Taken together, we demonstrate here a novel, easy-to-administer, and highly accessible gene therapy capable of reversing genetic disease through repeated application directly to patient skin wounds.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">Restoration of C7 expression in RDEB patient cell culture</h3><p>To initially evaluate B-VEC as a cutaneous gene delivery vector, we examined its ability to promote C7 expression in primary skin cells of patients with RDEB in vitro. As seen in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1a</a>, C7-null primary RDEB patient keratinocyte and fibroblast cultures demonstrated C7 expression 48â€‰hours after B-VEC treatment. Dose-dependent increases in transduction efficiency were also demonstrated, targeting up to 100% of cells at a multiplicity of infection (MOI) of 1, 3 and 10 (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1b,c</a>), with a slowing of proliferation observed at an MOI of 10 after 48â€‰hours. Western blot analysis of primary RDEB keratinocyte and fibroblast cell lysates identified a dose-dependent increase in the expression of full-length C7 (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1d</a>). Demonstrating that C7 expression is attributable to B-VEC, the expression of the HSV-1 early protein, ICP0, closely correlated with C7 expression in vitro (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig5">1</a>). These data demonstrate that B-VEC is capable of gene delivery and expression in the specific C7-contributing cell types in patient skin.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Collagen VII (C7) expression in primary RDEB patient cells, RDEB mice, and human RDEB xenografts on immunodeficient mice following B-VEC therapy."><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1: Collagen VII (C7) expression in primary RDEB patient cells, RDEB mice, and human RDEB xenografts on immunodeficient mice following B-VEC therapy.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="886"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p><b>a</b>, RDEB keratinocytes and fibroblasts were infected in vitro with B-VEC vector at various ratios of cell to viral particle (MOI). Cells were fixed 48â€‰h after infection and analyzed by indirect immunofluorescence microscopy (IDIF) to validate C7 expression in keratinocytes (kc; yellow) and fibroblasts (fb; green). Scale bar, 100â€‰Âµm. <b>b</b>,<b>c</b>, Infection efficiency and live cell number in cultures after infection (<i>n</i>â€‰=â€‰3 for each condition). <b>d</b>, Keratinocytes and fibroblasts were collected after various MOI (<i>n</i>â€‰=â€‰3 for each condition) and analyzed by Western blot. C, control vector. <b>e</b>, Mice were injected intradermally at four separate sites on the back (one vehicle control site and three B-VEC treatment sites, one injection per site). Some mice received a second injection on day 3 at the same four sites. At day 3 after B-VEC treatment (dose of 4.6â€‰xâ€‰10<sup>7</sup>â€‰p.f.u. per 50â€‰Âµl per injection), RDEB mice injected intradermally with B-VEC vector had linear C7 basement membrane zone (BMZ) expression (yellow, dotted line) including in hair follicle basement membranes (arrows). Scale bar, 100â€‰Âµm. f, At day 7, C7 expression (yellow) was analyzed using IDIF after one or two injections in RDEB mouse skin. Scale bar, 200â€‰Âµm. <b>g</b>,<b>h</b>, <i>COL7A1</i> DNA (<b>g</b>) and C7 transcript expression levels (<b>h</b>) were analyzed using qPCR or RTâ€“qPCR, after one or two injections (dose of 4.6â€‰xâ€‰10<sup>7</sup>â€‰p.f.u. per 50â€‰Âµl per injection) in RDEB mouse skin, on day 3 and 7 after single or repeated injections (<i>n</i>â€‰=â€‰9 injections, triplicate for each condition, per timepoint). <b>i</b>, Demonstration of C7 expression dose dependency in RDEB mouse skin for low-dose injections (top row) and high-dose injections (bottom row) at days 3, 5, and 7 after injection. The far right panels show C7 expression at high and low B-VEC doses 7â€‰days after both injections. <b>j</b>, Heterozygous RDEB mice were treated with daily topical B-VEC or vehicle (PBS) applications on wounded skin for 5â€‰days. Fourteenâ€‰days after the first application, linear C7 expression using human-specific antibody is shown in yellow at the epidermalâ€“dermal junction and hair follicle epithelialâ€“dermal junctions, and co-localization with the BMZ marker Î±6 integrin staining is shown in red. The inserts in the right panels demonstrate higher magnification of the sample region. Four areas on the back were treated per mouse (1 control and 3 B-VEC) and four mice in total were tested. Scale bar, 100â€‰Âµm. <b>k</b>, Xenografts comprising human RDEB fibroblasts and keratinocytes were treated by topical B-VEC and imaged 5â€‰days later. The grafts were analyzed by light (first row) and immunofluorescence (rows 2â€“5) microscopy. Light microscopy demonstrated areas of dermalâ€“epidermal blistering (left panel, arrow), which was not seen after B-VEC treatment (right panel). In the treated region, expression of the NC1 (red) and NC2 (green) domains of C7 co-localized with the control BMZ marker laminin-332 (yellow). Row 5 demonstrates the persistence and location of human fibroblasts in the dermis of the graft. Scale bar, 100â€‰Âµm. Representative of eight grafts treated with B-VEC (mice) and 2 with placebo. <b>l</b>, Human RDEB skin xenografts were treated with topical B-VEC and analyzed after 3 and 12â€‰days using immunoelectron microscopy with C7 NC1-directed antibodies (NP185), followed by gold nanoparticles (first, third rows; white arrows), and NC2-directed primary antibodies (LH24), followed by gold nanoparticles (second, fourth rows; black arrows). Error bars on all panels represent standard error of the mean of all replicates. Representative of eight grafts treated with B-VEC and two grafts treated with placebo. Scale bars, 300â€‰nm. Data plots, including error bars and <i>P</i>â€‰values, were generated using GraphPad Prism v8.3.0.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec4">Molecular correction of C7 expression in vivo</h3><p>To evaluate in vivo B-VEC-mediated <i>COL7A1</i> gene delivery, intradermal B-VEC injections were administrated to C7-deficient mice, which closely recapitulate the RDEB skin phenotype<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Fritsch, A. et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J. Clin. Invest. 118, 1669â€“1679 (2008)." href="/articles/s41591-022-01737-y#ref-CR22" id="ref-link-section-d68921275e904">22</a></sup>. We performed three sets of experiments with the RDEB mice cohort, using three mice per cohort. Each mouse received three injections of B-VEC and one saline injection (<i>n</i>â€‰=â€‰27 B-VEC, <i>n</i>â€‰=â€‰9 saline). Some mice received a second injection on day 3 at the same four sites. At day 3 after B-VEC treatment (dose of 4.6â€‰Ã—â€‰10<sup>7</sup>â€‰p.f.u. per 50â€‰Âµl per injection), C7 protein was localized in a linear pattern (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1e</a>) at the dermalâ€“epithelial junctions of the epidermis and in hair follicles. At day 7, widespread continuous linear C7 distribution through a larger area of skin was detected (as shown by joining multiple overlapping microscopy fields by tile imaging; Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1f</a>). <i>COL7A1</i> transgene delivery and expression was detected using quantitative polymerase chain reaction with or without reverse transcription (RTâ€“qPCR or qPCR) at two time points, at 3 and 7â€‰days, after a single or two injections (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1g,h</a>). Evaluation of C7 expression kinetics (day 3, day 5, day 7) using indirect immunofluorescence microscopy (IDIF) demonstrated C7 expression in treated skin at both high doses (4.6â€‰Ã—â€‰10<sup>7</sup>â€‰p.f.u. per 50â€‰Âµl per injection) and low doses (4.6â€‰Ã—â€‰10<sup>6</sup>â€‰p.f.u. per 50â€‰Âµl per injection) of the virus (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1i</a>). Because homozygous RDEB mice are too fragile to tolerate a wounding and topical application assessment, heterozygous RDEB mouse skin was evaluated following topical application of B-VEC on wounded skin. Linear C7 expression, as detected using human-specific C7 antibodies, was observed 14â€‰days after treatment (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1j</a>).</p><p>To further evaluate the in vivo effect of B-VEC, we studied primary regenerated human C7-null RDEB skin xenografted onto immunodeficient mice, a model generally regarded as the closest preclinical approximation to human RDEB skin. Xenograft experiments were conducted in two rounds, using 10 mice in each round. Eight mice in each round were treated with B-VEC, and two mice in each round were treated with topical saline control (total grafts, <i>n</i>â€‰=â€‰16 B-VEC, <i>n</i>â€‰=â€‰4 control). Control grafts (<i>n</i>â€‰=â€‰4) had multiple areas of dermalâ€“epidermal separation (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1k</a>) not observed in xenografts following application of topical B-VEC (<i>n</i>â€‰=â€‰16). These results are in agreement with a previous study that also reported dermalâ€“epidermal separation in primary regenerated human RDEB xenografts and correction, following restoration of C7 expression due to treatment with an ex vivo cell-mediated <i>COL7A1</i> gene therapy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Ortiz-Urda, S. et al. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J. Clin. Invest. 111, 251â€“255 (2003)." href="/articles/s41591-022-01737-y#ref-CR23" id="ref-link-section-d68921275e962">23</a></sup>. Figure <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1k</a> also shows the immunofluorescence microscopy analysis of C7 expression in xenografts 5â€‰days after topical B-VEC application. RDEB xenografts infected with control vector had no C7 expression. However, B-VEC-treated xenografts had robust linear detection of both the NC1 and NC2 domains of C7, indicating full-length C7 expression<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231â€“235 (2013)." href="/articles/s41591-022-01737-y#ref-CR24" id="ref-link-section-d68921275e969">24</a></sup>.</p><p>A crucial functional test of C7 is its assembly into basement membrane zone-associated AFs, a process requiring full-length C7 molecules containing both NC1 and NC2 domains. To determine full-length C7 expression following topical B-VEC treatment in human RDEB xenografts, biopsy tissue from the treated area was processed for immunoelectron microscopy using human-specific antibodies against the NC1 and NC2 domains. C7 NC1 and NC2 expression was detected as early as 3â€‰days after B-VEC treatment and became more prominent 12â€‰days after treatment. Correct ultrastructural localization of NC1 in the lamina densa (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1l</a>) and NC2 approximately 300â€‰nm below the lamina densa (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig1">1l</a>) was noted, consistent with previous structural localization studies of C7 NC1 and NC2 domains in AFs of normal human skin<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Ishii, N. et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br. J. Dermatol. 150, 843â€“851 (2004)." href="/articles/s41591-022-01737-y#ref-CR25" id="ref-link-section-d68921275e982">25</a></sup>. Taken together, these data demonstrate B-VEC-mediated <i>COL7A1</i> gene delivery, expression, and correct ultrastructural localization of functional, full-length C7 (inclusive of both NC1 and NC2) in RDEB mouse and primary human RDEB skin xenograft models, both of which closely recapitulate the RDEB skin phenotype. Furthermore, to demonstrate that C7 expression is attributable to B-VEC in vivo, the expression of the HSV-1 early protein, ICP0, was closely correlated with C7 expression in mouse skin after B-VEC injection (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig5">1</a>). Following B-VEC treatment, in vivo co-localization of ICP0 expression with hair follicle keratinocytes, as well as dermal fibroblasts, was also noted (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig6">2</a>).</p><h3 class="c-article__sub-heading" id="Sec5">Molecular correction and treatment effect in patients with RDEB</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec6">Patients and treatment</h4><p>Preclinical in vitro and in vivo data provided the scientific rationale for the initiation of a randomized, open-label, placebo-controlled phase 1 and 2 trial of topical B-VEC for treatment of RDEB conducted in an outpatient setting at Stanford University. The phase 1 and 2 study enrolled nine adult and pediatric patients (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig2">2</a>, Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>) who had a clinical phenotype consistent with generalized RDEB<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. 183, 614â€“627 (2020)." href="/articles/s41591-022-01737-y#ref-CR6" id="ref-link-section-d68921275e1017">6</a></sup>, confirmed <i>COL7A1</i> gene mutations, reduced C7 NC1, and absent C7 NC2 protein expression and absent AFs as assessed with immunofluorescence and immunoelectron microscopy. Baseline wound surface area ranged from 0.89 to 65.29â€‰cm<sup>2</sup> (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab4">2</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Trial profile."><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2: Trial profile.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="604"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>The safety population was evaluated considering an individual systemic patient response being the independent event (<i>n</i>â€‰=â€‰9 patients). The efficacy assessments and analyses were conducted considering an individual wound response as the independent event (<i>n</i>â€‰=â€‰28 wounds treated with B-VEC or placebo in the efficacy evaluable population: 18 B-VEC-treated wounds, 10 placebo-treated wounds). Responder analysis included patient wounds observed at weeks 8, 10 and 12 (21 wounds). <sup>a</sup>Nine individuals of whom three participated in both 2a and 2b. One of nine individuals dropped out 30â€‰days after initial dosing due to inability to travel. <sup>b</sup>Intra-patient wound randomization: phase 1, 1:1; phase 2a, 2b, 2:1.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec7">Safety</h4><p>No deaths, serious or significant adverse events were reported (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab5">3</a>). Of 129 topical B-VEC doses given in the trial, 21 adverse events were reported. One adverse event was moderate and was deemed unlikely to be related to the investigational product by the principal investigator. The remaining adverse events were mild: 13 adverse events were deemed unrelated to the investigational product, one was deemed unlikely to be related, four were reported as possibly related (fever, peculiar taste, rash, itching) and two were reported as probably related (application site discharge). All adverse events resolved during the study and none necessitated the reduction of B-VEC dosing or frequency. No vector shedding was reported (Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">1</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">2</a>). Increased inflammation above and beyond what would be expected during normal wound healing was not seen in any of the B-VEC-treated wounds during any of the patient visits.</p><p>The HSV-1 serology status of the study patients was in line with the HSV-1 seropositivity rate of the US population (&gt;50%)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Ayoub, H. H., Chemaitelly, H. &amp; Abu-Raddad, L. J. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 17, 57 (2019)." href="/articles/s41591-022-01737-y#ref-CR26" id="ref-link-section-d68921275e1080">26</a></sup>. HSV-1 antibodies, when present, were detected at variable levels before and after B-VEC treatment (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig8">4</a>) and did not affect the efficacy or safety. Some patients had baseline C7 antibodies (patients 2, 5) and some C7 ELISA titers increased after treatment (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig8">4</a>); however, no tissue-bound skin immunoreactants were noted on immunofluorescence microscopy. The serum of patient 2 was subsequently found to be C7 antibody negative nearly 28â€‰months later. Patient 12 had no C7 immunogenicity, despite having the greatest B-VEC exposure (8â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per dose every 1â€“2â€‰days for two 25â€‰day treatment cycles).</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec8">Findings following intervention</h4><p>Images of all wounds studied in patients 1â€“11 are shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3</a>, both at baseline and at 3â€‰months after treatment with B-VEC or placebo. Closure in the B-VEC group was achieved in all wounds after 3â€‰months, with the exception of a chronic (5â€‰year) dorsal foot wound in patient 3. This wound had partial closure within 1â€‰month of B-VEC treatment (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3</a>; patient 3, wound 3), and complete closure upon re-treatment (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3</a>; patient 11, wound 3). This wound remained healed throughout monitoring (8â€‰months), highlighting the continued B-VEC effectiveness following repeated application. All other B-VEC-treated study wounds closed and remained healed for at least 3â€‰months, while placebo wounds demonstrated a fluctuation of healing and re-blistering (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3</a>). No healing rate differences were noted with respect to patient age or sex, B-VEC dosage or rates of application.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Assessment of RDEB patient skin wound healing following topical B-VEC or placebo."><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3: Assessment of RDEB patient skin wound healing following topical B-VEC or placebo.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/3" rel="nofollow"><picture><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="908"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p><b>a</b>,<b>b</b> Photos of B-VEC treated wounds (<b>a</b>) or placebo-treated wounds (<b>b</b>) on the indicated patients at baseline (before therapy) and at approximately 3â€‰months after treatment. <b>c</b>, Mean percent change from baseline in the area of all target wounds, in patients 1â€“11 over the 12â€‰week treatment period. KB103, B-VEC. <i>P</i>â€‰value was determined using the Wilcoxon rank-sum test. d, number of days from the start of therapy; p, patient number; w, wound number.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Wound closure analyses are given in Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab1">1</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab6">4</a>. Results and analysis reported are based upon observed data without imputed values for missing data. B-VEC-treated wounds were statistically significantly different from placebo wounds (<i>P</i>â€‰=â€‰0.0026) based upon wound closure responder analysis; however, on both time to and duration of wound closure, the trend was numerically favorable towards B-VEC (Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab1">1</a>). This observed treatment effect in B-VEC-treated wounds compared with the placebo control is suggestive of improved wound healing. Taken together with the evidence for molecular correction demonstrated in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4</a>, this observed treatment effect suggests that, attributable to the expression of full-length C7, topical application of B-VEC improves RDEB wound healing, specifically, in the clinically meaningful terms of complete wound closure, time to wound closure and durability of wound closure.</p><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Table 1 Summary of wound closure analyses</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="C7 expression and AF formation after B-VEC topical therapy."><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 4: C7 expression and AF formation after B-VEC topical therapy.</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/4" rel="nofollow"><picture><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="888"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p><b>a</b>, Indirect immunofluorescence analysis of C7 NC1 and NC2 expression in topical B-VEC-treated patient skin. In a subset of seven patients (Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">3</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">4</a>), biopsies from intact B-VEC-treated skin were evaluated for C7 NC1 and NC2 expression. Representative images are shown from patients (P) 9 and 10 (collected on the indicated days (D)). These were analyzed using dual label immunofluorescence for expression of the C7 NC1 and NC2 domains using anti-NC1 antisera (red) and an anti-NC2 monoclonal antibody, LH24 (green), and counterstained with nuclear stain (blue). The arrows indicate the dermalâ€“epidermal junction. <b>b</b>, Extended examination of C7 NC2 expression across an entire tissue section of topical B-VEC-treated patient skin. Multiple sections of a skin biopsy taken from a healed wound area 15â€‰days after treatment with topical B-VEC were analyzed using immunofluorescence and tiled together to show the results across the entire tissue section. <b>c</b>, Immunoelectron microscopy<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Keene, D. R., Sakai, L. Y., Lunstrum, G. P., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen forms an extended network of anchoring fibrils. J. Cell Biol. 104, 611â€“621 (1987)." href="/articles/s41591-022-01737-y#ref-CR29" id="ref-link-section-d68921275e1605">29</a></sup> of C7 NC1 and NC2 expression and AFs in B-VEC-treated patient skin. Representative images are shown from patient 10 (collected at the indicated times) and were analyzed with immunoelectron microscopy using antibodies to the C7 NC1 domain (NP185) and C7 NC2 domain (LH24). (C7 NC1 and NC2 expression was assessed in patients whose specimens were amenable to immunoelectron microscopy analysis (<i>n</i>â€‰=â€‰3; Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">4</a>.) The arrow in the upper panel and center panel shows positive immuno-gold staining for the NC1 domain in the lamina densa region. Arrows in the lower two panels show the presence of mature banded AFs associated with immuno-gold staining for the NC2 domain approximately 300â€‰nm from the lamina densa. Scale bars, 500â€‰nm.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41591-022-01737-y/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>To further support these results, the mean percent change from baseline in wound surface area was analyzed (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3c</a>). Comparisons used the Wilcoxon rank-sum test to demonstrate that the treatment effect of reduction in wound area is statistically significant (<i>P</i>â€‰&lt;â€‰0.025) at weeks 8, 10 and 12.</p><p>To validate wound closure assessments, 90â€‰day wound images were evaluated by two blinded independent reviewers. Comparison of the unblinded principal investigator image assessments to this blinded review demonstrated 100% concordance.</p><p>Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab1">1</a> presents the analysis of time to and duration of wound closure using the Kaplanâ€“Meier method. Time to wound closure was defined as the time from the first treatment to complete wound closure (defined as a â‰¥95% reduction in wound surface from baseline for 2 consecutive weeks). Duration of wound closure was defined as the time from complete closure to the first re-opening. Compared with placebo, B-VEC-treated wounds demonstrated a numerical trend of shorter time to wound closure and longer wound closure duration.</p><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-2"><figure><figcaption class="c-article-table__figcaption"><b id="Tab2" data-test="table-caption">Table 2 Baseline characteristics of the study patients</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/2" aria-label="Full size table 2"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Characteristic of RDEB wounds, placebo-treated wounds fluctuated between natural open and healed states<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Solis, D. C. et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: a retrospective and cohort natural history study. J. Am. Acad. Dermatol. 85, 1296â€“1298 (2021)." href="/articles/s41591-022-01737-y#ref-CR27" id="ref-link-section-d68921275e2413">27</a></sup>, while B-VEC-treated wounds remained durably and consistently closed (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3</a>). This wound closure durability is supportive of the effectiveness of B-VEC in promoting dermalâ€“epidermal cohesion. Resistance to blister extension into a B-VEC-treated wound area is shown in Supplementary Videos <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM3">1</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM4">2</a>, supportive of the effectiveness of B-VEC in promoting dermalâ€“epidermal cohesion.</p><p>Patient 12 was a 10-year-old boy who enrolled late in the study with large right and left lateral chronic (4â€‰years) chest wounds that were much larger than those observed in the other patients. For that reason, his wound analysis was completed separately from the other patients (Extended Data Figs. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig9">5</a>, <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig10">6</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab4">2</a>). He completed two 25â€‰day cycles of topical B-VEC (8â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per dose) every 1â€“2â€‰days on his left chest (placebo on right chest) (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab4">2</a>). Wound images 1â€‰year prior to baseline, at baseline, and at 1â€‰month after the last treatment are shown in Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig9">5</a>. By the end of the treatment, the B-VEC-treated wound was reduced by 70% from baseline whereas the placebo-treated wound had reduced by only 34% (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig10">6</a>).</p><p>In a subset of seven patients (Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">3</a> and <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">4</a>), biopsies from intact B-VEC-treated skin were evaluated for percent C7 NC1/NC2 expression compared with unaffected human skin (non-RDEB) using immunofluorescence and for AFs using immunoelectron microscopy, as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Fritsch, A. et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J. Clin. Invest. 118, 1669â€“1679 (2008)." href="/articles/s41591-022-01737-y#ref-CR22" id="ref-link-section-d68921275e2459">22</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Woodley, D. T. et al. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. J. Clin. Invest. 127, 3028â€“3038 (2017)." href="/articles/s41591-022-01737-y#ref-CR28" id="ref-link-section-d68921275e2462">28</a></sup>. Some C7 NC1 and NC2 expression variability was noted in these post-treatment biopsies (Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">3</a>). However, most healed samples from this subset of seven patients had positive linear deposition indicative of full-length C7 expression as seen in representative images from patients 9 (day 15) and 10 (days 15 and 97) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4a</a>). NC2 expression in patient 10 on treatment day 15 was further analyzed by tiling multiple fields together to demonstrate continuous linear expression across the entire tissue section (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4b</a>).</p><p>All patients who had biopsies prior to treatment had a lack of AFs at baseline (Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab2">2</a>). Following B-VEC treatment, immunoelectron microscopy analysis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="Keene, D. R., Sakai, L. Y., Lunstrum, G. P., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen forms an extended network of anchoring fibrils. J. Cell Biol. 104, 611â€“621 (1987)." href="/articles/s41591-022-01737-y#ref-CR29" id="ref-link-section-d68921275e2482">29</a></sup> showed C7 NC1 and NC2 expression and mature AFs (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4c</a> and Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">4</a>) in patients whose specimens were amenable to immunoelectron microscopy analysis (<i>n</i>â€‰=â€‰3). As shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4c</a>, patient 10 lacked AFs and C7 NC2 staining, and had reduced C7 NC1 expression at baseline. Healed skin at treatment day 97 demonstrated increased C7 NC1 lamina densa localization and prominent C7 NC2 localization approximately 300â€‰nm below the lamina densa (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig4">4c</a>), consistent with localization in normal skin<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Ishii, N. et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br. J. Dermatol. 150, 843â€“851 (2004)." href="/articles/s41591-022-01737-y#ref-CR25" id="ref-link-section-d68921275e2502">25</a></sup>. These patient immunofluorescence and immunoelectron microscopy data suggest that B-VEC-mediated <i>COL7A1</i> gene delivery targets the proper cells and directs the expression of functional, full-length C7 (inclusive of both NC1 and NC2) at the correct location in the dermalâ€“epidermal basement membrane. Providing even further evidence for expression of functional C7 and molecular correction, B-VEC-mediated <i>COL7A1</i> gene delivery promoted assembly of mature AFs.</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec9-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec9">Discussion</h2><div class="c-article-section__content" id="Sec9-content"><p>Direct topical in vivo gene transfer with B-VEC fulfills a longstanding goal of direct in vivo gene therapy to the skin. The ability of B-VEC to be shipped off the shelf, applied topically in a local outpatient setting and repeatedly dosed on demand offers a number of advantages over earlier ex vivo approaches. These include eliminating the need for long-distance travel by fragile-skinned RDEB patients to specialized medical centers, making gene therapy accessible to patients who do not have access to specialized medical facilities, such as those living in underdeveloped countries. B-VEC therapy does not require patient biopsies for autologous cell engineering, nor does it require anesthesia or hospitalization. Instead, in vivo B-VEC topical gene therapy can be applied during routine dressing changes, minimizing any additional trauma and maximizing convenience to the patient.</p><p>Inflammation following in vivo treatment with gene therapy vectors has been a longstanding problem in the gene therapy field<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Kotterman, M. A., Chalberg, T. W. &amp; Schaffer, D. V. Viral vectors for gene therapy: translational and clinical outlook. Annu. Rev. Biomed. Eng. 17, 63â€“89 (2015)." href="/articles/s41591-022-01737-y#ref-CR30" id="ref-link-section-d68921275e2525">30</a></sup>. The most well-known example of this involved a patient fatality following the use of an adenoviral vector for the treatment of ornithine transcarbamylase deficiency<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Wilson, J. M. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol. Genet. Metab. 96, 151â€“157 (2009)." href="/articles/s41591-022-01737-y#ref-CR31" id="ref-link-section-d68921275e2529">31</a></sup>, in which the adenoviral vector activated innate immune responses and caused the acute release of inflammatory cytokines. The development of less immunogenic vectors such as adeno-associated virus and lentivirus has decreased but not eliminated inflammation, and repeated application of these vectors in vivo still usually requires concomitant systemic steroids. By contrast to previous in vivo studies, repeated topical application of B-VEC was not associated with any serious or significant adverse events. The natural immune-evasive properties of HSV-1, coupled with deletions in the immediate-early gene<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Goins, W. F. et al. Engineering HSV-1 vectors for gene therapy. Methods Mol. Biol. 2060, 73â€“90 (2020)." href="/articles/s41591-022-01737-y#ref-CR20" id="ref-link-section-d68921275e2533">20</a></sup>, may explain the lack of inflammation associated with B-VEC and the lack of requirement for concomitant steroid or other anti-inflammatory medications, even after repeat applications. It may also explain why patient HSV-1 seropositivity has no discernible association with B-VEC efficacy. A previous ex vivo RDEB gene therapy study noted that circulating C7 antibodies did not interfere with C7 expression or wound healing and that the results of a C7-specific cytotoxic Tâ€‰cell assay were negative<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Eichstadt, S. et al. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight 4, e130554 (2019)." href="/articles/s41591-022-01737-y#ref-CR10" id="ref-link-section-d68921275e2537">10</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2540">11</a></sup>. Similarly, in our clinical study patient 3â€™s wounds remained closed following B-VEC dosing, despite the presence of C7 antibodies, suggesting their lack of impact on B-VEC-mediated treatment efficacy.</p><p>Previous ex vivo cutaneous gene therapy trials limited retroviral exposure to cultured patient cells in vitro as a safety requirement<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2547">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature 551, 327â€“332 (2017)." href="/articles/s41591-022-01737-y#ref-CR12" id="ref-link-section-d68921275e2550">12</a></sup>, given that random gene integration triggered cancers in some trials<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Knight, S., Collins, M. &amp; Takeuchi, Y. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. Curr. Gene Ther. 13, 211â€“227 (2013)." href="/articles/s41591-022-01737-y#ref-CR32" id="ref-link-section-d68921275e2554">32</a></sup>. Although ex vivo retroviral gene transfer reduces systemic cancer risk, it does not eliminate oncogenic potential in transgene-expressing grafts, which is why these trials require long-term cancer surveillance<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Knight, S., Collins, M. &amp; Takeuchi, Y. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. Curr. Gene Ther. 13, 211â€“227 (2013)." href="/articles/s41591-022-01737-y#ref-CR32" id="ref-link-section-d68921275e2558">32</a></sup>. Although adeno-associated virus is believed to involve less insertional mutagenesis risk<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Chandler, R. J. et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. J. Clin. Invest. 125, 870â€“880 (2015)." href="/articles/s41591-022-01737-y#ref-CR33" id="ref-link-section-d68921275e2562">33</a></sup>, the recent development of cancer in two patients on a lentivirus-mediated sickle cell disease trial has raised additional lentivirus cancer safety concerns<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Gene therapy needs a long-term approach. Nat. Med. 27, 563 (2021)." href="/articles/s41591-022-01737-y#ref-CR34" id="ref-link-section-d68921275e2566">34</a></sup>. HSV-1 vectors such as B-VEC, by contrast, are episomal and non-integrating, eliminating insertional oncogenesis risk.</p><p>B-VEC therapy may reduce cancer risk via mechanisms independent of insertional oncogenesis. Lethal squamous cell carcinoma, a devastating RDEB complication, arises from chronic wounding, inflammation and fibrosis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Cho, R. J. et al. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Sci. Transl. Med. 10(455), eaas9668 (2018)." href="/articles/s41591-022-01737-y#ref-CR35" id="ref-link-section-d68921275e2573">35</a></sup>. Any C7 replacement therapy, such as topical B-VEC, if implemented early in the wounding process, has the potential to halt wound chronicity and fibrosis, which in turn could reduce lethal squamous cell carcinoma development, one of the most devastating complications in severe RDEB patients. Thus B-VEC therapy may not only improve but also prolong the lives of patients with RDEB. Further studies are needed to address this.</p><p>B-VEC treatment promoted molecular correction of RDEB skin concurrent with durable wound closure for 3â€‰months or longer. In this study, wound healing durability and resistance to blistering was potentially aided by the long half-life of C7 in human skin<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Remington, J. et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol. Ther. 17, 26â€“33 (2009)." href="/articles/s41591-022-01737-y#ref-CR36" id="ref-link-section-d68921275e2581">36</a></sup>. Given that new trauma to other areas of skin can cause new blisters outside of previously treated wounds, it is anticipated that periodic B-VEC dosing of new wounds outside of previously treated wound areas will be necessary.</p><p>Whereas ectopic suprabasal C7 expression has been noted as a side effect in previous C7 gene replacement studies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br. J. Dermatol. 183, 614â€“627 (2020)." href="/articles/s41591-022-01737-y#ref-CR6" id="ref-link-section-d68921275e2588">6</a></sup>, in the current study C7 was correctly localized solely to the dermalâ€“epidermal junction. Many previous RDEB skin studies examined C7 NC1 expression but not the C7 NC2 domain. Because the NC2 domain of C7 is essential for AF assembly and function, NC1 expression by itself has not always been found to correlate with AF formation in previous clinical studies<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Marinkovich, M. P. &amp; Tang, J. Y. Gene therapy for epidermolysis bullosa. J. Invest. Dermatol. 139, 1221â€“1226 (2019)." href="/articles/s41591-022-01737-y#ref-CR8" id="ref-link-section-d68921275e2592">8</a></sup>. In contrast, this study examined both NC1 and NC2 expression as an indication of full-length functional C7 expression, both by immunofluorescence and immunoelectron microscopy. Although some variability was observed in NC1 and NC2 expression in this study, as has been noted in previous studies of <i>COL7A1</i> gene replacement<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Marinkovich, M. P. &amp; Tang, J. Y. Gene therapy for epidermolysis bullosa. J. Invest. Dermatol. 139, 1221â€“1226 (2019)." href="/articles/s41591-022-01737-y#ref-CR8" id="ref-link-section-d68921275e2599">8</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2602">11</a></sup>, when areas of C7 expression were noted, they were linear and continuous.</p><p>Keratinocytes and fibroblasts each contribute C7 to the dermalâ€“epidermal basement membrane<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Marinkovich, M. P., Keene, D. R., Rimberg, C. S. &amp; Burgeson, R. E. Cellular origin of the dermalâ€“epidermal basement membrane. Dev. Dyn. 197, 255â€“267 (1993)." href="/articles/s41591-022-01737-y#ref-CR37" id="ref-link-section-d68921275e2609">37</a></sup>, and a recent study has suggested that expression of C7 by both cell types may be required for optimal formation of normal AFs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Supp, D. M. et al. Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes. Cell Transplant. 28, 1242â€“1256 (2019)." href="/articles/s41591-022-01737-y#ref-CR38" id="ref-link-section-d68921275e2613">38</a></sup>. Although other <i>COL7A1</i> gene replacement approaches have targeted either keratinocytes<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2620">11</a></sup> or fibroblasts<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight 4, e126243 (2019)." href="/articles/s41591-022-01737-y#ref-CR13" id="ref-link-section-d68921275e2624">13</a></sup>, the ability of B-VEC to induce robust C7 expression in both cell types may offer a distinct advantage and may have contributed to the AF formation and wound healing seen in this study.</p><p>Limitations of this phase 1 and 2 trial include treatment of only open RDEB wounds with topical B-VEC as opposed to intact skin. B-VEC would not be expected to induce basal epidermal C7 expression when topically applied to intact skin because this vector has not been shown to efficiently penetrate intact skin in animal models. When possible, wounds of similar location and size were selected. However, due to the random nature of patient wounding and limited patient numbers, some wounds were not fully matched in location and size. Another limitation was the inability to correlate wound healing with patient-reported outcomes of severity and pain. The reasons for this we believe are twofold, in that patients on the study continued to use their regular pain medications, and the wounds treated in this early exploratory trial represented only a small subset of the total wounding and disability burden experienced by the patients. The secondary objective of investigator wound image assessment was redundant given that the primary objective of complete wound healing assessed by the investigator involved evaluation of both remote and on-site images taken at weeks 8, 10 and 12, and hence it was not re-analyzed.</p><p>In this exploratory phase 1 and 2 trial involving patients with RDEB, repeat topical B-VEC applications were associated with durable wound closure and full-length cutaneous C7 expression and AF assembly with minimal adverse events. Future therapeutic directions deserving to be investigated include topical delivery to mucosal surfaces affected in RDEB such as oropharynx, esophagus, or eyes, and HSV-1 transgene delivery for other genetic diseases. In total, the preliminary conclusions and treatment advances described here have far-reaching implications with the potential to broadly transform the gene therapy field. A phase 3 study of B-VEC is underway (ClinicalTrials.gov: <a href="https://clinicaltrials.gov/ct2/show/NCT04491604">NCT04491604</a>).</p></div></div></section><section data-title="Methods"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10">Methods</h2><div class="c-article-section__content" id="Sec10-content"><h3 class="c-article__sub-heading" id="Sec11">Study design</h3><p>This completed study was a single-center open-label, intra-patient, randomized, phase 1 and 2 placebo-controlled trial conducted at Stanford University (first patient enrolled on 6 May 2018, last patient enrolled on 3 September 2019). Eligible male and female patients were at least 6â€‰years old and had been diagnosed with generalized RDEB using clinical guidelines. RDEB diagnosis was molecularly confirmed and C7 serology was determined for each patient, as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2653">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Gorell, E. S., Nguyen, N., Siprashvili, Z., Marinkovich, M. P. &amp; Lane, A. T. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. Br. J. Dermatol. 173, 821â€“823 (2015)." href="/articles/s41591-022-01737-y#ref-CR39" id="ref-link-section-d68921275e2656">39</a></sup>.</p><p>Patients had at least two skin areas (0.89â€“65.29â€‰cm<sup>2</sup>) with at least one wound in each area at the time of enrollment. Of nine patients screened, all were enrolled in this trial (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig2">2</a>). One patient withdrew at day 30 due to travel inability. Three patients enrolled into a later trial phase following a 3â€‰month wash-out period and were considered independent for wound efficacy analyses. The principal investigator selected at least two and up to three target wounds meeting the inclusion criteria.</p><p>A complete randomized-block design, with each patient designated as a block to receive all conditions, was used to assign treatment. Investigator-assigned wound numbers were randomized using a pre-generated randomization schedule. Randomization schemes were generated via a customized program prior to the study, and randomization assignments for the treatment sites of each study patient were provided in sealed envelopes. Once the wound pairs were identified and labeled, the randomization envelope was opened and the assigned dose was then given.</p><p>One wound was treated with placebo and the other(s) treated with B-VEC (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab4">2</a>). Following the safety board review of initial results, pediatric patients were included, and total dosing was increased to 2â€“8â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per day.</p><p>The study was conducted in accordance with the 1996 Health Insurance Portability and Accountability Act and approved by the FDA Center for Biologics Evaluation and Research, and Stanfordâ€™s institutional review board (<a href="https://clinicaltrials.gov/ct2/show/NCT03536143">NCT03536143</a>, registered 20 April 2018). Written informed consent was obtained from patients or from the patientsâ€™ legally authorized representatives for participation in the study, as well as for publication of images and videos of treated wounds obtained during the study. Patients received compensation to cover travel costs and meals for the day of the visit. A safety review committee conducted periodic assessments. Data were collected by the principal investigator and staff. Krystal Biotech prepared the statistical analysis plan and performed the statistical analysis. Version 9.1.3 of the SAS statistical software package was used to generate summaries, listings, graphs and statistical analyses. The principal investigator prepared the first manuscript draft. All authors interpreted the data, collaborated in preparing the manuscript, and vouch for data accuracy, completeness, and fidelity of the trial description to the protocol and the reporting of adverse events presented within the full text of this article. All authors and their institutions had confidentiality agreements with the sponsor.</p><h3 class="c-article__sub-heading" id="Sec12">Study objectives</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec13">Phase 1</h4><p>The primary objectives were to preliminarily assess the safety of topical B-VEC compared with placebo and to demonstrate evidence of molecular correction, that is, functional collagen VII (C7) expression and AFs, associated with B-VEC after treatment. The secondary objective was to preliminarily assess the effect of B-VEC on wound closure compared with placebo (wound surface area reduction, duration of wound closure). Other safety-related objectives were to assess changes in laboratory values and the condition of the patients (HSV and C7 antibodies, vital signs, physical examination).</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec14">Phase 2</h4><p>The primary objective of the phase 2 trial was the further assessment of the effect of B-VEC on wound closure compared with placebo (wound surface area reduction, duration of wound closure, time to wound closure). An additional objective was to demonstrate evidence of molecular correction (functional C7 expression) associated with B-VEC after treatment.</p><p>Note that two additional secondary objectives were not reported in the manuscript. Patient-reported outcomes for pain and severity were not amenable to interpretation for two reasons: the patients on the study continued to use their regular pain medications, and the wounds treated in this early exploratory trial represented only a small subset of the total wounding and disability burden experienced by the patients. The investigatorâ€™s global assessment analysis was not reported due to redundancy relative to the primary objective. The investigator evaluated both remote and on-site images taken at weeks 8, 10 and 12 for wound healing, and these images were not re-analyzed.</p><h3 class="c-article__sub-heading" id="Sec15">Inclusion criteria</h3><p>To be eligible for inclusion, each patient fulfilled each of the following criteria: clinical diagnosis of the recessive form of dystrophic epidermolysis bullosa; age (initial three patients: 18â€‰years or older; subsequent three patients: 5â€‰years or older); willingness and ability to give consent or assent; confirmation of RDEB diagnosis on genetic testing, immunofluorescence and electron microscopy; LH24 antibody staining negativity and NC1 positivity (this criterion is applicable to the first two adults on the study; subsequent patients could be NC1 positive or negative); confirmed RDEB <i>COL7A1</i> mutations; at least one wound between 5 and 10â€‰cm<sup>2</sup> in wound area; and ability and willingness (in the opinion of the investigator) to understand the study, cooperate with the study procedures and to return to the clinic for all of the required follow-up visits.</p><h3 class="c-article__sub-heading" id="Sec16">Exclusion criteria</h3><p>Patients were excluded from the study if any of the following criteria were met: medical instability limiting ability to travel to the investigative center; the presence of medical illness expected to complicate participation and/or compromise the safety of this technique, such as active infection with HIV, hepatitis B or hepatitis C (as determined by hepatitis B surface antigen screening, detection of hepatitis C antibodies, or positive result of hepatitis C polymerase chain reaction (PCR) analysis); serum antibodies to type VII collagen demonstrated on ELISA, indirect immunofluorescence microscopy or Western blot, or cell-mediated immunity to ELISPOT (patients with negative results within 12â€‰months of screening are eligible); active infection in the area that will undergo injection; evidence of systemic infection; known allergy to any of the constituents of the product; current evidence or a history of squamous cell carcinoma in the area that will undergo treatment; active drug or alcohol addiction; hypersensitivity to local anesthesia (lidocaine or prilocaine cream); receipt of a chemical or biological study product for the specific treatment of RDEB in the past 3â€‰months; specific wounds that have previously been treated with investigational gene or cell therapy; the use of systemic antibiotics in the past 7â€‰days; positive pregnancy test or current breast-feeding; clinically significant abnormalities (grade 2 or higher on the National Cancer Institute (NCI) toxicity scale) on laboratory tests before treatment (except for the following specific exclusionary laboratory threshold results, subject to approval or exemption by the epidermolysis bullosa physician: albuminâ€‰&lt;â€‰1.7â€‰gâ€‰dl<sup>âˆ’1</sup>, leukocytesâ€‰&gt;â€‰20,000â€‰Î¼l<sup>âˆ’1</sup>, hemoglobinâ€‰&lt;â€‰7.5â€‰gâ€‰dl<sup>âˆ’1</sup> (low hemoglobin is treated at the discretion of the investigators and the epidermolysis bullosa physician) and any additional exceptions made at the discretion of the investigators and the epidermolysis bullosa physician); and clinically significant abnormalities (grade 2 or higher on the NCI toxicity scale) identified through medical history and physical examination at day 0 (with the following exceptions: anorexia, can enroll up to grade 4 (inclusive); constipation, can enroll up to grade 2 (inclusive); dysphagia, can enroll up to grade 4 (inclusive); keratitis, can enroll up to grade 4 (inclusive); bone pain, can enroll up to grade 2 (inclusive); and any additional exceptions made at the discretion of the investigators and the epidermolysis bullosa physician).</p><h3 class="c-article__sub-heading" id="Sec17">Clinical study treatment</h3><p>The topical B-VEC gel or the placebo gel (produced according to Good Manufacturing Practice, GMP) was given dropwise by pipette uniformly across the surface area of the wound, without touching the wound itself, and not extending to normal skin surrounding the wound. Once B-VEC was evenly applied to the wound, a non-adhesive bandage (Tegaderm, 3M Health Care) was placed over the treated area, creating a uniform spread of a thin layer of gel across the wound surface, which was then covered by a secondary bandage for padding (Mepilex, MÃ¶lnlycke), and self-clinging gauze (Kerlix) was used to hold the dressings in place. The patients were advised to leave the dressings in place for 24â€“48â€‰h. After bandage change, the bandage materials in direct contact with the treated wound were disposed of in a biohazard bag.</p><p>The vehicle was a heat sterilized 3% METHOCEL<sup>TM</sup> aqueous gel, formulated in water, and manufactured to GMP standards by Velesco Pharmaceuticals. Several viscosities of this composition (ranging from 2% to 4%) were tested prior to the selection of this gel. In addition, other excipients including poloxamer 407 and F127 were evaluated at multiple concentrations. The 3% METHOCEL<sup>TM</sup> formulation had optimal compatibility with B-VEC, based on the maximal stability of the investigational product (B-VECâ€‰+â€‰gel) at multiple temperatures (2â€“8â€‰Â°C, ambient, 33â€‰Â°C) and the in vivo safety and efficacy in animal models. A volume of ~0.2â€‰ml with a 1:1 ratio of B-VEC and excipient gel was used for all B-VEC wounds â‰¥20â€‰cm<sup>2</sup>. Placebo-treated wounds received the same volume of excipient diluted in 0.9% saline gel.</p><h3 class="c-article__sub-heading" id="Sec18">Vector detection (blood and urine)</h3><p>Blood and urine samples were collected before treatment and on all scheduled visits, as often as amenable (blood and urine sampling is uncomfortable for patients with epidermolysis bullosa) and assessed for the presence of B-VEC DNA using a validated quantitative PCR assay.</p><h3 class="c-article__sub-heading" id="Sec19">Evaluation of immune response to HSV</h3><p>Sera samples collected before treatment and during specific visits were evaluated for anti-drug antibodies against HSV with a qualified plaque reduction neutralization test (PRNT) that uses B-VEC. The PRNT assay determines the percent reduction in B-VEC-mediated plaque production in the presence of different dilutions of patient sera and is reported as PRNT<sub>50</sub>, which is the serum dilution at which a 50% reduction in plaques is observed. An increase in PRNT<sub>50</sub> over time is suggestive of an increase in the presence of anti-HSV antibodies in the sera.</p><h3 class="c-article__sub-heading" id="Sec20">Evaluation of immune response to collagen VII</h3><p>Sera samples, collected before treatment and at intervals during the study, were evaluated with an anti-collagen VII ELISA (EAâ€‰1947-4801â€‰G, Euroimmun), which determines the levels of human collagen VII immunoglobulin G (a level â‰¥20â€‰relative units (RU)â€‰ml<sup>âˆ’1</sup> is considered to be positive).</p><h3 class="c-article__sub-heading" id="Sec21">Wound imaging</h3><p>Images were taken using an iPhone camera system with the WoundMatrix application loaded on the iPhone device. WoundMatrix is a complete mobile wound management and telehealth solution for the secure capture, measurement and upload of images and data elements at the investigatorâ€“patient point of care. The WoundMatrix application requires a wound image with a predefined calibration marker (ruler in cm) placed on the same surface as the wound. The software allows the investigator or user to draw a line on the calibration marker that represents 1â€‰cm. The software uses this line to count the number of pixels that the 1â€‰cm represents. After the calibration process is complete, the software allows the user to trace the wound to determine its shape. Once the user completes the tracing, the software calculates the number of pixels (using predefined algorithms) for the irregular traced shape. The software uses this information to calculate the surface area using the number of pixels, the calibration line and the number of pixels in the irregular wound shape. All measurements are stored in the application and the investigator can create progress graphs to see the change in area, width and length over time. The application allows the investigator to create wound reports on specific patients to monitor the wound progression.</p><p>To obtain wound images, the investigator ensured that there was sufficient lighting and that the wound had been cleaned and dried. The calibration marker (ruler in cm) was placed next to the wound, avoiding direct contact and without causing any curvature to the ruler. The smart phone focused on the center of the wound and an image was captured holding the phone in landscape style straight on without the flash. Once the image was accepted, the investigator completed measurements through the WoundMatrix application downloaded to the smart phone. A calibration was completed by tracing 1â€‰cm on the ruler. Width was determined by creating a line across the wound followed by determination of the length in the same fashion. The investigator traced the granulation, slough, necrotic tissues and other tissues (if applicable) and accepted the tracing. The image was saved and closed in the application, which provides a surface area calculation of the wound based on the area traced by the investigator using the 1â€‰cm predefined reference calibration. If a wound was completely closed, no tracing is required, and the image would be saved for documentation. If the image is captured off-site, the patient or their caregiver captured an image using the WoundMatrix application on their personal device. The clinical site helped to download the software at the first visit and trained the patient or their caregiver in how to capture images. They were sent home with imaging guidance provided by WoundMatrix to assist them when they were off-site. The patient had limited access to and no control regarding the measurement of the images. When off-site the patient made sure that the lighting was similar to the on-site lighting and cleaned and dried the wounds before imaging. Once an image was captured using the predefined calibration marker (ruler in cm) the patient or their caregiver used the descriptive image given on the device, created by the investigator, noting which region to capture and select before imaging (that is, plantar (bottom) of the right foot). The image was uploaded to the investigator and they traced the wound through the application interface remotely to determine the surface area.</p><h3 class="c-article__sub-heading" id="Sec22">Evaluation of wound areas</h3><p>Post hoc statistical analysis was performed on the wound measurement data obtained from patients in the phase 1 and 2 clinical study. Data from randomized wounds were pooled for wound closure efficacy analysis of B-VEC compared with placebo. Wound closure data from patient 12 were not included in the analysis because the wound was a great deal larger than the others studied and the intent was to observe the impact of B-VEC on a large chronic wound.</p><h3 class="c-article__sub-heading" id="Sec23">Main protocol changes</h3><p>Three key protocol amendments corresponding to the study phases were made: phase 1 (v1.0, 19Apr2018) phase 2a (v2.2, 08Oct2018), phase 2b (v3.1, 12Mar2019) and phase 2c (v4.0, 01Aug2019) (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>). The protocol versions represent intended design that was amended in consultation and with approval from oversight committees and regulatory authorities.</p><p>After two patients were enrolled into phase 1, the protocol was amended to increase the frequency and p.f.u. level of doses and to include patients aged 5â€‰years and older (to v2.2). After four patients were enrolled into phase 2a, the protocol was amended to administer B-VEC every 2â€“3â€‰days to correspond with bandage changes. The potential number of doses was increased and the dose level was set at 2â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per treatment. Five patients were enrolled into phase 2b. Finally, the protocol was revised to version 4.0 to allow for the use of B-VEC for at least one large chronic wound. The potential dose level and the number of treatments were increased.</p><p>The phase 1 study enrolled two adults (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a> and Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a>). Two wounds â‰¤10â€‰cm<sup>2</sup> were selected per patient, and the wounds were randomized to receive either 1â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. of B-VEC per dose or vehicle gel (placebo) on days 1 and 3, and on days 29 and 31. Patient 2 received additional topical B-VEC doses on days 15 and 45.</p><p>Following v1.0, the protocol was amended to increase the frequency and level of the doses from 1 to 3â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per treatment, to increase the maximum wound size from 10 to 20â€‰cm<sup>2</sup>, and to lower the minimum age of patients from 18 to 5â€‰years.</p><p>The phase 2a study enrolled two adult and two pediatric patients (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a> and Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a>). Three wounds â‰¤20â€‰cm<sup>2</sup> were selected per patient: two wounds were randomized to receive 3â€‰Ã—â€‰10<sup>8</sup> B-VEC per dose and one was randomized to placebo. The protocol also allowed for dose escalation up to 6â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. B-VEC per treatment day. Patients received topical B-VEC to wounds on days 1, 2, 3, 4, 5 and then at follow-up visits to the clinic. Following v2.2, the protocol was amended to administer B-VEC every 2â€“3â€‰days to correspond with bandage changes and to increase the total number of doses. The dose level was set at 2â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per treatment.</p><p>Phase 2b enrolled five patients (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>). Three patients who participated in phase 2a also participated in phase 2b (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a> and Extended Data Tables <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>, <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab4">2</a>). New, untreated wounds were evaluated for the patients who rolled over into the phase 2b portion of the protocol except for one chronic wound in patient 3 who became patient 11. For the re-enrolled patients, a wash-out period of 3â€‰months passed between treatments in phases 2a and 2b. These patients were enrolled in phase 2a as patients 3, 5 and 6 and in phase 2b as patients 11, 8 and 7, respectively (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a>). (Note that the patient identification numbers run from 1 to 12 because although nine patients enrolled, three enrolled in both 2a and 2b with unique identification numbers.) The primary differences between phase 2a and phase 2b were dose frequency and dose level. Phase 2b allowed for treatment at bandage changes, every 1â€“3â€‰days, and the dose level was set at 2â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per treatment (Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>). Following v3.2, the protocol was amended to administer B-VEC in two cycles. The age of inclusion was lowered to 2â€‰years old. Wound areas were increased to up to 50â€‰cm<sup>2</sup>, and with the increase in area the dose was increased to 6â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. per wound per treatment (see protocol appendix for further details).</p><p>Phase 2c enrolled one pediatric male patient (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig7">3</a> and Extended Data Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab3">1</a>). One large, chronic wound larger than 60â€‰cm<sup>2</sup> was treated with B-VEC. A similar wound, contralaterally located, was selected as the placebo wound. Due to the large surface area, 8â€‰Ã—â€‰10<sup>8</sup>â€‰p.f.u. B-VEC was topically administered to the wound per dose. The placebo wound was treated with vehicle control. The wounds underwent two cycles of topical treatment: cycle 1 was 25â€‰days and consisted of 20 treatments, and cycle 2 was 24â€‰days and consisted of 21 treatments.</p><p>In all phases of the study, topical B-VEC was applied during the wound dressing changes. Following dressing removal, wound surfaces were gently rinsed with sterile saline solution and patted dry with sterile gauze. B-VEC or placebo gel was applied over the surface of the wound (vehicle was a carboxymethylcellulose containing slightly viscous hydrogel) and the wound was overlaid with an occlusive dressing that was immobilized by wrapping with self-clinging gauze.</p><h3 class="c-article__sub-heading" id="Sec24">Statistical analysis</h3><p>Two wound types were assessed: a more common variant, recurrent wounds, which repeatedly close and re-blister; and a less common variant, chronic wounds, of 12â€‰weeks or more duration<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Solis, D. C. et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: a retrospective and cohort natural history study. J. Am. Acad. Dermatol. 85, 1296â€“1298 (2021)." href="/articles/s41591-022-01737-y#ref-CR27" id="ref-link-section-d68921275e2919">27</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Eng, V. A. et al. Patient reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: a global cross-sectional survey. J. Am. Acad. Dermatol. 85, 1161â€“1167 (2021)." href="/articles/s41591-022-01737-y#ref-CR40" id="ref-link-section-d68921275e2922">40</a></sup>. In this study, patients could have either or both wound types. Considering the diverse wound nature and the local topical B-VEC treatment effect without systemic exposure, efficacy assessments and analyses were performed on wounds randomized to either B-VEC or placebo for each patient. Target wounds were imaged at trial visits and at home using the WoundMatrix phone application. Wound images were assessed by the unblinded principal investigator and by two independent blinded physician-dermatologists with bullous disease expertise.</p><p>Biopsies from intact B-VEC-treated skin were evaluated for percent C7 NC1 and NC2 expression compared with normal skin (non-RDEB) using immunofluorescence, and for AFs using immunoelectron microscopy, as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. JAMA 316, 1808â€“1817 (2016)." href="/articles/s41591-022-01737-y#ref-CR11" id="ref-link-section-d68921275e2929">11</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Woodley, D. T. et al. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. J. Clin. Invest. 127, 3028â€“3038 (2017)." href="/articles/s41591-022-01737-y#ref-CR28" id="ref-link-section-d68921275e2932">28</a></sup>.</p><p>Safety assessments were conducted with a single systemic patient response as the independent outcome. Adverse events and concomitant medications were assessed at each visit. Blood and urine were assessed for B-VEC DNA using a validated qPCR assay, and blood was assayed for C7 and HSV-1 antibodies (Extended Data Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig8">4</a> and Supplementary Tables <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">1</a>, <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">2</a>).</p><p>Because this was a first-in-human topical gene therapy exploratory study in an ultra-rare disease, a formal sample size calculation was not performed before commencement. However, preclinical work demonstrated the vectorâ€™s ability to direct sufficient C7 expression to reverse the disease. This enabled preliminary confirmation of the mechanism and efficacy in a small number of patients with confidence. The sample size was thus based on what was believed to be an adequate number of patients for this exploratory study to evaluate safety and efficacy.</p><p>After consultation with the regulatory agencies and upon further consideration, the original statistical analysis approach using the Cochran-Mantel-Haenszel test and the Breslowâ€“Day test was modified considering the paired binary nature of endpoint measurements. To account for within-pair or within-patient correlations and prevent bias of treatment effect estimation and statistical inference, McNemarâ€™s test was used for the primary analysis of efficacy data (responder analysis) reported in Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41591-022-01737-y#Tab1">1</a>.</p><p>Given the 2â€‰month cutaneous half-life of C7<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Remington, J. et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol. Ther. 17, 26â€“33 (2009)." href="/articles/s41591-022-01737-y#ref-CR36" id="ref-link-section-d68921275e2961">36</a></sup> and the 4â€“8â€‰week epidermis turnover rate<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Koster, M. I. Making an epidermis. Ann. NY Acad. Sci. 1170, 7â€“10 (2009)." href="/articles/s41591-022-01737-y#ref-CR41" id="ref-link-section-d68921275e2965">41</a></sup>, the durability of B-VEC wound closure is anticipated to last around 12â€‰weeks. This expectation informed the timepoint selection for analysis (landmark analysis). Based on a responder definition of complete wound closure (&gt;95% reduction in wound surface area from baseline) for at least 2 consecutive weeks (weeks 8 and 10, or weeks 10 and 12), responder analysis comparison of the incidence of complete wound closure between B-VEC-treated wounds and placebo-treated wounds was performed on observed data (no imputed values). This responder analysis included only patients for whom datapoints for either the week 8 and 10 timepoint, and/or the week 10 and 12 timepoint were collected (patients 3 and 5â€“10). The phase 1 protocol did not include collection of wound measurements at weeks 8, 10 and 12 (patients 1 and 2). Patient 4 dropped out of the study after initial treatment and was unable to make the consecutive visits to the site hence no data could be collected. Patient 11â€™s B-VEC-treated wounds reduced in size (wound 1, responder, reduced 71% from baseline at week 8, 100% at weeks 10 and 12; wound 2, non-responder, reduced 56% from baseline at week 8, 75% at week 10, and 100% at week 12) but this patientâ€™s data were not included in the responder analysis. Data were not collected for patient 11â€™s placebo-treated wound at weeks 8 and 10 due to an inability to remove the bandaging from the wound without causing significant discomfort to the patient. Patient 12â€™s wounds were outside of the size range of other wounds in the analysis and were excluded from the analysis.</p><p>In Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41591-022-01737-y#Fig3">3c</a>, in which the mean percent change in wound area was assessed by treatment and timepoint, all observed wound closure data for patients 1â€“11 were analyzed and are presented with <i>P</i>â€‰values based on the Wilcoxon rank-sum test.</p><h3 class="c-article__sub-heading" id="Sec25">Vector structure and description</h3><p>B-VEC is a vector derived from wild-type HSV-1 through the deletion of two copies of the viral immediate-early gene ICP4, rendering the vector replication incompetent; in addition, ICP22 was also deleted to reduce the cytotoxic effect (the vector diagram is given in Supplementary Fig. <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">1</a>). Two full-length copies of the human <i>COL7A1</i> gene, each with their own expression control elements, were then independently inserted into each ICP4 locus.</p><h3 class="c-article__sub-heading" id="Sec26">Vector production</h3><p>B-VEC was produced in a GMP-certified engineered cell bank infected with the B-VEC virus seed stock. Virus stocks were stored at âˆ’80â€‰Â°C until just before use. The vehicle used was Dulbeccoâ€™s phosphate-buffered salineâ€‰+â€‰10% glycerol.</p><h3 class="c-article__sub-heading" id="Sec27">Cell culture</h3><p>Cells were previously isolated from skin biopsies taken as part of routine surgical or diagnostic procedures. All cells were cultured at 37â€‰Â°C in 5% CO<sub>2</sub>. RDEB and normal human fibroblasts were grown in DMEM (Corning cellgro, Mediatech) supplemented with 10% FBS (PEAK Serum, cat. no. PS-FB1). RDEB and normal human keratinocytes were cultured in a 1:1 mix of defined keratinocyte serum-free medium (SFM; Life Technologies) and Medium 154 (Cascade Biologics) at 37â€‰Â°C in a humidified 5% CO<sub>2</sub> incubator.</p><h3 class="c-article__sub-heading" id="Sec28">Virus infection</h3><p>Viral aliquots were stored at âˆ’80â€‰Â°C and thawed 10â€‰min before infection. Multiplicity of infection was calculated from the virus titer and target cell number and the appropriate volume of virus stock was diluted in DMEM and incubated with the target cells for 2â€‰h at 37â€‰Â°C. Virus was then removed, inactivated with acetic acid and discarded, and fresh media was supplied to target cells after washing twice with pre-warmed media.</p><h3 class="c-article__sub-heading" id="Sec29">Western blot analysis</h3><p>The cell lysate was prepared as follows: 8â€‰Ã—â€‰10<sup>5</sup> fibroblasts or keratinocytes were plated in a 100â€‰mm dish to achieve 70â€“80% confluence the following day. At 48â€‰h after infection, cells were lysed with radioimmunoprecipitation assay buffer<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Marinkovich, M. P., Lunstrum, G. P., Keene, D. R. &amp; Burgeson, R. E. The dermalâ€“epidermal junction of human skin contains a novel laminin variant. J. Cell Biol. 119, 695â€“703 (1992)." href="/articles/s41591-022-01737-y#ref-CR42" id="ref-link-section-d68921275e3031">42</a></sup>. Lysate was centrifuged at 13,500â€‰Ã—<i>g</i> for 5â€‰min at 4â€‰Â°C, and the supernatant was mixed with a 6x Laemmli loading buffer. Before loading onto the SDSâ€“PAGE gel, the samples were heated for 5â€‰min at 95â€‰Â°C. For C7 detection, 5â€“30â€‰Î¼g protein was loaded onto a 6% acrylamide gel. The primary antibodies used were C7 polyclonal rabbit antibody (Sigma prestige Ab, cat. no. HPA042420), GAPDH and Î²-actin (Santa Cruz Biotechnology). Resolved proteins were transferred onto nitrocellulose membrane with a BioRad Trans-Blot-Turbo (BioRad), blocked in PBS and 0.1% Tween with 5% milk or 5% BSA according to the requirements of the primary antibody, and incubated overnight with the primary antibody. After incubation with IgG-HRP-conjugated secondary antibody (Santa Cruz Biotechnology), the membrane was incubated with Pierce ECL western blotting substrate (ThermoFisher Scientific) and exposed to CL-XPosure X-ray film (ThermoFisher Scientific). C7 was quantified by densitometry (ImageJ v1.52), using a known concentration of purified recombinant C7 (donated by Krystal Biotech) for comparison.</p><h3 class="c-article__sub-heading" id="Sec30">Protein quantification</h3><p>Total cell lysates were quantified with the Pierce BCA (bicinchoninic acid) Protein Assay kit (ThermoFisher Scientific) and proteins were loaded onto an SDSâ€“PAGE gel. The Western blot signal was quantified with ImageJ v1.52. Type VII collagen was quantified relative to the non-treated control, to GAPDH, and to purified recombinant type VII collagen supplied by Krystal Biotech.</p><h3 class="c-article__sub-heading" id="Sec31">qRTâ€“PCR</h3><p>RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturerâ€™s instructions. RNA extractions were quantified using a NanoDrop Spectrophotometer (ThermoFisher Scientific), and 1.5â€‰Î¼g RNA was used for complementary DNA synthesis with the SuperScript III First-Strand Synthesis System (ThermoFisher Scientific). For detection of <i>COL7A1</i> expression the following primers were used: forward primer, GGCTGCAATTCTCCATGTGG; reverse primer, CTGTGAGGCAACTCGCTTCA. For ACTB amplification the following primers were used: forward primer, CATGTACGTTGCTATCCAGGC; reverse primer, CTCCTTAATGTCACGCACGAT. For qPCR, the SYBR Select Master mix (Life Technologies) was used and cDNA samples were diluted 1:25 to serve as the template. Experiments were performed in triplicate.</p><h3 class="c-article__sub-heading" id="Sec32">Animals</h3><p>A colony of homozygous <i>Col7a1</i><sup>flNeo</sup> mice, which are a strain expressing only 10% of the amount of murine type VII collagen found in normal mouse skin, was used. These mice have a phenotype similar to severe generalized human RDEB<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Fritsch, A. et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J. Clin. Invest. 118, 1669â€“1679 (2008)." href="/articles/s41591-022-01737-y#ref-CR22" id="ref-link-section-d68921275e3069">22</a></sup>. These were established from a breeding pair donated by L. Bruckner-Tuderman (Freiberg, Germany). Mice were genotyped with DNA extracted from an ear punch tissue sample. PCR analysis detected the presence of a loxP site upstream of exon 2 of <i>Col7a1</i>. Wild-type mice show a band at 269â€‰bp and hypomorph mice show the band at 435â€‰bp, while heterozygous mice have both. Balb/C mice were obtained from The Jackson Laboratory. For xenografting, NOD/SCID mice were used (NOD.CB17-PrkdcSCID/J mice; stock 001303; The Jackson Laboratory). All procedures used in the protocol were in compliance with applicable animal welfare acts and were approved by the Stanford Institutional Animal Care and Use Committee (IACUC). Animals were housed under the following conditions: a 14â€‰hâ€“10â€‰h lightâ€“dark cycle, temperature of 18â€“23â€‰Â°C and 40â€“60% humidity.</p><h3 class="c-article__sub-heading" id="Sec33">Preclinical B-VEC viral vector application</h3><p>Before and during the test article treatment, mice were maintained under inhalation anesthesia using 2% isoflurane. Eye ointment (Puralube Vet) was applied on the eyes to prevent dryness. The back and flank area was shaved using an electrical pet clipper and the area was wiped with an alcohol wipe. The viral vector was kept on dry ice until 10â€“15â€‰min before injection, thawed at room temperature, and used within 15â€“30â€‰min of thawing.</p><p>For intradermal injections the animalâ€™s back was shaved and the mouse was injected at four sites on the back, consisting of one control vehicle injection and three B-VEC injections. Intradermal injections were performed using the Mantoux technique with a 31â€‰G BD SafetyGlide 0.3â€‰ml insulin syringe, ensuring creation of a superficial wheal at each site. Up to four intradermal injections were given to the back of each mouse at the doses specified in the Results section. The edges of the wheal were marked with a permanent marker. All mice received a dose of 4.6â€‰Ã—â€‰10<sup>7</sup>â€‰p.f.u. per 50â€‰Î¼l per injection site by intradermal injection. In some experiments the mice received a second injection at the same four sites on day 3. For RDEB mouse topical applications, a full-thickness 8-mm-diameter wound on the animalâ€™s mid-back was locally anesthetized and covered with Tegaderm (3M Health Care), and the virus was injected into the space between the Tegaderm and wound surface. The Tegaderm was preserved on a mouse until tissue collection (2, 7, 10, 14â€‰days). For xenograft topical applications the virus was injected into the Telfa non-adherent pad directly in contact with the xenograft surface.</p><h3 class="c-article__sub-heading" id="Sec34">3D xenograft preparation</h3><p>Primary fibroblasts and keratinocytes cultured from a skin biopsy of patient with RDEB lacking C7 NC1 and NC2 expression were used to seed on porcine devitalized dermis. To produce the composite skin graft preparation, porcine devitalized dermis was cut into 2â€‰Ã—â€‰2â€‰cm square pieces and left to dry under aseptic conditions at the bottom of the 6-well tissue culture plate for 2â€‰h. Fibroblasts were seeded from the bottom of the dermis and grown for 3â€‰days. At day 4, 5â€‰Ã—â€‰10<sup>6</sup> keratinocytes were resuspended in a maximal volume of 150â€‰ml of 50/50â€‰V and placed in the middle of the dermis to avoid spillage of the cells onto the plate surface. The dermis squares were placed on special frames, to allow nutrients access to both sides of the graft. After another 2â€‰h, wells were filled with 2.5â€‰ml keratinocyte growth medium and allowed to grow further for at least 5â€‰days. Next, the composite skin graft was removed from the plate with forceps touching only one side of the graft and used immediately for transplantation as described in the following section.</p><h3 class="c-article__sub-heading" id="Sec35">Graft transplantation</h3><p>Mouse grafting was performed as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Choate, K. A., Medalie, D. A., Morgan, J. R. &amp; Khavari, P. A. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Genet. 2, 1263â€“1267 (1996)." href="/articles/s41591-022-01737-y#ref-CR43" id="ref-link-section-d68921275e3108">43</a></sup>. In brief, 6â€“8-week-old mice were anesthetized with inhalation of 1.5â€“2% isofluorane. After shaving the hair from the mouse back, a rectangular region of mouse skin (~1.6â€‰Ã—â€‰1.4â€‰cm) was removed with scissors and the composite graft was sutured to the mouse skin using an interrupted stitch technique. Both dermal and epidermal components were kept moist with sterile culture medium throughout the transplantation procedure. Non-adherent dressing (TELFA; Tyco Healthcare/Kendall) was cut into 2â€‰Ã—â€‰2â€‰cm squares and placed on top of the graft. Next, Tegaderm dressing (3M Health Care) was wrapped around the mouse and then covered with a Coverlet adhesive dressing (BSN Medical). Last, a double layer of CoFlex (Andover Healthcare) was wrapped around the mouse. The mouse was subcutaneously injected with carprophen analgesic in the vicinity of the graft. The dressing was removed 10â€“14â€‰days after grafting and the grafts were then further characterized.</p><h3 class="c-article__sub-heading" id="Sec36">Tissue collection</h3><p>Before tissue collection, animals were euthanized by CO<sub>2</sub> inhalation followed by cervical dislocation. The back area was shaved, as needed to identify the marked injection sites or topical application areas, and the treated sites were biopsied using sharp scissors. Approximately one-half was snap-frozen in liquid nitrogen for qPCR analysis and the other half was cryopreserved in optimal cutting temperature (OCT) compound.</p><h3 class="c-article__sub-heading" id="Sec37">Histologic analysis</h3><p>The cryopreserved tissues in OCT compound were sectioned at a thickness of 5â€“8â€‰Âµm and left to air dry for up to 1â€‰h. The slides were dipped in 100% MeOH for 10â€‰min at âˆ’20â€‰Â°C and left to air dry. Methanol-fixed sections were rehydrated in PBS for 5â€‰min at room temperature. The slides were analyzed using hematoxylin and eosin (H&amp;E) staining or indirect immunofluorescence microscopy. H&amp;E staining was performed using standard procedures with Weigertâ€™s modified hematoxylin (HEXWHALE 100) and Eosin Y solution (HT110116). Indirect immunofluorescence microscopy was performed as previously described<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Sakai, L. Y., Keene, D. R., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen is a major structural component of anchoring fibrils. J. Cell Biol. 103, 1577â€“1586 (1986)." href="/articles/s41591-022-01737-y#ref-CR44" id="ref-link-section-d68921275e3130">44</a></sup>. Primary antibodies were incubated for 16â€‰h at 4â€‰Â°C after 1â€‰h of incubation at 20 Â°C with fluorescence (4â€²,6-diamidino-2-phenylindole) for nuclei staining. The stained sections were mounted with mounting media (Fluoromount G, cat. no. 0100-01, Southern Biotech) and overlaid with a glass coverslip. Antibodies used for the staining are listed in Supplementary Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM1">5</a>. All imaging and image processing (fluorescent and H&amp;E), including tiling of the images, was done using AxioVision SE64 v4.9.1 by Zeiss.</p><h3 class="c-article__sub-heading" id="Sec38">Reporting Summary</h3><p>Further information on research design is available in the <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41591-022-01737-y#MOESM2">Nature Research Reporting Summary</a> linked to this article.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>All requests for data will be reviewed by the leading clinical site, Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, and the study sponsor, Krystal Biotech, to verify whether the request is subject to any intellectual property or confidentiality obligations. Requests for access to the patient-level data from this study can be submitted via email to medinfo@krystalbio.com with detailed proposals for approval. A signed data access agreement with the sponsor is required before accessing shared data. <a data-track="click" data-track-label="link" data-track-action="section anchor" href="/articles/s41591-022-01737-y#Sec42">Source data</a> are provided with this paper. The availability of the B-VEC vector is subject to a material transfer agreement.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Fine, J.-D. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. <i>JAMA Dermatol.</i> <b>152</b>, 1231â€“1238 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jamadermatol.2016.2473" data-track-item_id="10.1001/jamadermatol.2016.2473" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjamadermatol.2016.2473" aria-label="Article reference 1" data-doi="10.1001/jamadermatol.2016.2473">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27463098" aria-label="PubMed reference 1">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Epidemiology%20of%20inherited%20epidermolysis%20bullosa%20based%20on%20incidence%20and%20prevalence%20estimates%20from%20the%20National%20Epidermolysis%20Bullosa%20Registry&amp;journal=JAMA%20Dermatol.&amp;doi=10.1001%2Fjamadermatol.2016.2473&amp;volume=152&amp;pages=1231-1238&amp;publication_year=2016&amp;author=Fine%2CJ-D">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Rousselle, P. et al. Laminin 5 binds the NC-1 domain of type VII collagen. <i>J. Cell Biol.</i> <b>138</b>, 719â€“728 (1997).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1083/jcb.138.3.719" data-track-item_id="10.1083/jcb.138.3.719" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1083%2Fjcb.138.3.719" aria-label="Article reference 2" data-doi="10.1083/jcb.138.3.719">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2sXltlKhs7k%3D" aria-label="CAS reference 2">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9245798" aria-label="PubMed reference 2">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2141627" aria-label="PubMed Central reference 2">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Laminin%205%20binds%20the%20NC-1%20domain%20of%20type%20VII%20collagen&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.138.3.719&amp;volume=138&amp;pages=719-728&amp;publication_year=1997&amp;author=Rousselle%2CP">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Chen, M. et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermalâ€“dermal adherence in human skin. <i>J. Biol. Chem.</i> <b>272</b>, 14516â€“14522 (1997).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.272.23.14516" data-track-item_id="10.1074/jbc.272.23.14516" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.272.23.14516" aria-label="Article reference 3" data-doi="10.1074/jbc.272.23.14516">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2sXjslagsb4%3D" aria-label="CAS reference 3">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9169408" aria-label="PubMed reference 3">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Interactions%20of%20the%20amino-terminal%20noncollagenous%20%28NC1%29%20domain%20of%20type%20VII%20collagen%20with%20extracellular%20matrix%20components.%20A%20potential%20role%20in%20epidermal%E2%80%93dermal%20adherence%20in%20human%20skin&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.272.23.14516&amp;volume=272&amp;pages=14516-14522&amp;publication_year=1997&amp;author=Chen%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Bruckner-Tuderman, L. et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. <i>J. Cell Biol.</i> <b>131</b>, 551â€“559 (1995).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1083/jcb.131.2.551" data-track-item_id="10.1083/jcb.131.2.551" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1083%2Fjcb.131.2.551" aria-label="Article reference 4" data-doi="10.1083/jcb.131.2.551">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2MXosFygtbk%3D" aria-label="CAS reference 4">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7593178" aria-label="PubMed reference 4">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunohistochemical%20and%20mutation%20analyses%20demonstrate%20that%20procollagen%20VII%20is%20processed%20to%20collagen%20VII%20through%20removal%20of%20the%20NC-2%20domain&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.131.2.551&amp;volume=131&amp;pages=551-559&amp;publication_year=1995&amp;author=Bruckner-Tuderman%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Marinkovich, M. P. Inherited epidermolysis bullosa. In <i>Fitzpatrickâ€™s Dermatology</i> 9th edn (eds Kang, S. et al.) Ch. 60 (McGraw Hill Medical, 2019).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. <i>Br. J. Dermatol.</i> <b>183</b>, 614â€“627 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/bjd.18921" data-track-item_id="10.1111/bjd.18921" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fbjd.18921" aria-label="Article reference 6" data-doi="10.1111/bjd.18921">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BB38%2FotVWlsg%3D%3D" aria-label="CAS reference 6">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32017015" aria-label="PubMed reference 6">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Consensus%20reclassification%20of%20inherited%20epidermolysis%20bullosa%20and%20other%20disorders%20with%20skin%20fragility&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fbjd.18921&amp;volume=183&amp;pages=614-627&amp;publication_year=2020&amp;author=Has%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Tang, J. Y. et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. <i>Orphanet J. Rare Dis.</i> <b>16</b>, 175 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13023-021-01811-7" data-track-item_id="10.1186/s13023-021-01811-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13023-021-01811-7" aria-label="Article reference 7" data-doi="10.1186/s13023-021-01811-7">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33849616" aria-label="PubMed reference 7">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045359" aria-label="PubMed Central reference 7">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20systematic%20literature%20review%20of%20the%20disease%20burden%20in%20patients%20with%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=Orphanet%20J.%20Rare%20Dis.&amp;doi=10.1186%2Fs13023-021-01811-7&amp;volume=16&amp;publication_year=2021&amp;author=Tang%2CJY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Marinkovich, M. P. &amp; Tang, J. Y. Gene therapy for epidermolysis bullosa. <i>J. Invest. Dermatol.</i> <b>139</b>, 1221â€“1226 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jid.2018.11.036" data-track-item_id="10.1016/j.jid.2018.11.036" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jid.2018.11.036" aria-label="Article reference 8" data-doi="10.1016/j.jid.2018.11.036">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXovFegt74%3D" aria-label="CAS reference 8">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31068252" aria-label="PubMed reference 8">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Gene%20therapy%20for%20epidermolysis%20bullosa&amp;journal=J.%20Invest.%20Dermatol.&amp;doi=10.1016%2Fj.jid.2018.11.036&amp;volume=139&amp;pages=1221-1226&amp;publication_year=2019&amp;author=Marinkovich%2CMP&amp;author=Tang%2CJY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Wagner, J. E. et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. <i>N. Engl. J. Med.</i> <b>363</b>, 629â€“639 (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa0910501" data-track-item_id="10.1056/NEJMoa0910501" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa0910501" aria-label="Article reference 9" data-doi="10.1056/NEJMoa0910501">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVamsLfL" aria-label="CAS reference 9">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20818854" aria-label="PubMed reference 9">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967187" aria-label="PubMed Central reference 9">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Bone%20marrow%20transplantation%20for%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa0910501&amp;volume=363&amp;pages=629-639&amp;publication_year=2010&amp;author=Wagner%2CJE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Eichstadt, S. et al. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. <i>JCI Insight</i> <b>4</b>, e130554 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/jci.insight.130554" data-track-item_id="10.1172/jci.insight.130554" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2Fjci.insight.130554" aria-label="Article reference 10" data-doi="10.1172/jci.insight.130554">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795403" aria-label="PubMed Central reference 10">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=Phase%201%2F2a%20clinical%20trial%20of%20gene-corrected%20autologous%20cell%20therapy%20for%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JCI%20Insight&amp;doi=10.1172%2Fjci.insight.130554&amp;volume=4&amp;publication_year=2019&amp;author=Eichstadt%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. <i>JAMA</i> <b>316</b>, 1808â€“1817 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.2016.15588" data-track-item_id="10.1001/jama.2016.15588" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.2016.15588" aria-label="Article reference 11" data-doi="10.1001/jama.2016.15588">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27802546" aria-label="PubMed reference 11">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20wound%20outcomes%20following%20genetically%20corrected%20autologous%20epidermal%20grafts%20in%20patients%20with%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2016.15588&amp;volume=316&amp;pages=1808-1817&amp;publication_year=2016&amp;author=Siprashvili%2CZ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. <i>Nature</i> <b>551</b>, 327â€“332 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature24487" data-track-item_id="10.1038/nature24487" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature24487" aria-label="Article reference 12" data-doi="10.1038/nature24487">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslygtLvE" aria-label="CAS reference 12">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29144448" aria-label="PubMed reference 12">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283270" aria-label="PubMed Central reference 12">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Regeneration%20of%20the%20entire%20human%20epidermis%20using%20transgenic%20stem%20cells&amp;journal=Nature&amp;doi=10.1038%2Fnature24487&amp;volume=551&amp;pages=327-332&amp;publication_year=2017&amp;author=Hirsch%2CT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. <i>JCI Insight</i> <b>4</b>, e126243 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/jci.insight.126243" data-track-item_id="10.1172/jci.insight.126243" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2Fjci.insight.126243" aria-label="Article reference 13" data-doi="10.1172/jci.insight.126243">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629162" aria-label="PubMed Central reference 13">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20early%20efficacy%20outcomes%20for%20lentiviral%20fibroblast%20gene%20therapy%20in%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JCI%20Insight&amp;doi=10.1172%2Fjci.insight.126243&amp;volume=4&amp;publication_year=2019&amp;author=Lwin%2CSM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Fan, H., Lin, Q., Morrissey, G. R. &amp; Khavari, P. A. Immunization via hair follicles by topical application of naked DNA to normal skin. <i>Nat. Biotechnol.</i> <b>17</b>, 870â€“872 (1999).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/12856" data-track-item_id="10.1038/12856" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2F12856" aria-label="Article reference 14" data-doi="10.1038/12856">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK1MXlslOgtbs%3D" aria-label="CAS reference 14">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10471927" aria-label="PubMed reference 14">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Immunization%20via%20hair%20follicles%20by%20topical%20application%20of%20naked%20DNA%20to%20normal%20skin&amp;journal=Nat.%20Biotechnol.&amp;doi=10.1038%2F12856&amp;volume=17&amp;pages=870-872&amp;publication_year=1999&amp;author=Fan%2CH&amp;author=Lin%2CQ&amp;author=Morrissey%2CGR&amp;author=Khavari%2CPA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Shirley, J. L., de Jong, Y. P., Terhorst, C. &amp; Herzog, R. W. Immune responses to viral gene therapy vectors. <i>Mol. Ther.</i> <b>28</b>, 709â€“722 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ymthe.2020.01.001" data-track-item_id="10.1016/j.ymthe.2020.01.001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ymthe.2020.01.001" aria-label="Article reference 15" data-doi="10.1016/j.ymthe.2020.01.001">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsVyqtrY%3D" aria-label="CAS reference 15">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31968213" aria-label="PubMed reference 15">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054714" aria-label="PubMed Central reference 15">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 15" href="http://scholar.google.com/scholar_lookup?&amp;title=Immune%20responses%20to%20viral%20gene%20therapy%20vectors&amp;journal=Mol.%20Ther.&amp;doi=10.1016%2Fj.ymthe.2020.01.001&amp;volume=28&amp;pages=709-722&amp;publication_year=2020&amp;author=Shirley%2CJL&amp;author=Jong%2CYP&amp;author=Terhorst%2CC&amp;author=Herzog%2CRW">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Heldwein, E. E. &amp; Krummenacher, C. Entry of herpesviruses into mammalian cells. <i>Cell. Mol. Life Sci.</i> <b>65</b>, 1653â€“1668 (2008).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00018-008-7570-z" data-track-item_id="10.1007/s00018-008-7570-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00018-008-7570-z" aria-label="Article reference 16" data-doi="10.1007/s00018-008-7570-z">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXmslyltr4%3D" aria-label="CAS reference 16">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18351291" aria-label="PubMed reference 16">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Entry%20of%20herpesviruses%20into%20mammalian%20cells&amp;journal=Cell.%20Mol.%20Life%20Sci.&amp;doi=10.1007%2Fs00018-008-7570-z&amp;volume=65&amp;pages=1653-1668&amp;publication_year=2008&amp;author=Heldwein%2CEE&amp;author=Krummenacher%2CC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Tognarelli, E. I. et al. Herpes simplex virus evasion of early host antiviral responses. <i>Front. Cell. Infect. Microbiol.</i> <b>9</b>, 127 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fcimb.2019.00127" data-track-item_id="10.3389/fcimb.2019.00127" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffcimb.2019.00127" aria-label="Article reference 17" data-doi="10.3389/fcimb.2019.00127">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslClt7o%3D" aria-label="CAS reference 17">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31114761" aria-label="PubMed reference 17">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503643" aria-label="PubMed Central reference 17">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Herpes%20simplex%20virus%20evasion%20of%20early%20host%20antiviral%20responses&amp;journal=Front.%20Cell.%20Infect.%20Microbiol.&amp;doi=10.3389%2Ffcimb.2019.00127&amp;volume=9&amp;publication_year=2019&amp;author=Tognarelli%2CEI">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Yang, L. et al. Innate immune evasion of alphaherpesvirus tegument proteins. <i>Front. Immunol.</i> <b>10</b>, 2196 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fimmu.2019.02196" data-track-item_id="10.3389/fimmu.2019.02196" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffimmu.2019.02196" aria-label="Article reference 18" data-doi="10.3389/fimmu.2019.02196">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXns1Gkt7k%3D" aria-label="CAS reference 18">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31572398" aria-label="PubMed reference 18">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753173" aria-label="PubMed Central reference 18">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Innate%20immune%20evasion%20of%20alphaherpesvirus%20tegument%20proteins&amp;journal=Front.%20Immunol.&amp;doi=10.3389%2Ffimmu.2019.02196&amp;volume=10&amp;publication_year=2019&amp;author=Yang%2CL">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Oldham, M. L. et al. A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter. <i>Nature</i> <b>529</b>, 537â€“540 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature16506" data-track-item_id="10.1038/nature16506" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature16506" aria-label="Article reference 19" data-doi="10.1038/nature16506">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XhtFOku7s%3D" aria-label="CAS reference 19">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26789246" aria-label="PubMed reference 19">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848044" aria-label="PubMed Central reference 19">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20mechanism%20of%20viral%20immune%20evasion%20revealed%20by%20cryo-EM%20analysis%20of%20the%20TAP%20transporter&amp;journal=Nature&amp;doi=10.1038%2Fnature16506&amp;volume=529&amp;pages=537-540&amp;publication_year=2016&amp;author=Oldham%2CML">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Goins, W. F. et al. Engineering HSV-1 vectors for gene therapy. <i>Methods Mol. Biol.</i> <b>2060</b>, 73â€“90 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/978-1-4939-9814-2_4" data-track-item_id="10.1007/978-1-4939-9814-2_4" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/978-1-4939-9814-2_4" aria-label="Article reference 20" data-doi="10.1007/978-1-4939-9814-2_4">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXntlChsro%3D" aria-label="CAS reference 20">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31617173" aria-label="PubMed reference 20">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=Engineering%20HSV-1%20vectors%20for%20gene%20therapy&amp;journal=Methods%20Mol.%20Biol.&amp;doi=10.1007%2F978-1-4939-9814-2_4&amp;volume=2060&amp;pages=73-90&amp;publication_year=2020&amp;author=Goins%2CWF">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Epstein, A. L., Marconi, P., Argnani, R. &amp; Manservigi, R. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. <i>Curr. Gene Ther.</i> <b>5</b>, 445â€“458 (2005).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2174/156652305774329285" data-track-item_id="10.2174/156652305774329285" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2174%2F156652305774329285" aria-label="Article reference 21" data-doi="10.2174/156652305774329285">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtV2gt7%2FP" aria-label="CAS reference 21">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16250886" aria-label="PubMed reference 21">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=HSV-1-derived%20recombinant%20and%20amplicon%20vectors%20for%20gene%20transfer%20and%20gene%20therapy&amp;journal=Curr.%20Gene%20Ther.&amp;doi=10.2174%2F156652305774329285&amp;volume=5&amp;pages=445-458&amp;publication_year=2005&amp;author=Epstein%2CAL&amp;author=Marconi%2CP&amp;author=Argnani%2CR&amp;author=Manservigi%2CR">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Fritsch, A. et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. <i>J. Clin. Invest.</i> <b>118</b>, 1669â€“1679 (2008).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI34292" data-track-item_id="10.1172/JCI34292" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI34292" aria-label="Article reference 22" data-doi="10.1172/JCI34292">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXlsF2ntLw%3D" aria-label="CAS reference 22">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18382769" aria-label="PubMed reference 22">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276400" aria-label="PubMed Central reference 22">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20hypomorphic%20mouse%20model%20of%20dystrophic%20epidermolysis%20bullosa%20reveals%20mechanisms%20of%20disease%20and%20response%20to%20fibroblast%20therapy&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI34292&amp;volume=118&amp;pages=1669-1679&amp;publication_year=2008&amp;author=Fritsch%2CA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Ortiz-Urda, S. et al. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. <i>J. Clin. Invest.</i> <b>111</b>, 251â€“255 (2003).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI200317193" data-track-item_id="10.1172/JCI200317193" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI200317193" aria-label="Article reference 23" data-doi="10.1172/JCI200317193">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXlsVGqsA%3D%3D" aria-label="CAS reference 23">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12531881" aria-label="PubMed reference 23">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151880" aria-label="PubMed Central reference 23">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Injection%20of%20genetically%20engineered%20fibroblasts%20corrects%20regenerated%20human%20epidermolysis%20bullosa%20skin%20tissue&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI200317193&amp;volume=111&amp;pages=251-255&amp;publication_year=2003&amp;author=Ortiz-Urda%2CS">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. <i>Nature</i> <b>493</b>, 231â€“235 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nature11661" data-track-item_id="10.1038/nature11661" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnature11661" aria-label="Article reference 24" data-doi="10.1038/nature11661">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhslyntbbF" aria-label="CAS reference 24">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23201690" aria-label="PubMed reference 24">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Control%20of%20somatic%20tissue%20differentiation%20by%20the%20long%20non-coding%20RNA%20TINCR&amp;journal=Nature&amp;doi=10.1038%2Fnature11661&amp;volume=493&amp;pages=231-235&amp;publication_year=2013&amp;author=Kretz%2CM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Ishii, N. et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. <i>Br. J. Dermatol.</i> <b>150</b>, 843â€“851 (2004).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1365-2133.2004.05933.x" data-track-item_id="10.1111/j.1365-2133.2004.05933.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1365-2133.2004.05933.x" aria-label="Article reference 25" data-doi="10.1111/j.1365-2133.2004.05933.x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXlt1Kgurs%3D" aria-label="CAS reference 25">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15149495" aria-label="PubMed reference 25">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Epidermolysis%20bullosa%20acquisita%20sera%20react%20with%20distinct%20epitopes%20on%20the%20NC1%20and%20NC2%20domains%20of%20type%20VII%20collagen%3A%20study%20using%20immunoblotting%20of%20domain-specific%20recombinant%20proteins%20and%20postembedding%20immunoelectron%20microscopy&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fj.1365-2133.2004.05933.x&amp;volume=150&amp;pages=843-851&amp;publication_year=2004&amp;author=Ishii%2CN">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Ayoub, H. H., Chemaitelly, H. &amp; Abu-Raddad, L. J. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. <i>BMC Med.</i> <b>17</b>, 57 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s12916-019-1285-x" data-track-item_id="10.1186/s12916-019-1285-x" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s12916-019-1285-x" aria-label="Article reference 26" data-doi="10.1186/s12916-019-1285-x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30853029" aria-label="PubMed reference 26">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410528" aria-label="PubMed Central reference 26">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Characterizing%20the%20transitioning%20epidemiology%20of%20herpes%20simplex%20virus%20type%201%20in%20the%20USA%3A%20model-based%20predictions&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-019-1285-x&amp;volume=17&amp;publication_year=2019&amp;author=Ayoub%2CHH&amp;author=Chemaitelly%2CH&amp;author=Abu-Raddad%2CLJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Solis, D. C. et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: a retrospective and cohort natural history study. <i>J. Am. Acad. Dermatol.</i> <b>85</b>, 1296â€“1298 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jaad.2020.08.118" data-track-item_id="10.1016/j.jaad.2020.08.118" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jaad.2020.08.118" aria-label="Article reference 27" data-doi="10.1016/j.jaad.2020.08.118">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32896597" aria-label="PubMed reference 27">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Classification%20of%202%20distinct%20wound%20types%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%3A%20a%20retrospective%20and%20cohort%20natural%20history%20study&amp;journal=J.%20Am.%20Acad.%20Dermatol.&amp;doi=10.1016%2Fj.jaad.2020.08.118&amp;volume=85&amp;pages=1296-1298&amp;publication_year=2021&amp;author=Solis%2CDC">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Woodley, D. T. et al. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. <i>J. Clin. Invest.</i> <b>127</b>, 3028â€“3038 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI92707" data-track-item_id="10.1172/JCI92707" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI92707" aria-label="Article reference 28" data-doi="10.1172/JCI92707">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28691931" aria-label="PubMed reference 28">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531396" aria-label="PubMed Central reference 28">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Gentamicin%20induces%20functional%20type%20VII%20collagen%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%20patients&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI92707&amp;volume=127&amp;pages=3028-3038&amp;publication_year=2017&amp;author=Woodley%2CDT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Keene, D. R., Sakai, L. Y., Lunstrum, G. P., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen forms an extended network of anchoring fibrils. <i>J. Cell Biol.</i> <b>104</b>, 611â€“621 (1987).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1083/jcb.104.3.611" data-track-item_id="10.1083/jcb.104.3.611" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1083%2Fjcb.104.3.611" aria-label="Article reference 29" data-doi="10.1083/jcb.104.3.611">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL2sXhsFelsbs%3D" aria-label="CAS reference 29">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3818794" aria-label="PubMed reference 29">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Type%20VII%20collagen%20forms%20an%20extended%20network%20of%20anchoring%20fibrils&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.104.3.611&amp;volume=104&amp;pages=611-621&amp;publication_year=1987&amp;author=Keene%2CDR&amp;author=Sakai%2CLY&amp;author=Lunstrum%2CGP&amp;author=Morris%2CNP&amp;author=Burgeson%2CRE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Kotterman, M. A., Chalberg, T. W. &amp; Schaffer, D. V. Viral vectors for gene therapy: translational and clinical outlook. <i>Annu. Rev. Biomed. Eng.</i> <b>17</b>, 63â€“89 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1146/annurev-bioeng-071813-104938" data-track-item_id="10.1146/annurev-bioeng-071813-104938" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1146%2Fannurev-bioeng-071813-104938" aria-label="Article reference 30" data-doi="10.1146/annurev-bioeng-071813-104938">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvFOqsL%2FL" aria-label="CAS reference 30">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26643018" aria-label="PubMed reference 30">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Viral%20vectors%20for%20gene%20therapy%3A%20translational%20and%20clinical%20outlook&amp;journal=Annu.%20Rev.%20Biomed.%20Eng.&amp;doi=10.1146%2Fannurev-bioeng-071813-104938&amp;volume=17&amp;pages=63-89&amp;publication_year=2015&amp;author=Kotterman%2CMA&amp;author=Chalberg%2CTW&amp;author=Schaffer%2CDV">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">Wilson, J. M. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. <i>Mol. Genet. Metab.</i> <b>96</b>, 151â€“157 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ymgme.2008.12.016" data-track-item_id="10.1016/j.ymgme.2008.12.016" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ymgme.2008.12.016" aria-label="Article reference 31" data-doi="10.1016/j.ymgme.2008.12.016">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXjt1agtb0%3D" aria-label="CAS reference 31">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19211285" aria-label="PubMed reference 31">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Lessons%20learned%20from%20the%20gene%20therapy%20trial%20for%20ornithine%20transcarbamylase%20deficiency&amp;journal=Mol.%20Genet.%20Metab.&amp;doi=10.1016%2Fj.ymgme.2008.12.016&amp;volume=96&amp;pages=151-157&amp;publication_year=2009&amp;author=Wilson%2CJM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Knight, S., Collins, M. &amp; Takeuchi, Y. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. <i>Curr. Gene Ther.</i> <b>13</b>, 211â€“227 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2174/1566523211313030006" data-track-item_id="10.2174/1566523211313030006" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2174%2F1566523211313030006" aria-label="Article reference 32" data-doi="10.2174/1566523211313030006">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXpt1WnsL0%3D" aria-label="CAS reference 32">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23590635" aria-label="PubMed reference 32">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Insertional%20mutagenesis%20by%20retroviral%20vectors%3A%20current%20concepts%20and%20methods%20of%20analysis&amp;journal=Curr.%20Gene%20Ther.&amp;doi=10.2174%2F1566523211313030006&amp;volume=13&amp;pages=211-227&amp;publication_year=2013&amp;author=Knight%2CS&amp;author=Collins%2CM&amp;author=Takeuchi%2CY">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Chandler, R. J. et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. <i>J. Clin. Invest.</i> <b>125</b>, 870â€“880 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1172/JCI79213" data-track-item_id="10.1172/JCI79213" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1172%2FJCI79213" aria-label="Article reference 33" data-doi="10.1172/JCI79213">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25607839" aria-label="PubMed reference 33">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319425" aria-label="PubMed Central reference 33">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Vector%20design%20influences%20hepatic%20genotoxicity%20after%20adeno-associated%20virus%20gene%20therapy&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI79213&amp;volume=125&amp;pages=870-880&amp;publication_year=2015&amp;author=Chandler%2CRJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Gene therapy needs a long-term approach. <i>Nat. Med</i>. <b>27</b>, 563 (2021).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Cho, R. J. et al. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. <i>Sci. Transl. Med.</i> <b>10</b>(455), eaas9668 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1126/scitranslmed.aas9668" data-track-item_id="10.1126/scitranslmed.aas9668" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1126%2Fscitranslmed.aas9668" aria-label="Article reference 35" data-doi="10.1126/scitranslmed.aas9668">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXisFemtLo%3D" aria-label="CAS reference 35">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30135250" aria-label="PubMed reference 35">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=APOBEC%20mutation%20drives%20early-onset%20squamous%20cell%20carcinomas%20in%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=Sci.%20Transl.%20Med.&amp;doi=10.1126%2Fscitranslmed.aas9668&amp;volume=10&amp;issue=455&amp;publication_year=2018&amp;author=Cho%2CRJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Remington, J. et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. <i>Mol. Ther.</i> <b>17</b>, 26â€“33 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/mt.2008.234" data-track-item_id="10.1038/mt.2008.234" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fmt.2008.234" aria-label="Article reference 36" data-doi="10.1038/mt.2008.234">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtlyhur7O" aria-label="CAS reference 36">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19018253" aria-label="PubMed reference 36">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=Injection%20of%20recombinant%20human%20type%20VII%20collagen%20corrects%20the%20disease%20phenotype%20in%20a%20murine%20model%20of%20dystrophic%20epidermolysis%20bullosa&amp;journal=Mol.%20Ther.&amp;doi=10.1038%2Fmt.2008.234&amp;volume=17&amp;pages=26-33&amp;publication_year=2009&amp;author=Remington%2CJ">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Marinkovich, M. P., Keene, D. R., Rimberg, C. S. &amp; Burgeson, R. E. Cellular origin of the dermalâ€“epidermal basement membrane. <i>Dev. Dyn.</i> <b>197</b>, 255â€“267 (1993).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/aja.1001970404" data-track-item_id="10.1002/aja.1001970404" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Faja.1001970404" aria-label="Article reference 37" data-doi="10.1002/aja.1001970404">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK2c7it1Chuw%3D%3D" aria-label="CAS reference 37">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8292823" aria-label="PubMed reference 37">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Cellular%20origin%20of%20the%20dermal%E2%80%93epidermal%20basement%20membrane&amp;journal=Dev.%20Dyn.&amp;doi=10.1002%2Faja.1001970404&amp;volume=197&amp;pages=255-267&amp;publication_year=1993&amp;author=Marinkovich%2CMP&amp;author=Keene%2CDR&amp;author=Rimberg%2CCS&amp;author=Burgeson%2CRE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Supp, D. M. et al. Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes. <i>Cell Transplant.</i> <b>28</b>, 1242â€“1256 (2019).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1177/0963689719857657" data-track-item_id="10.1177/0963689719857657" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1177%2F0963689719857657" aria-label="Article reference 38" data-doi="10.1177/0963689719857657">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31271052" aria-label="PubMed reference 38">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767893" aria-label="PubMed Central reference 38">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Collagen%20VII%20expression%20is%20required%20in%20both%20keratinocytes%20and%20fibroblasts%20for%20anchoring%20fibril%20formation%20in%20bilayer%20engineered%20skin%20substitutes&amp;journal=Cell%20Transplant.&amp;doi=10.1177%2F0963689719857657&amp;volume=28&amp;pages=1242-1256&amp;publication_year=2019&amp;author=Supp%2CDM">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Gorell, E. S., Nguyen, N., Siprashvili, Z., Marinkovich, M. P. &amp; Lane, A. T. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. <i>Br. J. Dermatol.</i> <b>173</b>, 821â€“823 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/bjd.13737" data-track-item_id="10.1111/bjd.13737" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fbjd.13737" aria-label="Article reference 39" data-doi="10.1111/bjd.13737">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BC2Mrns1Snug%3D%3D" aria-label="CAS reference 39">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25703736" aria-label="PubMed reference 39">PubMed</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545744" aria-label="PubMed Central reference 39">PubMed Central</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Characterization%20of%20patients%20with%20dystrophic%20epidermolysis%20bullosa%20for%20collagen%20VII%20therapy&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fbjd.13737&amp;volume=173&amp;pages=821-823&amp;publication_year=2015&amp;author=Gorell%2CES&amp;author=Nguyen%2CN&amp;author=Siprashvili%2CZ&amp;author=Marinkovich%2CMP&amp;author=Lane%2CAT">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Eng, V. A. et al. Patient reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: a global cross-sectional survey. <i>J. Am. Acad. Dermatol.</i> <b>85</b>, 1161â€“1167 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jaad.2020.03.028" data-track-item_id="10.1016/j.jaad.2020.03.028" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jaad.2020.03.028" aria-label="Article reference 40" data-doi="10.1016/j.jaad.2020.03.028">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32199895" aria-label="PubMed reference 40">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Patient%20reported%20outcomes%20and%20quality%20of%20life%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%3A%20a%20global%20cross-sectional%20survey&amp;journal=J.%20Am.%20Acad.%20Dermatol.&amp;doi=10.1016%2Fj.jaad.2020.03.028&amp;volume=85&amp;pages=1161-1167&amp;publication_year=2021&amp;author=Eng%2CVA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Koster, M. I. Making an epidermis. <i>Ann. NY Acad. Sci.</i> <b>1170</b>, 7â€“10 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1749-6632.2009.04363.x" data-track-item_id="10.1111/j.1749-6632.2009.04363.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1749-6632.2009.04363.x" aria-label="Article reference 41" data-doi="10.1111/j.1749-6632.2009.04363.x">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19686098" aria-label="PubMed reference 41">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Making%20an%20epidermis&amp;journal=Ann.%20NY%20Acad.%20Sci.&amp;doi=10.1111%2Fj.1749-6632.2009.04363.x&amp;volume=1170&amp;pages=7-10&amp;publication_year=2009&amp;author=Koster%2CMI">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Marinkovich, M. P., Lunstrum, G. P., Keene, D. R. &amp; Burgeson, R. E. The dermalâ€“epidermal junction of human skin contains a novel laminin variant. <i>J. Cell Biol.</i> <b>119</b>, 695â€“703 (1992).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1083/jcb.119.3.695" data-track-item_id="10.1083/jcb.119.3.695" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1083%2Fjcb.119.3.695" aria-label="Article reference 42" data-doi="10.1083/jcb.119.3.695">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK38XmtlSkt7g%3D" aria-label="CAS reference 42">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1383241" aria-label="PubMed reference 42">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20dermal%E2%80%93epidermal%20junction%20of%20human%20skin%20contains%20a%20novel%20laminin%20variant&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.119.3.695&amp;volume=119&amp;pages=695-703&amp;publication_year=1992&amp;author=Marinkovich%2CMP&amp;author=Lunstrum%2CGP&amp;author=Keene%2CDR&amp;author=Burgeson%2CRE">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Choate, K. A., Medalie, D. A., Morgan, J. R. &amp; Khavari, P. A. Corrective gene transfer in the human skin disorder lamellar ichthyosis. <i>Nat. Genet.</i> <b>2</b>, 1263â€“1267 (1996).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nm1196-1263" data-track-item_id="10.1038/nm1196-1263" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnm1196-1263" aria-label="Article reference 43" data-doi="10.1038/nm1196-1263">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK28Xms1ajsbo%3D" aria-label="CAS reference 43">CAS</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Corrective%20gene%20transfer%20in%20the%20human%20skin%20disorder%20lamellar%20ichthyosis&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fnm1196-1263&amp;volume=2&amp;pages=1263-1267&amp;publication_year=1996&amp;author=Choate%2CKA&amp;author=Medalie%2CDA&amp;author=Morgan%2CJR&amp;author=Khavari%2CPA">
                    Google Scholar</a>&nbsp;
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Sakai, L. Y., Keene, D. R., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen is a major structural component of anchoring fibrils. <i>J. Cell Biol.</i> <b>103</b>, 1577â€“1586 (1986).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1083/jcb.103.4.1577" data-track-item_id="10.1083/jcb.103.4.1577" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1083%2Fjcb.103.4.1577" aria-label="Article reference 44" data-doi="10.1083/jcb.103.4.1577">Article</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL2sXhsFelsLk%3D" aria-label="CAS reference 44">CAS</a>&nbsp;
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3771648" aria-label="PubMed reference 44">PubMed</a>&nbsp;
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Type%20VII%20collagen%20is%20a%20major%20structural%20component%20of%20anchoring%20fibrils&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.103.4.1577&amp;volume=103&amp;pages=1577-1586&amp;publication_year=1986&amp;author=Sakai%2CLY&amp;author=Keene%2CDR&amp;author=Morris%2CNP&amp;author=Burgeson%2CRE">
                    Google Scholar</a>&nbsp;
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01737-y?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>The authors thank A. Ponakala, S. Boddu, P. Khuu and T. Parry for their assistance with this study, and all of the patients who participated in this trial. This study was funded by Krystal Biotech through a sponsored research award administered through the Stanford University Office of Research Management. M.P.M. also received funding from the Office of Research and Development at the Palo Alto Veterans Affairs Medical Center.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Program in Epithelial Biology and Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA</p><p class="c-article-author-affiliation__authors-list">Irina Gurevich,&nbsp;John A. Dolorito,&nbsp;Isin Sinem Bagci,&nbsp;Kunju Sridhar,&nbsp;Visesha Kakarla,&nbsp;Vamsi K. Yenamandra&nbsp;&amp;&nbsp;M. Peter Marinkovich</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Krystal Biotech, Pittsburgh, PA, USA</p><p class="c-article-author-affiliation__authors-list">Pooja Agarwal,&nbsp;PeiPei Zhang,&nbsp;Stacie Oliver,&nbsp;Henry Liu,&nbsp;Nicholas Reitze,&nbsp;Nikhil Sarma,&nbsp;Mark Oâ€™Malley&nbsp;&amp;&nbsp;Suma M. Krishnan</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA</p><p class="c-article-author-affiliation__authors-list">Marco Prisco&nbsp;&amp;&nbsp;Andrew P. South</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Microscopy Unit, Shriners Hospital for Children, Portland, OR, USA</p><p class="c-article-author-affiliation__authors-list">Sara F. Tufa&nbsp;&amp;&nbsp;Douglas R. Keene</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Veterans Affairs Medical Center, Palo Alto, Stanford, CA, USA</p><p class="c-article-author-affiliation__authors-list">M. Peter Marinkovich</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Irina-Gurevich-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Irina Gurevich</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Irina%20Gurevich" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Irina%20Gurevich" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Irina%20Gurevich%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Pooja-Agarwal-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Pooja Agarwal</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Pooja%20Agarwal" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Pooja%20Agarwal" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Pooja%20Agarwal%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-PeiPei-Zhang-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">PeiPei Zhang</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=PeiPei%20Zhang" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=PeiPei%20Zhang" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22PeiPei%20Zhang%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-John_A_-Dolorito-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">John A. Dolorito</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=John%20A.%20Dolorito" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=John%20A.%20Dolorito" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22John%20A.%20Dolorito%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Stacie-Oliver-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Stacie Oliver</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Stacie%20Oliver" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Stacie%20Oliver" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Stacie%20Oliver%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Henry-Liu-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Henry Liu</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Henry%20Liu" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Henry%20Liu" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Henry%20Liu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Nicholas-Reitze-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Nicholas Reitze</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Nicholas%20Reitze" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Nicholas%20Reitze" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Nicholas%20Reitze%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Nikhil-Sarma-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Nikhil Sarma</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Nikhil%20Sarma" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Nikhil%20Sarma" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Nikhil%20Sarma%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Isin_Sinem-Bagci-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Isin Sinem Bagci</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Isin%20Sinem%20Bagci" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Isin%20Sinem%20Bagci" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Isin%20Sinem%20Bagci%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Kunju-Sridhar-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Kunju Sridhar</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Kunju%20Sridhar" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Kunju%20Sridhar" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Kunju%20Sridhar%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Visesha-Kakarla-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Visesha Kakarla</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Visesha%20Kakarla" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Visesha%20Kakarla" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Visesha%20Kakarla%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Vamsi_K_-Yenamandra-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Vamsi K. Yenamandra</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Vamsi%20K.%20Yenamandra" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Vamsi%20K.%20Yenamandra" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Vamsi%20K.%20Yenamandra%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Mark-O_Malley-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Mark Oâ€™Malley</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Mark%20O%E2%80%99Malley" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Mark%20O%E2%80%99Malley" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Mark%20O%E2%80%99Malley%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Marco-Prisco-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Marco Prisco</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Marco%20Prisco" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marco%20Prisco" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marco%20Prisco%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Sara_F_-Tufa-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Sara F. Tufa</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Sara%20F.%20Tufa" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Sara%20F.%20Tufa" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Sara%20F.%20Tufa%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Douglas_R_-Keene-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Douglas R. Keene</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Douglas%20R.%20Keene" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Douglas%20R.%20Keene" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Douglas%20R.%20Keene%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Andrew_P_-South-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Andrew P. South</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Andrew%20P.%20South" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Andrew%20P.%20South" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Andrew%20P.%20South%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Suma_M_-Krishnan-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Suma M. Krishnan</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Suma%20M.%20Krishnan" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Suma%20M.%20Krishnan" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Suma%20M.%20Krishnan%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-M__Peter-Marinkovich-Aff1-Aff5"><span class="c-article-authors-search__title u-h3 js-search-name">M. Peter Marinkovich</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=M.%20Peter%20Marinkovich" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=M.%20Peter%20Marinkovich" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide">&nbsp;</span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22M.%20Peter%20Marinkovich%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>M.P.M. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: M.P.M., A.P.S., S.M.K. Acquisition, analysis, or interpretation of data: M.P.M., I.G., K.S., V.K., V.K.Y., S.F.T., D.R.K., J.A.D., I.S.B. Drafting of the manuscript: M.P.M. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: M.P.M., S.M.K. Obtained funding: M.P.M. Administrative technical, or material support: S.M.K., P.A., P.P.Z., S.O., H.L., N.R., N.S., M.O., A.P.S., M.P. Supervision: M.P.M., S.M.K. Working in concert with the principal investigator (M.P.M.), the sponsor provided suggestions on the design and conduct of the study, reviewed the data and reviewed the manuscript. M.P.M. made the final decision to submit the manuscript to <i>Nature Medicine</i> for publication.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:mpm@stanford.edu">M. Peter Marinkovich</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
                <h3 class="c-article__sub-heading" id="FPar4">Competing interests</h3>
                <p>M.P.M. received funding from Krystal Biotech to conduct this study through a sponsored research award administered through the Stanford University Office of Research Management. M.P.M. is also an investigator for the following companies that are studying molecular corrective therapies for recessive dystrophic epidermolysis bullosa: Castle Creek Pharmaceuticals, Abeona Therapeutics, WINGS therapeutics and Phoenix Tissue Repair. A.P.S. owns stock in Krystal Biotech. P.A., P.P.Z. and S.O., as well as H.L., N.R., N.S., M.O. and S.M.K. are employees of Krystal Biotech. All other authors have no competing interests.</p>
              
            </div></div></section><section data-title="Peer review"><div class="c-article-section" id="peer-review-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="peer-review">Peer review</h2><div class="c-article-section__content" id="peer-review-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar3">Peer review information</h3>
                <p><i>Nature Medicine</i> thanks David Schaffer and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Anna Maria Ranzoni was the primary editor on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><p><b>Publisherâ€™s note</b> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Extended data"><div class="c-article-section" id="Sec40-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec40">Extended data</h2><div class="c-article-section__content" id="Sec40-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 1 co-expression of c7 with b-ve" href="/articles/s41591-022-01737-y/figures/5" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig5_ESM.jpg">Extended Data Fig. 1 Co-expression of C7 with B-VEC viral markers.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>RDEB fibroblasts and keratinocytes were infected in vitro with B-VEC vector (top 2 rows). Representative of 3 replicates for each condition. RDEB mice were injected intradermally with B-VEC vector (bottom row). Representative of 3 mice; 3 treated back areas per mouse. Co-expression of C7 (yellow) and ICP0 (pink) is shown in RDEB fibroblast culture (top panel), keratinocyte culture (middle panel), and in mouse skin (bottom panel). Scale bar is 100 Î¼m. B-VEC, beremagene geperpavec; RDEB, recessive dystrophic epidermolysis bullosa.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 2 in vivo co-expression of b-ve" href="/articles/s41591-022-01737-y/figures/6" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig6_ESM.jpg">Extended Data Fig. 2 In vivo co-expression of B-VEC and keratinocyte, fibroblast-specific markers.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Threeâ€‰days following B-VEC injection, RDEB mouse skin was biopsied and analyzed by dual label immunofluorescence microscopy using antibodies to the fibroblast marker vimentin (red, arrow upper panel), or antibodies to keratin 14 (yellow, arrow lower panel) combined with antibodies to ICP0. Scale bar is 50 Î¼m. Representative of 3 mice; 3 treated back areas per mouse. B-VEC, beremagene geperpavec; RDEB, recessive dystrophic epidermolysis bullosa.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig7"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 3 overview of phase 1 and 2 stu" href="/articles/s41591-022-01737-y/figures/7" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig7_ESM.jpg">Extended Data Fig. 3 Overview of Phase 1 and 2 study design.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p><sup>a</sup>Three (3) patients were enrolled into both Phase 2a and Phase 2b. These patientsâ€™ Phase 2b wounds were treatment-naÃ¯ve except for chronic (5â€‰year) dorsal foot wound on Pt 3. A wash-out period of 3â€‰months passed between treatments in Phase 2a and 2b. Patients were enrolled in Phase 2a as Pts 3, 5, and 6, and in Phase 2b as Pts 11, 8, and 7, respectively. <sup>1</sup>Phase 1, 2a, 2b, 2c; all interventions all wounds. <sup>2</sup>Phase 1, 2a, 2b; randomized wounds (Pt 12, 2c considered separately for efficacy). <sup>3</sup>Patients were enrolled in Phase 2a as Pts 3, 5, and 6 and in Phase 2b as Pts 11, 8, and 7, respectively. Pt, Patient.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig8"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 4 patient antibody analysis." href="/articles/s41591-022-01737-y/figures/8" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig8_ESM.jpg">Extended Data Fig. 4 Patient antibody analysis.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>A. Quantification of collagen VII antibodies in patient sera. Patient sera was collected at baseline (day 0) or at indicated times following initiation of B-VEC treatment and analyzed for presence of collagen VII IgG antibodies using ELISA. A level greater than or equal to 20 reference units (RU) per mL is considered to be positive. B. Quantification of HSV-1 antibodies in patient sera. Patient sera was collected at baseline (day 0) or at indicated times following initiation of B-VEC treatment and analyzed for the presence of antibodies against HSV using a qualified Plaque Reduction Neutralization Test (PRNT), which utilizes B-VEC. *Patients 3, 5, and 6 subsequently re-enrolled as Patients 11, 8, and 7, respectively. B-VEC, beremagene geperpavec; ELISA, enzyme-linked immunosorbent assay; HSV-1, herpes simplex virus type 1; IgG, immunoglobulin G; RDEB, recessive dystrophic epidermolysis bullosa.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig9"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 5 b-vec treatment of large chro" href="/articles/s41591-022-01737-y/figures/9" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig9_ESM.jpg">Extended Data Fig. 5 B-VEC treatment of large chronic wound.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Results of Patient 12 treatment after two cycles of topical B-VEC therapy. Left panel shows presence of chronic wound 1â€‰year prior to treatment. Center panel shows baseline appearance. Right panel shows the wound following B-VEC treatment. B-VEC, beremagene geperpavec.</p></div></div><div class="c-article-supplementary__item js-c-reading-companion-figures-item" data-test="supp-item" id="Fig10"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="extended data fig. 6 patient 12, % change from bas" href="/articles/s41591-022-01737-y/figures/10" data-supp-info-image="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig10_ESM.jpg">Extended Data Fig. 6 Patient 12, % change from baseline over time.</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>The percent change in wound surface area for both B-VEC and placebo wounds was calculated over the course of treatment of Patient 12 and was plotted as a bar graph (end of cycle, % change area of wound from baseline). B-VEC, beremagene geperpavec.</p></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-3"><figure><figcaption class="c-article-table__figcaption"><b id="Tab3" data-test="table-caption">Extended Data Table 1 Summary of protocol phases/versions and amendments submitted to FDA and oversight committees</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/3" aria-label="Full size table 3"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-4"><figure><figcaption class="c-article-table__figcaption"><b id="Tab4" data-test="table-caption">Extended Data Table 2 Patient wound disposition and treatment</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/4" aria-label="Full size table 4"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-5"><figure><figcaption class="c-article-table__figcaption"><b id="Tab5" data-test="table-caption">Extended Data Table 3 Adverse events list</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/5" aria-label="Full size table 5"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div><div class="c-article-supplementary__item" data-test="supp-item"><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-6"><figure><figcaption class="c-article-table__figcaption"><b id="Tab6" data-test="table-caption">Extended Data Table 4 Supplemental analysis of reduction in wound surface area</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41591-022-01737-y/tables/6" aria-label="Full size table 6"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div></div></div></div></section><section data-title="Supplementary information"><div class="c-article-section" id="Sec41-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec41">Supplementary information</h2><div class="c-article-section__content" id="Sec41-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary information" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM1_ESM.pdf" data-supp-info-image="">Supplementary Information</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Supplementary Tables 1â€“5, Supplementary Fig. 1</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="reporting summary" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM2_ESM.pdf" data-supp-info-image="">Reporting Summary</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM3"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary video 1" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM3_ESM.mov" data-supp-info-image="">Supplementary Video 1</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Functional demonstration of dermalâ€“epidermal cohesion following B-VEC therapy</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM4"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary video 2" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM4_ESM.mov" data-supp-info-image="">Supplementary Video 2</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Functional demonstration of dermalâ€“epidermal cohesion following B-VEC therapy</p></div></div></div></div></div></section><section data-title="Source data"><div class="c-article-section" id="Sec42-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec42">Source data</h2><div class="c-article-section__content" id="Sec42-content"><div data-test="supplementary-info"><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM5"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="source data for figs. 1b, 1c, 1g, 1h" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM5_ESM.xlsx" data-supp-info-image="">Source Data for Figs. 1B, 1C, 1G, 1H</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Statistical source data</p></div></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM6"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="source data for fig. 1d" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_MOESM6_ESM.jpg" data-supp-info-image="">Source Data for Fig. 1d</a></h3><div class="c-article-supplementary__description" data-component="thumbnail-container"><p>Unprocessed Western blots</p></div></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the articleâ€™s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the articleâ€™s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=In%20vivo%20topical%20gene%20therapy%20for%20recessive%20dystrophic%20epidermolysis%20bullosa%3A%20a%20phase%201%20and%202%20trial&amp;author=Irina%20Gurevich%20et%20al&amp;contentID=10.1038%2Fs41591-022-01737-y&amp;copyright=This%20is%20a%20U.S.%20government%20work%20and%20not%20under%20copyright%20protection%20in%20the%20U.S.%3B%20foreign%20copyright%20protection%20may%20apply&amp;publication=1078-8956&amp;publicationDate=2022-03-28&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41591-022-01737-y" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41591-022-01737-y" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Gurevich, I., Agarwal, P., Zhang, P. <i>et al.</i> In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
                    <i>Nat Med</i> <b>28</b>, 780â€“788 (2022). https://doi.org/10.1038/s41591-022-01737-y</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41591-022-01737-y?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2021-04-26">26 April 2021</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-02-08">08 February 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-03-28">28 March 2022</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Issue Date<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2022-04">April 2022</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41591-022-01737-y</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-block"><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><div data-component="article-info-list">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/genetics-research" data-track="click" data-track-action="view subject" data-track-label="link">Genetics research</a></li><li class="c-article-subject-list__subject"><a href="/subjects/translational-research" data-track="click" data-track-action="view subject" data-track-label="link">Translational research</a></li>
        </ul>
    </div></div></div></div></div></section>
            </div>

            
        <section>
            <div class="c-article-section js-article-section" id="further-reading-section" data-test="further-reading-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="further-reading">This article is cited by</h2>
                <div class="c-article-section__content js-collapsible-section" id="further-reading-content">
                    <ul class="c-article-further-reading__list" id="further-reading-list">
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa" href="https://doi.org/10.1038/s41467-025-55934-7">
                                        Systems immunology integrates the complex endotypes of recessive dystrophic epidermolysis bullosa
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Nell Hirt</li><li>Enzo Manchon</li><li>Reem Al-Daccak</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Nature Communications</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa" href="https://doi.org/10.1007/s40257-025-00942-y">
                                        Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>M. Peter Marinkovich</li><li>Amy S. Paller</li><li>Suma M. Krishnan</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>American Journal of Clinical Dermatology</i> (2025)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Cas12f1 gene drives propagate efficiently in herpesviruses and induce minimal resistance" href="https://doi.org/10.1186/s13059-024-03455-9">
                                        Cas12f1 gene drives propagate efficiently in herpesviruses and induce minimal resistance
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Zhuangjie Lin</li><li>Qiaorui Yao</li><li>Hongsheng Dai</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Genome Biology</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights" href="https://doi.org/10.1186/s42826-024-00195-6">
                                        A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Parham Soufizadeh</li><li>Vahid Mansouri</li><li>Naser Ahmadbeigi</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Laboratory Animal Research</i> (2024)</p>
                            </li>
                        
                            <li class="c-article-further-reading__item js-ref-item">
                            
                                <h3 class="c-article-further-reading__title" data-test="article-title">
                                    <a class="print-link" data-track="click" data-track-action="view further reading article" data-track-label="link:Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an update" href="https://doi.org/10.1038/s41434-024-00500-x">
                                        Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an update
                                    </a>
                                </h3>
                            
                                
                                    <ul data-test="author-list" class="app-author-list app-author-list--compact app-author-list--truncated u-sans-serif u-mb-4 u-mt-auto">
                                        <li>Matthieu Le Hars</li><li>Charles Joussain</li><li>Alberto L. Epstein</li>
                                    </ul>
                                
                                <p class="c-article-further-reading__journal-title"><i>Gene Therapy</i> (2024)</p>
                            </li>
                        
                    </ul>
                </div>
            </div>
        </section>
    

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion="" data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41591-022-01737-y.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external="" download="">
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"></use></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky" style="top: 40px;">
            <ul class="c-reading-companion__tabs" role="tablist"><li role="presentation"><button data-tab-target="sections" role="tab" id="tab-sections" aria-controls="tabpanel-sections" aria-selected="true" class="c-reading-companion__tab c-reading-companion__tab--active" data-track="click" data-track-action="sections tab" data-track-label="tab">Sections</button></li><li role="presentation"><button data-tab-target="figures" role="tab" id="tab-figures" aria-controls="tabpanel-figures" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="figures tab" data-track-label="tab">Figures</button></li><li role="presentation"><button data-tab-target="references" role="tab" id="tab-references" aria-controls="tabpanel-references" aria-selected="false" tabindex="-1" class="c-reading-companion__tab" data-track="click" data-track-action="references tab" data-track-label="tab">References</button></li></ul><div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections" aria-labelledby="tab-sections" role="tabpanel"><div class="c-reading-companion__scroll-pane" style="max-height: none;"><ul class="c-reading-companion__sections-list"><li id="rc-sec-Abs1" class="c-reading-companion__section-item"><a href="#Abs1" data-track="click" data-track-action="section anchor" data-track-label="link:Abstract">Abstract</a></li><li id="rc-sec-Sec1" class="c-reading-companion__section-item"><a href="#Sec1" data-track="click" data-track-action="section anchor" data-track-label="link:Main">Main</a></li><li id="rc-sec-Sec2" class="c-reading-companion__section-item"><a href="#Sec2" data-track="click" data-track-action="section anchor" data-track-label="link:Results">Results</a></li><li id="rc-sec-Sec9" class="c-reading-companion__section-item"><a href="#Sec9" data-track="click" data-track-action="section anchor" data-track-label="link:Discussion">Discussion</a></li><li id="rc-sec-Sec10" class="c-reading-companion__section-item"><a href="#Sec10" data-track="click" data-track-action="section anchor" data-track-label="link:Methods">Methods</a></li><li id="rc-sec-data-availability" class="c-reading-companion__section-item"><a href="#data-availability" data-track="click" data-track-action="section anchor" data-track-label="link:Data availability">Data availability</a></li><li id="rc-sec-Bib1" class="c-reading-companion__section-item"><a href="#Bib1" data-track="click" data-track-action="section anchor" data-track-label="link:References">References</a></li><li id="rc-sec-Ack1" class="c-reading-companion__section-item"><a href="#Ack1" data-track="click" data-track-action="section anchor" data-track-label="link:Acknowledgements">Acknowledgements</a></li><li id="rc-sec-author-information" class="c-reading-companion__section-item"><a href="#author-information" data-track="click" data-track-action="section anchor" data-track-label="link:Author information">Author information</a></li><li id="rc-sec-ethics" class="c-reading-companion__section-item"><a href="#ethics" data-track="click" data-track-action="section anchor" data-track-label="link:Ethics declarations">Ethics declarations</a></li><li id="rc-sec-peer-review" class="c-reading-companion__section-item"><a href="#peer-review" data-track="click" data-track-action="section anchor" data-track-label="link:Peer review">Peer review</a></li><li id="rc-sec-additional-information" class="c-reading-companion__section-item"><a href="#additional-information" data-track="click" data-track-action="section anchor" data-track-label="link:Additional information">Additional information</a></li><li id="rc-sec-Sec40" class="c-reading-companion__section-item"><a href="#Sec40" data-track="click" data-track-action="section anchor" data-track-label="link:Extended data">Extended data</a></li><li id="rc-sec-Sec41" class="c-reading-companion__section-item"><a href="#Sec41" data-track="click" data-track-action="section anchor" data-track-label="link:Supplementary information">Supplementary information</a></li><li id="rc-sec-Sec42" class="c-reading-companion__section-item"><a href="#Sec42" data-track="click" data-track-action="section anchor" data-track-label="link:Source data">Source data</a></li><li id="rc-sec-rightslink" class="c-reading-companion__section-item"><a href="#rightslink" data-track="click" data-track-action="section anchor" data-track-label="link:Rights and permissions">Rights and permissions</a></li><li id="rc-sec-article-info" class="c-reading-companion__section-item"><a href="#article-info" data-track="click" data-track-action="section anchor" data-track-label="link:About this article">About this article</a></li><li id="rc-sec-further-reading" class="c-reading-companion__section-item"><a href="#further-reading" data-track="click" data-track-action="section anchor" data-track-label="link:This article is cited by">This article is cited by</a></li></ul></div>
                <div class="u-lazy-ad-wrapper u-mt-16 u-show" data-component-mpu="" style="display: none !important;">
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2" class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide" data-ad-type="right" data-test="right-ad" data-pa11y-ignore="" data-gpt="" data-gpt-unitpath="/285/medicine.nature.com/article" data-gpt-sizes="300x250" data-gpt-targeting="type=article;pos=right;artid=s41591-022-01737-y;doi=10.1038/s41591-022-01737-y;subjmeta=2056,308,575,692;kwrd=Genetics+research,Translational+research">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=-347599032&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01737-y%26doi%3D10.1038/s41591-022-01737-y%26subjmeta%3D2056,308,575,692%26kwrd%3DGenetics+research,Translational+research">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/medicine.nature.com/article&amp;sz=300x250&amp;c=-347599032&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41591-022-01737-y%26doi%3D10.1038/s41591-022-01737-y%26subjmeta%3D2056,308,575,692%26kwrd%3DGenetics+research,Translational+research"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures" aria-labelledby="tab-figures" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ul class="c-reading-companion__figures-list"><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig1">Fig. 1: Collagen VII (C7) expression in primary RDEB patient cells, RDEB mice, and human RDEB xenografts on immunodeficient mice following B-VEC therapy.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig1_HTML.png" alt="figure 1" aria-describedby="rc-Fig1"></picture><p class="c-reading-companion__figure-links"><a href="#Fig1" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/1" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig2">Fig. 2: Trial profile.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig2_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig2_HTML.png" alt="figure 2" aria-describedby="rc-Fig2"></picture><p class="c-reading-companion__figure-links"><a href="#Fig2" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/2" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig3">Fig. 3: Assessment of RDEB patient skin wound healing following topical B-VEC or placebo.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig3_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig3_HTML.png" alt="figure 3" aria-describedby="rc-Fig3"></picture><p class="c-reading-companion__figure-links"><a href="#Fig3" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/3" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig4">Fig. 4: C7 expression and AF formation after B-VEC topical therapy.</b></figcaption><picture><source data-srcset="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig4_HTML.png?"><img data-src="https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig4_HTML.png" alt="figure 4" aria-describedby="rc-Fig4"></picture><p class="c-reading-companion__figure-links"><a href="#Fig4" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/4" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig5">Extended Data Fig. 1 Co-expression of C7 with B-VEC viral markers.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig5_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig5_ESM.jpg" alt="extended data figure 5" aria-describedby="rc-Fig5"></picture><p class="c-reading-companion__figure-links"><a href="#Fig5" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/5" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig6">Extended Data Fig. 2 In vivo co-expression of B-VEC and keratinocyte, fibroblast-specific markers.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig6_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig6_ESM.jpg" alt="extended data figure 6" aria-describedby="rc-Fig6"></picture><p class="c-reading-companion__figure-links"><a href="#Fig6" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/6" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig7">Extended Data Fig. 3 Overview of Phase 1 and 2 study design.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig7_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig7_ESM.jpg" alt="extended data figure 7" aria-describedby="rc-Fig7"></picture><p class="c-reading-companion__figure-links"><a href="#Fig7" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/7" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig8">Extended Data Fig. 4 Patient antibody analysis.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig8_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig8_ESM.jpg" alt="extended data figure 8" aria-describedby="rc-Fig8"></picture><p class="c-reading-companion__figure-links"><a href="#Fig8" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/8" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig9">Extended Data Fig. 5 B-VEC treatment of large chronic wound.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig9_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig9_ESM.jpg" alt="extended data figure 9" aria-describedby="rc-Fig9"></picture><p class="c-reading-companion__figure-links"><a href="#Fig9" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/9" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li><li class="c-reading-companion__figure-item"><figure><figcaption><b class="c-reading-companion__figure-title u-h4" id="rc-Fig10">Extended Data Fig. 6 Patient 12, % change from baseline over time.</b></figcaption><picture><source data-srcset="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig10_ESM.jpg?"><img data-src="//media.springernature.com/lw685/springer-static/esm/art%3A10.1038%2Fs41591-022-01737-y/MediaObjects/41591_2022_1737_Fig10_ESM.jpg" alt="extended data figure 10" aria-describedby="rc-Fig10"></picture><p class="c-reading-companion__figure-links"><a href="#Fig10" data-track="click" data-track-action="figure anchor" data-track-label="link">View in article</a><a href="https://www.nature.com/articles/s41591-022-01737-y/figures/10" class="c-reading-companion__figure-full-link" data-track="click" data-track-action="view figure" data-track-label="link" rel="nofollow">Full size image<svg width="16" height="16" class="u-icon"><use href="#icon-chevron-right"></use></svg></a></p></figure></li></ul></div></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references" aria-labelledby="tab-references" role="tabpanel"><div class="c-reading-companion__scroll-pane"><ol class="c-reading-companion__references-list c-reading-companion__references-list--numeric" data-track-context="article references sidebar"><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR1">Fine, J.-D. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. <i>JAMA Dermatol.</i> <b>152</b>, 1231â€“1238 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjamadermatol.2016.2473" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jamadermatol.2016.2473" data-track-item_id="10.1001/jamadermatol.2016.2473">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27463098" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Epidemiology%20of%20inherited%20epidermolysis%20bullosa%20based%20on%20incidence%20and%20prevalence%20estimates%20from%20the%20National%20Epidermolysis%20Bullosa%20Registry&amp;journal=JAMA%20Dermatol.&amp;doi=10.1001%2Fjamadermatol.2016.2473&amp;volume=152&amp;pages=1231-1238&amp;publication_year=2016&amp;author=Fine%2CJ-D" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR2">Rousselle, P. et al. Laminin 5 binds the NC-1 domain of type VII collagen. <i>J. Cell Biol.</i> <b>138</b>, 719â€“728 (1997).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1083%2Fjcb.138.3.719" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1083/jcb.138.3.719" data-track-item_id="10.1083/jcb.138.3.719">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK2sXltlKhs7k%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9245798" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2141627" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Laminin%205%20binds%20the%20NC-1%20domain%20of%20type%20VII%20collagen&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.138.3.719&amp;volume=138&amp;pages=719-728&amp;publication_year=1997&amp;author=Rousselle%2CP" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR3">Chen, M. et al. Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermalâ€“dermal adherence in human skin. <i>J. Biol. Chem.</i> <b>272</b>, 14516â€“14522 (1997).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1074%2Fjbc.272.23.14516" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1074/jbc.272.23.14516" data-track-item_id="10.1074/jbc.272.23.14516">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK2sXjslagsb4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9169408" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Interactions%20of%20the%20amino-terminal%20noncollagenous%20%28NC1%29%20domain%20of%20type%20VII%20collagen%20with%20extracellular%20matrix%20components.%20A%20potential%20role%20in%20epidermal%E2%80%93dermal%20adherence%20in%20human%20skin&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.272.23.14516&amp;volume=272&amp;pages=14516-14522&amp;publication_year=1997&amp;author=Chen%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR4">Bruckner-Tuderman, L. et al. Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain. <i>J. Cell Biol.</i> <b>131</b>, 551â€“559 (1995).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1083%2Fjcb.131.2.551" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1083/jcb.131.2.551" data-track-item_id="10.1083/jcb.131.2.551">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK2MXosFygtbk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7593178" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immunohistochemical%20and%20mutation%20analyses%20demonstrate%20that%20procollagen%20VII%20is%20processed%20to%20collagen%20VII%20through%20removal%20of%20the%20NC-2%20domain&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.131.2.551&amp;volume=131&amp;pages=551-559&amp;publication_year=1995&amp;author=Bruckner-Tuderman%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR5">Marinkovich, M. P. Inherited epidermolysis bullosa. In <i>Fitzpatrickâ€™s Dermatology</i> 9th edn (eds Kang, S. et al.) Ch. 60 (McGraw Hill Medical, 2019).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR6">Has, C. et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. <i>Br. J. Dermatol.</i> <b>183</b>, 614â€“627 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fbjd.18921" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/bjd.18921" data-track-item_id="10.1111/bjd.18921">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BB38%2FotVWlsg%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32017015" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Consensus%20reclassification%20of%20inherited%20epidermolysis%20bullosa%20and%20other%20disorders%20with%20skin%20fragility&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fbjd.18921&amp;volume=183&amp;pages=614-627&amp;publication_year=2020&amp;author=Has%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR7">Tang, J. Y. et al. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. <i>Orphanet J. Rare Dis.</i> <b>16</b>, 175 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s13023-021-01811-7" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s13023-021-01811-7" data-track-item_id="10.1186/s13023-021-01811-7">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33849616" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045359" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20systematic%20literature%20review%20of%20the%20disease%20burden%20in%20patients%20with%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=Orphanet%20J.%20Rare%20Dis.&amp;doi=10.1186%2Fs13023-021-01811-7&amp;volume=16&amp;publication_year=2021&amp;author=Tang%2CJY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR8">Marinkovich, M. P. &amp; Tang, J. Y. Gene therapy for epidermolysis bullosa. <i>J. Invest. Dermatol.</i> <b>139</b>, 1221â€“1226 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.jid.2018.11.036" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.jid.2018.11.036" data-track-item_id="10.1016/j.jid.2018.11.036">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXovFegt74%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31068252" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Gene%20therapy%20for%20epidermolysis%20bullosa&amp;journal=J.%20Invest.%20Dermatol.&amp;doi=10.1016%2Fj.jid.2018.11.036&amp;volume=139&amp;pages=1221-1226&amp;publication_year=2019&amp;author=Marinkovich%2CMP&amp;author=Tang%2CJY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR9">Wagner, J. E. et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. <i>N. Engl. J. Med.</i> <b>363</b>, 629â€“639 (2010).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1056%2FNEJMoa0910501" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1056/NEJMoa0910501" data-track-item_id="10.1056/NEJMoa0910501">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtVamsLfL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20818854" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967187" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Bone%20marrow%20transplantation%20for%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa0910501&amp;volume=363&amp;pages=629-639&amp;publication_year=2010&amp;author=Wagner%2CJE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR10">Eichstadt, S. et al. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. <i>JCI Insight</i> <b>4</b>, e130554 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2Fjci.insight.130554" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/jci.insight.130554" data-track-item_id="10.1172/jci.insight.130554">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795403" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Phase%201%2F2a%20clinical%20trial%20of%20gene-corrected%20autologous%20cell%20therapy%20for%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JCI%20Insight&amp;doi=10.1172%2Fjci.insight.130554&amp;volume=4&amp;publication_year=2019&amp;author=Eichstadt%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR11">Siprashvili, Z. et al. Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa. <i>JAMA</i> <b>316</b>, 1808â€“1817 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1001%2Fjama.2016.15588" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1001/jama.2016.15588" data-track-item_id="10.1001/jama.2016.15588">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27802546" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20wound%20outcomes%20following%20genetically%20corrected%20autologous%20epidermal%20grafts%20in%20patients%20with%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JAMA&amp;doi=10.1001%2Fjama.2016.15588&amp;volume=316&amp;pages=1808-1817&amp;publication_year=2016&amp;author=Siprashvili%2CZ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR12">Hirsch, T. et al. Regeneration of the entire human epidermis using transgenic stem cells. <i>Nature</i> <b>551</b>, 327â€“332 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnature24487" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nature24487" data-track-item_id="10.1038/nature24487">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslygtLvE" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29144448" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283270" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Regeneration%20of%20the%20entire%20human%20epidermis%20using%20transgenic%20stem%20cells&amp;journal=Nature&amp;doi=10.1038%2Fnature24487&amp;volume=551&amp;pages=327-332&amp;publication_year=2017&amp;author=Hirsch%2CT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR13">Lwin, S. M. et al. Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. <i>JCI Insight</i> <b>4</b>, e126243 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2Fjci.insight.126243" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/jci.insight.126243" data-track-item_id="10.1172/jci.insight.126243">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629162" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Safety%20and%20early%20efficacy%20outcomes%20for%20lentiviral%20fibroblast%20gene%20therapy%20in%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=JCI%20Insight&amp;doi=10.1172%2Fjci.insight.126243&amp;volume=4&amp;publication_year=2019&amp;author=Lwin%2CSM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR14">Fan, H., Lin, Q., Morrissey, G. R. &amp; Khavari, P. A. Immunization via hair follicles by topical application of naked DNA to normal skin. <i>Nat. Biotechnol.</i> <b>17</b>, 870â€“872 (1999).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2F12856" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/12856" data-track-item_id="10.1038/12856">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK1MXlslOgtbs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10471927" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immunization%20via%20hair%20follicles%20by%20topical%20application%20of%20naked%20DNA%20to%20normal%20skin&amp;journal=Nat.%20Biotechnol.&amp;doi=10.1038%2F12856&amp;volume=17&amp;pages=870-872&amp;publication_year=1999&amp;author=Fan%2CH&amp;author=Lin%2CQ&amp;author=Morrissey%2CGR&amp;author=Khavari%2CPA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR15">Shirley, J. L., de Jong, Y. P., Terhorst, C. &amp; Herzog, R. W. Immune responses to viral gene therapy vectors. <i>Mol. Ther.</i> <b>28</b>, 709â€“722 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ymthe.2020.01.001" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ymthe.2020.01.001" data-track-item_id="10.1016/j.ymthe.2020.01.001">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXnsVyqtrY%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31968213" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054714" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Immune%20responses%20to%20viral%20gene%20therapy%20vectors&amp;journal=Mol.%20Ther.&amp;doi=10.1016%2Fj.ymthe.2020.01.001&amp;volume=28&amp;pages=709-722&amp;publication_year=2020&amp;author=Shirley%2CJL&amp;author=Jong%2CYP&amp;author=Terhorst%2CC&amp;author=Herzog%2CRW" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR16">Heldwein, E. E. &amp; Krummenacher, C. Entry of herpesviruses into mammalian cells. <i>Cell. Mol. Life Sci.</i> <b>65</b>, 1653â€“1668 (2008).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1007/s00018-008-7570-z" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1007/s00018-008-7570-z" data-track-item_id="10.1007/s00018-008-7570-z">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXmslyltr4%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18351291" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Entry%20of%20herpesviruses%20into%20mammalian%20cells&amp;journal=Cell.%20Mol.%20Life%20Sci.&amp;doi=10.1007%2Fs00018-008-7570-z&amp;volume=65&amp;pages=1653-1668&amp;publication_year=2008&amp;author=Heldwein%2CEE&amp;author=Krummenacher%2CC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR17">Tognarelli, E. I. et al. Herpes simplex virus evasion of early host antiviral responses. <i>Front. Cell. Infect. Microbiol.</i> <b>9</b>, 127 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.3389%2Ffcimb.2019.00127" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.3389/fcimb.2019.00127" data-track-item_id="10.3389/fcimb.2019.00127">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXhslClt7o%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31114761" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503643" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Herpes%20simplex%20virus%20evasion%20of%20early%20host%20antiviral%20responses&amp;journal=Front.%20Cell.%20Infect.%20Microbiol.&amp;doi=10.3389%2Ffcimb.2019.00127&amp;volume=9&amp;publication_year=2019&amp;author=Tognarelli%2CEI" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR18">Yang, L. et al. Innate immune evasion of alphaherpesvirus tegument proteins. <i>Front. Immunol.</i> <b>10</b>, 2196 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.3389%2Ffimmu.2019.02196" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.3389/fimmu.2019.02196" data-track-item_id="10.3389/fimmu.2019.02196">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXns1Gkt7k%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31572398" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753173" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Innate%20immune%20evasion%20of%20alphaherpesvirus%20tegument%20proteins&amp;journal=Front.%20Immunol.&amp;doi=10.3389%2Ffimmu.2019.02196&amp;volume=10&amp;publication_year=2019&amp;author=Yang%2CL" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR19">Oldham, M. L. et al. A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter. <i>Nature</i> <b>529</b>, 537â€“540 (2016).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnature16506" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nature16506" data-track-item_id="10.1038/nature16506">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC28XhtFOku7s%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26789246" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848044" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20mechanism%20of%20viral%20immune%20evasion%20revealed%20by%20cryo-EM%20analysis%20of%20the%20TAP%20transporter&amp;journal=Nature&amp;doi=10.1038%2Fnature16506&amp;volume=529&amp;pages=537-540&amp;publication_year=2016&amp;author=Oldham%2CML" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR20">Goins, W. F. et al. Engineering HSV-1 vectors for gene therapy. <i>Methods Mol. Biol.</i> <b>2060</b>, 73â€“90 (2020).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1007/978-1-4939-9814-2_4" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1007/978-1-4939-9814-2_4" data-track-item_id="10.1007/978-1-4939-9814-2_4">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BB3cXntlChsro%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31617173" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Engineering%20HSV-1%20vectors%20for%20gene%20therapy&amp;journal=Methods%20Mol.%20Biol.&amp;doi=10.1007%2F978-1-4939-9814-2_4&amp;volume=2060&amp;pages=73-90&amp;publication_year=2020&amp;author=Goins%2CWF" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR21">Epstein, A. L., Marconi, P., Argnani, R. &amp; Manservigi, R. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. <i>Curr. Gene Ther.</i> <b>5</b>, 445â€“458 (2005).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.2174%2F156652305774329285" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.2174/156652305774329285" data-track-item_id="10.2174/156652305774329285">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2MXhtV2gt7%2FP" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16250886" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=HSV-1-derived%20recombinant%20and%20amplicon%20vectors%20for%20gene%20transfer%20and%20gene%20therapy&amp;journal=Curr.%20Gene%20Ther.&amp;doi=10.2174%2F156652305774329285&amp;volume=5&amp;pages=445-458&amp;publication_year=2005&amp;author=Epstein%2CAL&amp;author=Marconi%2CP&amp;author=Argnani%2CR&amp;author=Manservigi%2CR" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR22">Fritsch, A. et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. <i>J. Clin. Invest.</i> <b>118</b>, 1669â€“1679 (2008).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI34292" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI34292" data-track-item_id="10.1172/JCI34292">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXlsF2ntLw%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18382769" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276400" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=A%20hypomorphic%20mouse%20model%20of%20dystrophic%20epidermolysis%20bullosa%20reveals%20mechanisms%20of%20disease%20and%20response%20to%20fibroblast%20therapy&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI34292&amp;volume=118&amp;pages=1669-1679&amp;publication_year=2008&amp;author=Fritsch%2CA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR23">Ortiz-Urda, S. et al. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. <i>J. Clin. Invest.</i> <b>111</b>, 251â€“255 (2003).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI200317193" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI200317193" data-track-item_id="10.1172/JCI200317193">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD3sXlsVGqsA%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=12531881" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC151880" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Injection%20of%20genetically%20engineered%20fibroblasts%20corrects%20regenerated%20human%20epidermolysis%20bullosa%20skin%20tissue&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI200317193&amp;volume=111&amp;pages=251-255&amp;publication_year=2003&amp;author=Ortiz-Urda%2CS" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR24">Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. <i>Nature</i> <b>493</b>, 231â€“235 (2013).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnature11661" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nature11661" data-track-item_id="10.1038/nature11661">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC38XhslyntbbF" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23201690" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Control%20of%20somatic%20tissue%20differentiation%20by%20the%20long%20non-coding%20RNA%20TINCR&amp;journal=Nature&amp;doi=10.1038%2Fnature11661&amp;volume=493&amp;pages=231-235&amp;publication_year=2013&amp;author=Kretz%2CM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR25">Ishii, N. et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. <i>Br. J. Dermatol.</i> <b>150</b>, 843â€“851 (2004).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fj.1365-2133.2004.05933.x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/j.1365-2133.2004.05933.x" data-track-item_id="10.1111/j.1365-2133.2004.05933.x">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD2cXlt1Kgurs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15149495" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Epidermolysis%20bullosa%20acquisita%20sera%20react%20with%20distinct%20epitopes%20on%20the%20NC1%20and%20NC2%20domains%20of%20type%20VII%20collagen%3A%20study%20using%20immunoblotting%20of%20domain-specific%20recombinant%20proteins%20and%20postembedding%20immunoelectron%20microscopy&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fj.1365-2133.2004.05933.x&amp;volume=150&amp;pages=843-851&amp;publication_year=2004&amp;author=Ishii%2CN" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR26">Ayoub, H. H., Chemaitelly, H. &amp; Abu-Raddad, L. J. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. <i>BMC Med.</i> <b>17</b>, 57 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://link.springer.com/doi/10.1186/s12916-019-1285-x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1186/s12916-019-1285-x" data-track-item_id="10.1186/s12916-019-1285-x">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30853029" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410528" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Characterizing%20the%20transitioning%20epidemiology%20of%20herpes%20simplex%20virus%20type%201%20in%20the%20USA%3A%20model-based%20predictions&amp;journal=BMC%20Med.&amp;doi=10.1186%2Fs12916-019-1285-x&amp;volume=17&amp;publication_year=2019&amp;author=Ayoub%2CHH&amp;author=Chemaitelly%2CH&amp;author=Abu-Raddad%2CLJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR27">Solis, D. C. et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: a retrospective and cohort natural history study. <i>J. Am. Acad. Dermatol.</i> <b>85</b>, 1296â€“1298 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.jaad.2020.08.118" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.jaad.2020.08.118" data-track-item_id="10.1016/j.jaad.2020.08.118">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32896597" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Classification%20of%202%20distinct%20wound%20types%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%3A%20a%20retrospective%20and%20cohort%20natural%20history%20study&amp;journal=J.%20Am.%20Acad.%20Dermatol.&amp;doi=10.1016%2Fj.jaad.2020.08.118&amp;volume=85&amp;pages=1296-1298&amp;publication_year=2021&amp;author=Solis%2CDC" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR28">Woodley, D. T. et al. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. <i>J. Clin. Invest.</i> <b>127</b>, 3028â€“3038 (2017).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI92707" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI92707" data-track-item_id="10.1172/JCI92707">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28691931" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531396" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Gentamicin%20induces%20functional%20type%20VII%20collagen%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%20patients&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI92707&amp;volume=127&amp;pages=3028-3038&amp;publication_year=2017&amp;author=Woodley%2CDT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR29">Keene, D. R., Sakai, L. Y., Lunstrum, G. P., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen forms an extended network of anchoring fibrils. <i>J. Cell Biol.</i> <b>104</b>, 611â€“621 (1987).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1083%2Fjcb.104.3.611" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1083/jcb.104.3.611" data-track-item_id="10.1083/jcb.104.3.611">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaL2sXhsFelsbs%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3818794" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Type%20VII%20collagen%20forms%20an%20extended%20network%20of%20anchoring%20fibrils&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.104.3.611&amp;volume=104&amp;pages=611-621&amp;publication_year=1987&amp;author=Keene%2CDR&amp;author=Sakai%2CLY&amp;author=Lunstrum%2CGP&amp;author=Morris%2CNP&amp;author=Burgeson%2CRE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR30">Kotterman, M. A., Chalberg, T. W. &amp; Schaffer, D. V. Viral vectors for gene therapy: translational and clinical outlook. <i>Annu. Rev. Biomed. Eng.</i> <b>17</b>, 63â€“89 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1146%2Fannurev-bioeng-071813-104938" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1146/annurev-bioeng-071813-104938" data-track-item_id="10.1146/annurev-bioeng-071813-104938">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2MXhvFOqsL%2FL" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26643018" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Viral%20vectors%20for%20gene%20therapy%3A%20translational%20and%20clinical%20outlook&amp;journal=Annu.%20Rev.%20Biomed.%20Eng.&amp;doi=10.1146%2Fannurev-bioeng-071813-104938&amp;volume=17&amp;pages=63-89&amp;publication_year=2015&amp;author=Kotterman%2CMA&amp;author=Chalberg%2CTW&amp;author=Schaffer%2CDV" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR31">Wilson, J. M. Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. <i>Mol. Genet. Metab.</i> <b>96</b>, 151â€“157 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.ymgme.2008.12.016" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.ymgme.2008.12.016" data-track-item_id="10.1016/j.ymgme.2008.12.016">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1MXjt1agtb0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19211285" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Lessons%20learned%20from%20the%20gene%20therapy%20trial%20for%20ornithine%20transcarbamylase%20deficiency&amp;journal=Mol.%20Genet.%20Metab.&amp;doi=10.1016%2Fj.ymgme.2008.12.016&amp;volume=96&amp;pages=151-157&amp;publication_year=2009&amp;author=Wilson%2CJM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR32">Knight, S., Collins, M. &amp; Takeuchi, Y. Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. <i>Curr. Gene Ther.</i> <b>13</b>, 211â€“227 (2013).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.2174%2F1566523211313030006" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.2174/1566523211313030006" data-track-item_id="10.2174/1566523211313030006">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC2cXpt1WnsL0%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23590635" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Insertional%20mutagenesis%20by%20retroviral%20vectors%3A%20current%20concepts%20and%20methods%20of%20analysis&amp;journal=Curr.%20Gene%20Ther.&amp;doi=10.2174%2F1566523211313030006&amp;volume=13&amp;pages=211-227&amp;publication_year=2013&amp;author=Knight%2CS&amp;author=Collins%2CM&amp;author=Takeuchi%2CY" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR33">Chandler, R. J. et al. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. <i>J. Clin. Invest.</i> <b>125</b>, 870â€“880 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1172%2FJCI79213" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1172/JCI79213" data-track-item_id="10.1172/JCI79213">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25607839" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319425" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Vector%20design%20influences%20hepatic%20genotoxicity%20after%20adeno-associated%20virus%20gene%20therapy&amp;journal=J.%20Clin.%20Invest.&amp;doi=10.1172%2FJCI79213&amp;volume=125&amp;pages=870-880&amp;publication_year=2015&amp;author=Chandler%2CRJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR34">Gene therapy needs a long-term approach. <i>Nat. Med</i>. <b>27</b>, 563 (2021).</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR35">Cho, R. J. et al. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. <i>Sci. Transl. Med.</i> <b>10</b>(455), eaas9668 (2018).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1126%2Fscitranslmed.aas9668" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1126/scitranslmed.aas9668" data-track-item_id="10.1126/scitranslmed.aas9668">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BC1MXisFemtLo%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30135250" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=APOBEC%20mutation%20drives%20early-onset%20squamous%20cell%20carcinomas%20in%20recessive%20dystrophic%20epidermolysis%20bullosa&amp;journal=Sci.%20Transl.%20Med.&amp;doi=10.1126%2Fscitranslmed.aas9668&amp;volume=10&amp;issue=455&amp;publication_year=2018&amp;author=Cho%2CRJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR36">Remington, J. et al. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. <i>Mol. Ther.</i> <b>17</b>, 26â€“33 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fmt.2008.234" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/mt.2008.234" data-track-item_id="10.1038/mt.2008.234">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtlyhur7O" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19018253" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Injection%20of%20recombinant%20human%20type%20VII%20collagen%20corrects%20the%20disease%20phenotype%20in%20a%20murine%20model%20of%20dystrophic%20epidermolysis%20bullosa&amp;journal=Mol.%20Ther.&amp;doi=10.1038%2Fmt.2008.234&amp;volume=17&amp;pages=26-33&amp;publication_year=2009&amp;author=Remington%2CJ" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR37">Marinkovich, M. P., Keene, D. R., Rimberg, C. S. &amp; Burgeson, R. E. Cellular origin of the dermalâ€“epidermal basement membrane. <i>Dev. Dyn.</i> <b>197</b>, 255â€“267 (1993).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1002%2Faja.1001970404" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1002/aja.1001970404" data-track-item_id="10.1002/aja.1001970404">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DyaK2c7it1Chuw%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8292823" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Cellular%20origin%20of%20the%20dermal%E2%80%93epidermal%20basement%20membrane&amp;journal=Dev.%20Dyn.&amp;doi=10.1002%2Faja.1001970404&amp;volume=197&amp;pages=255-267&amp;publication_year=1993&amp;author=Marinkovich%2CMP&amp;author=Keene%2CDR&amp;author=Rimberg%2CCS&amp;author=Burgeson%2CRE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR38">Supp, D. M. et al. Collagen VII expression is required in both keratinocytes and fibroblasts for anchoring fibril formation in bilayer engineered skin substitutes. <i>Cell Transplant.</i> <b>28</b>, 1242â€“1256 (2019).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1177%2F0963689719857657" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1177/0963689719857657" data-track-item_id="10.1177/0963689719857657">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=31271052" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767893" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Collagen%20VII%20expression%20is%20required%20in%20both%20keratinocytes%20and%20fibroblasts%20for%20anchoring%20fibril%20formation%20in%20bilayer%20engineered%20skin%20substitutes&amp;journal=Cell%20Transplant.&amp;doi=10.1177%2F0963689719857657&amp;volume=28&amp;pages=1242-1256&amp;publication_year=2019&amp;author=Supp%2CDM" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR39">Gorell, E. S., Nguyen, N., Siprashvili, Z., Marinkovich, M. P. &amp; Lane, A. T. Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. <i>Br. J. Dermatol.</i> <b>173</b>, 821â€“823 (2015).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fbjd.13737" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/bjd.13737" data-track-item_id="10.1111/bjd.13737">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:STN:280:DC%2BC2Mrns1Snug%3D%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25703736" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545744" data-track="click_references" data-track-action="pubmed central reference" data-track-value="pubmed central reference" data-track-label="link" data-track-item_id="link">PubMed Central</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Characterization%20of%20patients%20with%20dystrophic%20epidermolysis%20bullosa%20for%20collagen%20VII%20therapy&amp;journal=Br.%20J.%20Dermatol.&amp;doi=10.1111%2Fbjd.13737&amp;volume=173&amp;pages=821-823&amp;publication_year=2015&amp;author=Gorell%2CES&amp;author=Nguyen%2CN&amp;author=Siprashvili%2CZ&amp;author=Marinkovich%2CMP&amp;author=Lane%2CAT" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR40">Eng, V. A. et al. Patient reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: a global cross-sectional survey. <i>J. Am. Acad. Dermatol.</i> <b>85</b>, 1161â€“1167 (2021).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1016%2Fj.jaad.2020.03.028" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1016/j.jaad.2020.03.028" data-track-item_id="10.1016/j.jaad.2020.03.028">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32199895" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Patient%20reported%20outcomes%20and%20quality%20of%20life%20in%20recessive%20dystrophic%20epidermolysis%20bullosa%3A%20a%20global%20cross-sectional%20survey&amp;journal=J.%20Am.%20Acad.%20Dermatol.&amp;doi=10.1016%2Fj.jaad.2020.03.028&amp;volume=85&amp;pages=1161-1167&amp;publication_year=2021&amp;author=Eng%2CVA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR41">Koster, M. I. Making an epidermis. <i>Ann. NY Acad. Sci.</i> <b>1170</b>, 7â€“10 (2009).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1111%2Fj.1749-6632.2009.04363.x" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1111/j.1749-6632.2009.04363.x" data-track-item_id="10.1111/j.1749-6632.2009.04363.x">Article</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19686098" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Making%20an%20epidermis&amp;journal=Ann.%20NY%20Acad.%20Sci.&amp;doi=10.1111%2Fj.1749-6632.2009.04363.x&amp;volume=1170&amp;pages=7-10&amp;publication_year=2009&amp;author=Koster%2CMI" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR42">Marinkovich, M. P., Lunstrum, G. P., Keene, D. R. &amp; Burgeson, R. E. The dermalâ€“epidermal junction of human skin contains a novel laminin variant. <i>J. Cell Biol.</i> <b>119</b>, 695â€“703 (1992).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1083%2Fjcb.119.3.695" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1083/jcb.119.3.695" data-track-item_id="10.1083/jcb.119.3.695">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK38XmtlSkt7g%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=1383241" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=The%20dermal%E2%80%93epidermal%20junction%20of%20human%20skin%20contains%20a%20novel%20laminin%20variant&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.119.3.695&amp;volume=119&amp;pages=695-703&amp;publication_year=1992&amp;author=Marinkovich%2CMP&amp;author=Lunstrum%2CGP&amp;author=Keene%2CDR&amp;author=Burgeson%2CRE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR43">Choate, K. A., Medalie, D. A., Morgan, J. R. &amp; Khavari, P. A. Corrective gene transfer in the human skin disorder lamellar ichthyosis. <i>Nat. Genet.</i> <b>2</b>, 1263â€“1267 (1996).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1038%2Fnm1196-1263" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1038/nm1196-1263" data-track-item_id="10.1038/nm1196-1263">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaK28Xms1ajsbo%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Corrective%20gene%20transfer%20in%20the%20human%20skin%20disorder%20lamellar%20ichthyosis&amp;journal=Nat.%20Genet.&amp;doi=10.1038%2Fnm1196-1263&amp;volume=2&amp;pages=1263-1267&amp;publication_year=1996&amp;author=Choate%2CKA&amp;author=Medalie%2CDA&amp;author=Morgan%2CJR&amp;author=Khavari%2CPA" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li><li class="c-reading-companion__reference-item"><p class="c-reading-companion__reference-citation u-font-family-serif" id="rc-ref-CR44">Sakai, L. Y., Keene, D. R., Morris, N. P. &amp; Burgeson, R. E. Type VII collagen is a major structural component of anchoring fibrils. <i>J. Cell Biol.</i> <b>103</b>, 1577â€“1586 (1986).</p><p class="c-reading-companion__reference-links"><a href="https://doi.org/10.1083%2Fjcb.103.4.1577" data-track="click_references" data-track-action="article reference" data-track-value="article reference" data-track-label="10.1083/jcb.103.4.1577" data-track-item_id="10.1083/jcb.103.4.1577">Article</a>&nbsp;<a href="https://www.nature.com/articles/cas-redirect/1:CAS:528:DyaL2sXhsFelsLk%3D" data-track="click_references" data-track-action="cas reference" data-track-value="cas reference" data-track-label="link" data-track-item_id="link">CAS</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=3771648" data-track="click_references" data-track-action="pubmed reference" data-track-value="pubmed reference" data-track-label="link" data-track-item_id="link">PubMed</a>&nbsp;<a href="http://scholar.google.com/scholar_lookup?&amp;title=Type%20VII%20collagen%20is%20a%20major%20structural%20component%20of%20anchoring%20fibrils&amp;journal=J.%20Cell%20Biol.&amp;doi=10.1083%2Fjcb.103.4.1577&amp;volume=103&amp;pages=1577-1586&amp;publication_year=1986&amp;author=Sakai%2CLY&amp;author=Keene%2CDR&amp;author=Morris%2CNP&amp;author=Burgeson%2CRE" data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link">
                    Google Scholar</a>&nbsp;</p></li></ol></div></div>
        </div>
    </div>
</aside>
</div>


    
        
    
    
        
            
        

        
            
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>




<footer class="composite-layer" itemscope="" itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Nature Medicine
                    </span>
                    (<i itemprop="alternateName">Nat Med</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1546-170X</span> (online)
        </p>
    

                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">1078-8956</span> (print)
        </p>
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/company_info/index.html" data-track="click" data-track-action="about us" data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/npg_/press_room/press_releases.html" data-track="click" data-track-action="press releases" data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/" data-track="click" data-track-action="press office" data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home" data-track="click" data-track-action="contact us" data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex" data-track="click" data-track-action="journals a-z" data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects" data-track="click" data-track-action="article by subject" data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/" data-track="click" data-track-action="protocols.io" data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/" data-track="click" data-track-action="nature index" data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/authors/editorial_policies" data-track="click" data-track-action="Nature portfolio policies" data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nature-research/open-access" data-track="click" data-track-action="open access" data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints" data-track="click" data-track-action="reprints and permissions" data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/authors/research-data" data-track="click" data-track-action="data research service" data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/language-editing/" data-track="click" data-track-action="language editing" data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://authorservices.springernature.com/scientific-editing/" data-track="click" data-track-action="scientific editing" data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/" data-track="click" data-track-action="nature masterclasses" data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/" data-track="click" data-track-action="research solutions" data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/tools-services" data-track="click" data-track-action="librarian service and tools" data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal" data-track="click" data-track-action="librarian portal" data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/openresearch/about-open-access/information-for-institutions" data-track="click" data-track-action="open research" data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/gp/librarians/recommend-to-your-library" data-track="click" data-track-action="Recommend to library" data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/digital-advertising/" data-track="click" data-track-action="advertising" data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/" data-track="click" data-track-action="partnerships and services" data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/media-kits/" data-track="click" data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/product/branded-content-native-advertising/" data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/" data-track="click" data-track-action="nature careers" data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com" data-track="click" data-track-action="nature conferences" data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica" data-track="click" data-track-action="nature africa" data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com" data-track="click" data-track-action="nature china" data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia" data-track="click" data-track-action="nature india" data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly" data-track="click" data-track-action="nature Italy" data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp" data-track="click" data-track-action="nature japan" data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast" data-track="click" data-track-action="nature middle east" data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy" data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies" data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;" data-cc-action="preferences" data-track="click" data-track-action="manage cookies" data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice" data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/accessibility-statement" data-track="click" data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions" data-track="click" data-track-action="terms and conditions" data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa" data-track="click" data-track-action="california privacy statement" data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20">
    </a>
    <p class="c-footer__legal" data-test="copyright">Â© 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <!--?xml version="1.0" encoding="UTF-8"?--><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"></path></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"></path></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"></path></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"></path></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"></path></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"></path></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"></path></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"></path></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"></path></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"></path></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"></path></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"></path></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"></path></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"></path></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"></path></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"></path></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"></path></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"></path></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"></path></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"></path></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"></path></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"></path></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"></path></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"></path></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"></path></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"></path></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"></path></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"></path></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"></path></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"></path></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"></path></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"></path></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"></path></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"></path></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"></path></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"></path></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"></path><clipPath id="b"><use xlink:href="#a" style="overflow:visible"></use></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"></path><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"></path></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"></path></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"></path></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"></path></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"></path></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"></path></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"></path><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"></path><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"></path><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"></path></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"></path></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"></path></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"></path></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"></path></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"></path></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"></path></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"></path></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"></path></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"></path></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"></path></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"></path></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"></path></symbol></svg>
</div>
</footer>




    


    

<div class="c-site-messages message u-hide u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif c-site-messages--nature-briefing-transres" data-component-id="nature-briefing-banner" data-component-expirydays="30" data-component-trigger-scroll-percentage="15" data-track="in-view" data-track-action="in-view" data-track-category="nature briefing" data-track-label="Briefing banner visible: TranslationalResearch">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: TranslationalResearch">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing: Translational Research" src="/static/images/logos/nature-briefing-logo-transres-white-1245a3c374.svg" width="213" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing: Translational Research</em> newsletter â€” top stories in biotechnology, drug discovery and pharma.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/translational_research" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: TranslationalResearch">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="TransResBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="TransResBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required="" data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:translational_research" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required="">
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close" data-track="click" data-track-category="nature briefing" data-track-label="Briefing banner dismiss: TranslationalResearch">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get what matters in translational research, free to your inbox weekly.</span>
            <a class="nature-briefing__link text14 sans-serif" data-track="click" data-track-category="nature briefing" data-track-label="Small-screen banner CTA to site" data-test-element="briefing-banner-link" target="_blank" rel="noreferrer noopener" href="/briefing/translational-research/?brieferEntryPoint=TransResBriefingBanner">Sign up for Nature Briefing: Translational Research
            </a>
        </div>

    </div>

</div>

    




<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41591-022-01737-y&amp;format=js&amp;last_modified=2022-03-28" async=""></script>

<dox-efgsujugheci></dox-efgsujugheci><div data-cc-ghost="" style="height: 352px;"></div><script type="text/javascript" id="fetch-contextual-ads-campaign-data" charset="">(function(){var g=function(a){a=new CustomEvent("campaignDataLoaded",{detail:a});document.dispatchEvent(a)},b=google_tag_manager["rm"]["50443292"](18);if(b){var k=1500;b=google_tag_manager["rm"]["50443292"](19);b="link"===b?google_tag_manager["rm"]["50443292"](20):google_tag_manager["rm"]["50443292"](21);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(","):null))};d.open("GET",
"/platform/contextual?doi\x3d"+a);d.send()},n=function(a,c){a&&-1===a.indexOf("not set")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds="",g(null)})();</script>
<script type="text/javascript" id="gtm-setup-accessdetailsloaded-handler" charset="">document.addEventListener("accessdetailsloaded",function(a){a=a.detail||{};var b={event:"update-access-details"};a.institutional_business_partner_ids&&a.resolved_by||console.log("BPID data could not be retrieved from /exposed-details");a.logged_in_to_sn_profile||console.log("logged_in_to_sn_profile could not be retrieved from /exposed-details");var c=a.institutional_business_partner_ids&&a.institutional_business_partner_ids.join?a.institutional_business_partner_ids.join(";"):"",d=a.resolved_by&&a.resolved_by.join?
a.resolved_by.join(";"):"",e=a.personal_business_partner_id_found,f=a.logged_in_to_sn_profile,g=a.snid;b.user={};b.user.profile={};b.user.profile.profileInfo={resolvedBy:d||null,bpid:c||null,personal:e||null,logged_in_to_sn_profile:f,snid:g||null};b.session={};b.session.authentication={};b.session.authentication.token=a.token||null;b.session.authentication.legacy={};window.dataLayer.push(b);window.idpUserDataLoaded=!0},!1);window.dataLayer.push({event:"accessdetailsloaded-handler-added"});
window.accessDetailsLoadedHandlerAdded=!0;</script><script type="text/javascript" id="gtm-mediatrust" charset="">var s=document.getElementsByTagName("script")[0],p=document.createElement("script");p.async="async";p.src="https://scripts.webcontentassessor.com/scripts/93dabb8d80079a87fec7bb6f67b807fce90e1688f8957ad7ad152bfd58ea01c2";s.parentNode.insertBefore(p,s);</script><script id="crossmark-script" text="" charset="" type="text/javascript" src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script><script type="text/javascript" id="polyfill-matches" charset="">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script><script type="text/javascript" id="fetch-idp-user-data" charset="">(function(a){if("function"===typeof window.CustomEvent)return!1;var c=function(d,b){b=b||{};var e=document.createEvent("CustomEvent");e.initCustomEvent(d,b.bubbles||!1,b.cancelable||!1,b.detail||a);return e};c.prototype=window.Event.prototype;window.CustomEvent=c})();var parse=function(a,c){try{return 200===a?JSON.parse(c):null}catch(d){return null}},dispatch=function(a){a=new CustomEvent("accessdetailsloaded",{detail:a});document.dispatchEvent(a)},site=google_tag_manager["rm"]["50443292"](59),idpUrl;
switch(site){case "nature":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?"https://staging-idp.nature.com/exposed-details":"https://idp.nature.com/exposed-details";break;case "link":idpUrl=-1<window.location.hostname.indexOf("link-qa")?"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details";break;case "springer":idpUrl=-1<window.location.hostname.indexOf("local-www")||-1<window.location.hostname.indexOf("test-www")?
"https://staging-idp.springer.com/exposed-details":"https://idp.springer.com/exposed-details"}if(void 0!==idpUrl){var transport=new XMLHttpRequest;transport.open("GET",idpUrl,!0);transport.withCredentials=!0;transport.onreadystatechange=function(){4===transport.readyState&&dispatch(parse(transport.status,transport.responseText))};transport.send()}else dispatch(null);</script><script src="https://verify.nature.com/verify/nature.min.js"></script><script type="text/javascript" id="create-ad-slots" charset="">function createAndLoadAds(){function h(b){"nature"===a&&google_tag_manager["rm"]["50443292"](87)(b);"bmc"!==a&&"springeropen"!==a||google_tag_manager["rm"]["50443292"](99)(b);("link"===a&&"oscar"===google_tag_manager["rm"]["50443292"](100)||"springer"===a||"link"===a&&!0===google_tag_manager["rm"]["50443292"](101))&&google_tag_manager["rm"]["50443292"](126)(b);"link"===a&&"bunsen"===google_tag_manager["rm"]["50443292"](127)&&google_tag_manager["rm"]["50443292"](152)(b);"link"===a&&"Core"===google_tag_manager["rm"]["50443292"](153)&&google_tag_manager["rm"]["50443292"](165)(b)}window.googletag=window.googletag||{cmd:[]};var a=google_tag_manager["rm"]["50443292"](166),e=google_tag_manager["rm"]["50443292"](168);
if(-1===window.location.search.indexOf("hide_ads\x3dtrue"))if(window.adSlots&&0!==Object.keys(window.adSlots).length)console.log("Ads previously loaded. Will not update ad slots until next page load.");else{window.adSlots||(window.adSlots={});window.getAd=function(b,f){for(var c in window.adSlots)if(-1<c.indexOf(b)){if("object"===f)return adSlots[c];if("slot"===f)return adSlots[c].slot}};googletag.cmd.push(function(){googletag.pubads().setPrivacySettings({limitedAds:e});console.log("limitedAds is ",
e);googletag.pubads().setRequestNonPersonalizedAds(google_tag_manager["rm"]["50443292"](170));googletag.pubads().enableSingleRequest();googletag.pubads().disableInitialLoad()});for(var g=document.querySelectorAll("[data-gpt]"),d=0;g[d];++d)h(g[d]);googletag.cmd.push(function(){googletag.enableServices()})}}createAndLoadAds();</script>
</body></html>